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Magnetic resonance chemical shift imaging can provide chemical information about 
biological tissue. However, 1H MR shift imaging in vivo is a much less exploited 
technique than standard MRI, due to the presence of strong NMR signals from water 
and fat. Paramagnetic lanthanide(III) complexes, in which a tert-butyl reporter group is 
incorporated, can be used to shift a proton resonance ±80 ppm from the water signal 
allowing selective observation. The proximity of the paramagnetic lanthanide(III) ion 
enhances the longitudinal relaxation rates of the surrounding nuclei, permitting faster 
data acquisition per unit time. 
The chemical shifts of paramagnetically shifted proton resonances, within kinetically 
stable macrocyclic lanthanide(III) complexes, inherently encode temperature 
information. The introduction of a phosphonate group adjacent to the tert-butyl 
reporter group introduces pH responsive behaviour. The dual sensitivity of such probes 
has allowed the simultaneous triple imaging of the water signal and the shifted 
tert-butyl signals of thulium(III) and dysprosium(III) complexes of a common ligand, 
separated by over 160 ppm. Spectral imaging experiments in vivo allow the pH and 
temperature of the liver, kidney and bladder to be measured within a mouse model. 
Further modification of the ligand structure changes the biodistribution profile of the 
complex whilst maintaining and even improving the chemical shift and relaxation rates 
of the probe.  
In-depth structural and NMR analysis of a series of lanthanide complexes based on 
different ligand motifs has demonstrated that the MR properties of a paramagnetic 
complex cannot be readily predicted using the longstanding theories of shift and 
relaxation. Seemingly small modifications to ligand structure can significantly alter the 
size, magnitude, sign and orientation of the magnetic susceptibility tensor. 
Finally, introduction of a specific zinc(II) ion chelating agent adjacent to the tert-butyl 
reporter group has created the first zinc(II) responsive paramagnetic probe for proton 
magnetic resonance spectroscopy. The strong and selective binding of zinc(II) was 
shown to be reversible.  
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1. Introduction 
Magnetic resonance (MR) is one of the most important tools in diagnostic medicine 
and biomedical research due to its ability to give anatomical information of the soft 
tissue with high spatial resolution. It is a non-ionising technique that measures the 
signals from relaxing nuclei to distinguish between different environments within the 
body. 
The nucleus typically observed in clinical magnetic resonance imaging is 1H which, 
within water, makes up over 50% of the atoms in the body. Additionally, the 1H 
nucleus is a good candidate for MR detection owing to its 100% natural abundance, 
simple nuclear spin angular momentum (I = ½) and high gyromagnetic ratio 
(γ = 42.6 MHz T-1), arising from the presence of a large magnetic moment.  
The signal intensity within an MRI image is dependent on the proton density and the 
longitudinal (T1) and transverse (T2) nuclear relaxation times of protons within a 
biological tissue. Pulse sequences can be designed to emphasise variations in T1 or T2 
and can be referred to as T1-weighted or T2-weighted scans. Proton density, T1 and T2 
values vary between different biological tissues, and it is these differences that enable 
tissue discrimination. 
Whilst MRI is an important and powerful clinical imaging technique, the information 
gained from such scans is indirect, only the bulk water of tissue is imaged. The direct 
imaging of metabolic processes or endogenous probes is challenging, owing to the 
inherently low sensitivity of the NMR experiment. The lack of sensitivity leads to poor 
resolution, poor contrast and long scan times. 
1.1 Contrast-enhanced MRI 
Current MRI contrast agents available clinically are synthetic probes used to enhance 
contrast in MRI scans. The agents are not visualised directly, rather the contrast 
enhancement arises from the modulation of the relaxation rates of water protons in 
close proximity to the agent. T1 contrast agents generally increase the longitudinal 
relaxation rates, R1 (R1= 1/T1), of the surrounding water molecules, increasing the MRI 
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signal intensity in regions where the probe accumulates, referred to as positive 
contrast. Conversely, T2 agents increase the transverse relaxation rates, R2 (R2 = 1/T2), 
of protons thus yielding a reduction in MRI signal in areas of higher probe 
concentrations, known as negative contrast. The change in contrast an MRI probe 
produces is dependent on its effectiveness in enhancing the surrounding protons’ 
relaxation rates (relaxivity) and the concentration of the probe in that location. 
Most clinically used MRI contrast agents are T1 agents, due to their positive image 
contrast. Typically, these probes are complexes of paramagnetic metal cations. The 
large oscillating magnetic moments arising from the unpaired electrons of such 
complexes provide additional relaxation mechanisms for surrounding protons. The 
trivalent lanthanide cations are an obvious choice for T1-weighted contrast agents due 
to their large number of unpaired electrons. Gadolinium(III) is the metal ion present in 
all lanthanide-based contrast agents currently in clinical use, as it has the highest spin 
paramagnetism arising from seven unpaired electrons. However, it does not possess 
the largest magnetic moment of the lanthanides with both dysprosium(III) and 
holmium(III) displaying larger moments due to orbital contributions to angular 
momentum.1 The electronic states of Dy3+ and Ho3+ are asymmetric, causing rapid 
electronic spin relaxation rates, whereas the isotopic distribution of electrons in Gd3+ 
leads to a symmetric S state. This symmetry gives rise to a much slower electronic spin 
relaxation rate that is much closer to the proton Larmor frequency and this allows 
faster relaxation of surrounding proton nuclei. The efficiency of a contrast agent to 
enhance the relaxation rates of protons with respect to the contrast agent 
concentration is referred to as relaxivity. The relaxivity is dependent on several factors, 
including the number of metal bound water molecules (q) and the mean residence 
time of bound water. 
The Gd3+ aqua ion is toxic (LD50 ≈ 0.1 mmol/kg) due to its similar size to Ca2+, which is 
vital in cell signalling processes; hence the need to encapsulate the cation within a 
kinetically and thermodynamically stable multidenate ligand or chelate.2 Due to the 
core-like nature of the 4f orbitals and their large ionic radius, the trivalent lanthanide 
ions favour complexes with high coordination numbers of 8 or 9. For imaging purposes 
these ligands are typically based upon polyaza-carboxylate ligands and may be acyclic 
(e.g. DPTA) or cyclic (e.g. DOTA) in nature (Figure 1.1). The majority of agents in clinical 
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use are non-specific extracellular agents, which distribute throughout the plasma and 
interstitial space in the body. They are typically excreted via the kidneys with a half-life 
of about 1.5 h.1 
 
Figure 1.1   Structures of selected DPTA- and DOTA- based clinically-approved Gd3+-based 
contrast agents. 
1.2 Magnetic Resonance Spectroscopy 
Magnetic Resonance Spectroscopy (MRS) is the clinical use of NMR spectroscopy. The 
presence and relative concentrations of analytes are probed directly by NMR within a 
region of interest (ROI), rather than looking at the bulk water signal. Unlike traditional 
MRI, which only yields structural images, MRS provides direct biochemical information 
on tissue using the frequencies (chemical shift) and relative intensities (integrals) of 
the observed NMR signals of metabolites (or exogenous probes). 
MRS may be performed on a single voxel (single voxel spectroscopy - SVS) or multiple 
voxels (magnetic resonance spectroscopic imaging - MRSI or chemical shift imaging - 
CSI). Protons are the ideal nuclei for use in in vivo spectroscopy due to their high 
natural abundance in tissues and high magnetic sensitivity compared to other 
magnetically active nuclei. However, the intense background 1H signals arising from 
the high concentrations of water and fat found in tissues require the use of signal 
suppression techniques to ensure other resonances of interest can be detected. 
Spectra must typically be run with water suppression and currently this technique has 
found most use in studies of the brain.3  
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1.3 Heteronuclear MRS 
One method of avoiding the endogenous background signal problems arising from 1H 
MRS is to perform heteronuclear MRS instead. Any NMR active (I > 0) nucleus, such as 
31P, 13C, and 19F, of endogenous metabolites or exogenous probes can be measured to 
report tissue information.  
1.3.1 31P MRS 
Initial studies into heteronuclei focused on 31P due to its I = ½ nuclear spin, 100% 
natural abundance, large NMR shift range and biological relevance. Although the 
spectroscopic sensitivity of 31P is lower than 1H, the measurement of phosphorus-
containing metabolites in the millimolar range has been achieved. The quantitative 
measurement and ratios of certain metabolites, such as adenosine triphosphate (ATP), 
phosphocreatine (PCr) and inorganic phosphate (Pi), can reveal various pathologies.4–7 
The frequency of the 31P chemical shift has also been utilised to measure pH in vivo 
non-invasively. Moon and Richards demonstrated that the difference between the two 
31P chemical shifts of the glycolytic intermediate 2,3-diphosphoglycerate (2,3-DPG – 
Figure 1.2) can be used as a measure of pH.8 In vitro experiments showed that the 
relative shift separation of the 2-phosphate (pKa = 7.0) and 3-phosphate (pKa = 6.3) 
resonances varied by 1 ppm between pH 5 to 8 and could be used to estimate the 
intracellular pH of erythrocytes. However, both resonances experience a large 
chemical shift change upon interaction with deoxyhaemoglobin, resulting in the 
requirement of an additional calibration step in order to accurately measure pH. 
Numerous additional pH-sensitive phosphorus metabolites have been identified and 
studied as potential intra- and extra-cellular pH indicators; including, PCr, Pi and 
3-aminopropylphosphonate (3-APP – Figure 1.2).9,10 
Phenylphosphonic acid (PPA – Figure 1.2) has also been proposed as an exogenous 31P 
MRS probe of extracellular pH in vivo. In vitro experiments on muscle tissue perfused 
with sodium phenylphosphonic acid enabled the measurement of pH between 6.4 -7.6, 
as the phosphonate 31P resonance shifted 1.12 ppm per pH unit. An additional benefit 
of the use of PPA is that the 31P chemical shift is found at 12.8 ppm which is relatively 
isolated from endogenous phosphorus-containing compounds. 
Chapter 1: Introduction 
5 
 
Figure 1.2   Structures of selected pH responsive 31P MRS indicators. 
1.3.2 13C MRS 
Carbon is one of the most abundant elements in biology and the use of MRS to 
monitor metabolites in vivo is an attractive prospect. The larger chemical shift range 
allows for improved resolution compared to 1H MRS. However, the natural abundance 
of the magnetically active 13C (I = ½) is only 1.1% and the magnetic sensitivity of the 
nucleus is also diminished compared to 1H. Thus, the intrinsic signal-to-noise ratio 
(SNR) of 13C is much lower compared to 1H and 31P. There are two methods by which 
the sensitivity of 13C MRS can be improved: labelling and hyperpolarisation. 
Exogenous isotope labelling of 13C into metabolic substrates such as glucose, lactate 
and acetate allows for imaging of these compounds and their metabolic pathways with 
effectively zero background.11 Increasing the abundance of 13C through isotopic 
labelling can be challenging and expensive. Additionally, even labelled species suffer 
from the inherently lower magnetic sensitivity of the 13C nucleus so that long scan 
times are still required. 
To further enhance the NMR response and increase the SNR of 13C, hyperpolarisation 
of the nuclear spins can be achieved. Hyperpolarisation allows the imaging of nuclei 
that have much lower sensitivity (low γ). In the case of 13C, hyperpolarisation is usually 
accomplished by dynamic nuclear polarisation (DNP). The technique utilises microwave 
irradiation to transfer polarisation from unpaired electrons to nuclei. It is carried out at 
low temperature (< 4 K), at 3 T and the presence of a free radical doping agent is 
required. The signal of such nuclei can be enhanced for a short period of time by more 
than 10,000-fold.12 
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Hyperpolarised 13C-labelled metabolites provide the potential for mapping metabolic 
process and pathways. Several in vivo studies have evaluated the distribution of 
[1-13C]pyruvate and its metabolic products, lactate, alanine and bicarbonate.13–15 
Whilst the technique shows promise, the polarised spins are unstable and will relax 
back to thermal equilibrium according to the longitudinal relaxation rates. Hence, 
scans must be completed within minutes after hyperpolarisation, limiting the clinical 
application of 13C MRS. 
1.3.3 Noble Gas MRI 
Hyperpolarisation has also been utilised to image other magnetically active 
heteronuclei. The use of hyperpolarised gases allows the direct visualisation of the 
airspace of the lung (Figure 1.3). Inert noble gases such as 3He and 129Xe (I = ½) are 
typically hyperpolarised by spin-exchange optical polarising (SEOP).16 Although 3He has 
a higher magnetic sensitivity, the low natural abundance has led to the increased use 
of 129Xe which accounts for 26% out of the 9 naturally abundant isotopes. Subjects 
inhale the isotopically enriched, hyperpolarised gas and images must be acquired 
within a single breath hold.17,18 
 
Figure 1.3   Ventilation MRI images of healthy lungs with 3He (top row) and 129Xe (bottom 
row).17 
1.3.4 19F MRS 
The 19F nucleus (I = ½) is a promising candidate for heteronuclear MRS. It has the 
highest magnetic sensitivity of all heteronuclei and is 100% naturally abundant. An 
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additional advantage of 19F is its trace presence in vivo. Whilst, there are high local 
concentrations of fluorine found in the bones and teeth, it is not visible by 
conventional MR methods due to extremely short T2 arising from immobilisation.19 
This lack of background signal means that the 19F resonances of fluorinated probes 
offer much higher SNR than 1H and 31P based probes. 19F NMR has previously been 
used to track the in vivo drug metabolism of fluorine atom-containing therapeutics, 
including that of the prodrug 5-fluorocytosine (5-FC). A study in 1999 found 19F NMR to 
be a non-invasive method to observe the enzyme-catalysed conversion of the prodrug 
into the chemotherapeutic agent 5-fluorouracil (5-FU).20 However, the in vivo 
experiments required a large dosage in order to give acceptable image quality. A 
serum concentration of ~900 mg/L was required, whereas in humans a maximum 
serum concentration of ~50 mg/L is recommended.21 
As with all MR techniques 19F NMR has inherently low sensitivity and to achieve an 
image with a sufficiently high SNR, either the concentration of the nucleus must be 
high or an increase in the number of transients of the pulse and acquisition sequence 
is needed. Increasing the number of nuclei present either per molecule of probe or 
through packaging a greater number of probe molecules into nanoparticles has been 
shown to have a direct effect on sensitivity.22,23 Probes such as perfluorocarbons 
(PFCs), which are simple organic compounds in which all the hydrogen atoms have 
been substituted by fluorine, increase the number of 19F nuclei per probe. However, 
perfluorotributylamine (PFTA) and other PFCs such as perfluorooctylbromide (PFOB) 
suffer from the appearance of chemical shift artifacts which arise from the presence of 
inequivalent 19F environments. In MRI, spatial position is frequency encoded in one 
direction, so when two differently shifted systems are in the same location they are 
seen at different frequencies, hence are not located in the same place within the 
image. There are NMR techniques that can reduce these effects,24,25 but more recent 
developments of simple organic 19F probes have focused on symmetrical 
perfluoropolyethers, due to the presence of many equivalent nuclei which give a single 
sharp resonance in the 19F NMR.26,27 These PFCs have the advantage of being 
chemically inert and non-toxic. However, they are usually extremely insoluble in water 
and hence have to be emulsified before being locally injected.19  
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Increasing the number of scans is not usually a practical option without vastly 
increasing total overall scan times. This is particularly true for small diamagnetic 
compounds in which the observed 19F nucleus has a long longitudinal relaxation time, 
T1. The longitudinal relaxation time determines the delay time between each pulse. A 
delay time approximately 5 times that of the T1 is typically required to ensure full 
recovery of net magnetisation before the subsequent pulse. Therefore, the repetition 
time of the pulse sequence is long, with a significant proportion of ‘dead time’ where 
no data is being acquired (Figure 1.4). 
 
Figure 1.4   Example of a simple MRS pulse sequence where at = acquisition time, dt = delay 
time and TR = repetition time. The total scan time is given by n(TR). 
A solution to this problem would be to increase the relaxation rate of the nucleus to 
allow for rapid pulsing, giving a shorter pulse repetition time and thus increasing the 
number of scans that can be taken per unit time. This has been achieved by the 
incorporation of a standard gadolinium contrast agent into the lipid monolayer 
surrounding a liquid PFC core, creating a nanoparticle that could be administered in a 
water soluble emulsion. The method was found to shorten the 19F T1 by up to 75%, but 
had a larger effect on T2. The linewidth of the signals increased drastically, decreasing 
the observed signal intensity.28 Another method is to introduce 19F nuclei into a 
kinetically stable paramagnetic complex (Figure 1.5). The effects of paramagnetism on 
the NMR properties of surrounding nuclei are discussed in further detail in Sections 1.4 
and 1.5. 
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Figure 1.5   Structures of selected paramagnetic 19F probes. 
Incorporation of CF3 reporter groups within paramagnetic complexes results in the 
enhancement of the chemical shift and relaxation rates of the 19F nuclei. Parker and 
co-workers designed a number of 19F MRS probes based on lanthanide complexes of 
1,4,7,10-tetraazacyclododecane (cyclen).29–37 The paramagnetic complexes of [LnLA]+ 
(Figure 1.5), a CF3-labelled mono-amide derivative of the tricarboxylate macrocycle 
(DO3A), increased the longitudinal relaxation rate of the reporter nuclei dramatically 
compared to the diamagnetic species.32 However, the presence of diastereoisomers of 
the complex resulted in multiple 19F resonances. The modification of ligand from 
carboxylate to methylphosphinate, [LnLA’]+ (Figure 1.5), both increased the signal 
intensity of the major species and resulted in faster nuclear relaxation. The 
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dicarboxylate analogue, [LnLB] (Figure 1.5), was also investigated, as the C2 symmetric 
complex should double the number of equivalent 19F nuclei.32  
A different method to maximise 19F nuclei within a probe was explored by Yu and co-
workers.38 The perfluoro-tert-butyl group of [LnLC], appended to a DO3A macrocycle 
via an oxyethylene chain, gave a single resonance corresponding to the 9 equivalent 
protons.38 Modest increases in relaxation rates were found upon complexation with 
paramagnetic ions such as Gd3+, Tb3+ and Cu2+. The authors suggested that the probe 
could be used as a multi-chromic 19F tracer by following different metal complexes 
independently by the different chemical shifts of the (C(CF3)3) reporter group. 
However, due to the length of the oxyethylene linker, the chemical shift variance 
across the entire series tested was <8 ppm. The in vivo measurement of 
paramagnetically broadened resonances with such small frequency variations would 
be difficult to achieve. The tetra-amide, C4-symmetric complex [LnLD]3+ has been 
proposed as a potential probe for 19F.39 The complex contains 12 magnetically 
equivalent 19F nuclei that exist as a single resonance. It was found that the Fe2+ 
complex demonstrated the most potential as an imaging probe due to its favourable 
relaxation properties. Recently, 19F-containing, paramagnetic Ni2+ complexes, such as 
[LnLE]2-, have also been investigated.40,41  
In general, the successes of heteronuclear imaging, as described above, have largely 
failed to translate to clinical use. The use of isotope enrichment and hyperpolarisation 
methods are technically demanding and expensive, preventing widespread use of 
nuclei with extremely low natural sensitivity. MRS of heteronuclei with higher 
sensitivities, such as phosphorus and fluorine, still suffers from reduced sensitivity 
when compared to proton scans. Additionally, the imaging of heteronuclei requires 
specialist coils associated with non-proton MRI.42 As such, protons remain the ideal 
nuclei for use for in vivo spectroscopy due to the ability to use existing clinical scanners 
with no hardware modifications.  
1.4 The effect of paramagnetism on chemical shift 
Direct detection by MRS of a proton-containing tracer molecule is possible, even at low 
concentration, by exploiting the paramagnetic shift phenomenon encountered in 
Chapter 1: Introduction 
11 
metal complexes with an anisotropic magnetic susceptibility. The reporter signal can 
be shifted away from the diamagnetic window (0 – 12 ppm), allowing its visualisation 
against a zero background (Figure 1.6).  
 
Figure 1.6   Schematic demonstrating paramagnetically-shifted 1H proton resonances away 
from the diamagnetic window (containing water and fat resonances) against zero background. 
The effect of paramagnetic species on NMR signals has been noted since the very 
beginnings of NMR.43–46 In the 1950s, Bloembergen and Dickinson observed 
unexpected shifts in the NMR resonances of paramagnetic solutions, and subsequently 
suggested that some paramagnetic ions possess magnetic anisotropy, i.e. the 
magnitude of the electron-induced magnetic susceptibility varies with orientation 
(Figure 1.7).47 A nucleus ‘sees’ the time-averaged magnetic moment of unpaired 
electrons, which is non-zero when the populations of the electronic states are not 
equal to one another. Such a situation occurs when there is a Boltzmann distribution 
across different low-lying energy states, e.g. across the crystal-field splitting in the J 
manifold in f-block compounds, or due to zero-field splitting and spin-orbiting coupling 
in d-block systems. 
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Figure 1.7   The nucleus ‘N’ feels the dipolar magnetic field of an unpaired electron ’e-‘, which 
subtracts (A, C) or adds (B, D) to the external field. Rotational motion averages these to zero 
for isotropic fields (A, B) but to non-zero for anisotropic fields (C, D). 
Unpaired electrons of paramagnetic compounds can therefore produce a large, 
temperature-dependent contribution to the observed shift (obs) of a nucleus, which 
adds to the orbital diamagnetic (dia) term, and is often referred to as the hyperfine 
shift. Although there are many possible contributions to the hyperfine shift, only the 
pseudocontact term (PCS) and/or the Fermi contact term (FCS) are usually considered, 
as other contributions are negligible (Equation 1.1): 
𝛿𝑜𝑏𝑠 =  𝛿𝑑𝑖𝑎 + 𝛿𝐹𝐶𝑆 + 𝛿𝑃𝐶𝑆 (1.1) 
The Fermi contact contribution, FCS, is proportional to the fraction of the unpaired 
electron spin density present ‘in contact’ with the nucleus of interest. In molecular 
orbital theory this can be thought as the value of the square of the electronic 
wavefunction at a particular nucleus. The pseudocontact term, δPCS, describes the 
dipolar interaction (through-space) of the ligand nuclei and unpaired electrons on the 
metal ion and depends upon the geometry of the complex. A dipolar shift can only 
occur in complexes that have magnetic anisotropy; the dipolar coupling of isotropic 
complexes will average to zero with molecular tumbling in solution. In transition metal 
complexes, generally both δFCS and δPCS contribute to the observed chemical shift. 
However, in lanthanide complexes there is little delocalisation of electrons onto the 
ligand and so δFCS is only important for atoms directly bonded to the paramagnetic 
centre, as it rapidly attenuates with the number of separating bonds.48  
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1.4.1 The pseudocontact shift 
A molecule containing unpaired electrons will produce a net magnetisation when 
placed in a strong magnetic field. This induced magnetisation produces a new 
magnetic field in the vicinity of the molecule, in addition to the static field of the 
spectrometer. The magnitude of the additional field at a particular nucleus depends on 
both the distance of the nucleus from the metal ion and the angle between the 
nucleus and the principal axes of the magnetic susceptibility tensor of the lanthanide 
ion, as given by Equation 1.2:49 




2 𝜃 − 1) + 3𝛸𝑟ℎ sin
2 𝜃 cos 2𝜑] (1.2) 
where θ, φ and r are the polar coordinates of the nucleus with respect to the principal 
axis of the magnetic susceptibility tensor, 𝛸, and 𝛸𝑎𝑥 and 𝛸𝑟ℎ are the axial and 
rhombic components of the magnetic susceptibility tensor defined as: 
𝛸𝑎𝑥 =  𝛸𝑧𝑧 −  
1
2
(𝛸𝑥𝑥 + 𝛸𝑦𝑦) (1.3) 
𝛸𝑟ℎ =  𝛸𝑥𝑥 −  𝛸𝑦𝑦 (1.4) 
The 𝛿𝑃𝐶𝑆 of a particular nucleus within the ligand structure is therefore dependent on 
its geometry with respect to the principal (easy) axis of the magnetic field. The r-3 
dependence arises from the dipolar nature of the nucleus-electron interaction and 
affects the magnitude of the pseudocontact shift. There is also an angular dependency 
with respect to the principal magnetic axis, usually resulting in a change in both the 
magnitude and sign of 𝛿𝑃𝐶𝑆. A 3D scalar field can be used to represent the angular 
dependence of the 𝛿𝑃𝐶𝑆 and within the same ligand, depending on their location, 
nuclei can be shifted in opposite directions. The pseudocontact shift (PCS) field can be 
modelled using the assigned chemical shifts and solution structure of a given complex. 
A ‘best-fit’ traceless susceptibility tensor can then be used to model the axiality, 𝛸𝑎𝑥, 
and rhombicity, 𝛸𝑟ℎ, of the anisotropic magnetic susceptibility (Figure 1.8).
50 
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Figure 1.8   Ideal pseudocontact shift (PCS) field representing an ideally axial (left) and ideally 
rhombic (right) 𝝌 tensor. Positive PCS is shown in red, negative in blue.51 
 The tensor can be described using appropriate Euler angles, typically α, β and γ, which 
specify the orientation of the susceptibility tensor with respect to the chosen 
molecular frame. 
However, the necessity for full assignment and analysis of the pseudocontact shifts 
make application of Equation 1.2 challenging and simplification can be achieved 
through consideration of the electronic energy levels of the lanthanide ion.  
The electronic energy levels of lanthanide ions can be described using the Russell-
Saunders coupling scheme. For a free lanthanide ion the total spin, S, angular 
momentum, L, can be used to give the total angular momentum, J. The energy levels 
can be described by an overall term symbol using these quantum numbers: 
(2S+1)LJ 
In the Russell-Saunders coupling scheme, electronic repulsion (spin-spin coupling) is 
the largest interaction, and spin-orbit coupling further divides these energy levels to 
different J states. Upon complexation within a chelating ligand the electron cloud and 
symmetry of the lanthanide ion is disturbed, resulting in further 2J+1 splitting of the 
energy levels (mJ states). It is generally assumed that the crystal field splitting is 
smaller than that of the spin-orbit coupling. The crystal field splitting arises from the 
perturbation of the lanthanide ion electron cloud by all other electrons in the system 
(i.e. of the chelating ligand). These electrostatic interactions can be described by the 
rank crystal field parameters, 𝐵𝑞
𝑘, which are directly linked to the symmetry of the 
complex.52 In lanthanide systems k = 0, 1, …, 7; however, only the even values of k are 
responsible for crystal field splitting. Values of q are limited by the point group of the 
lanthanide ion, and non-zero (k, q) combinations are restricted and can be determined 
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from the point group symmetry elements. The crystal field, in some cases, can be 
determined by detailed examination of the Eu3+ emission spectrum.52,53  
The axiality and rhombicity of the magnetic susceptibility tensor may be described by 
the second order crystal field parameters and lanthanide ion type by Equations 1.5 and 
1.6, first proposed by Bleaney.54 














where CJ is the Bleaney coefficient for a specific lanthanide, μB is the Bohr magneton, 
𝐵0
2 and 𝐵2
2 are the second order crystal field splitting parameters. The Bleaney 
constant, CJ, for a given lanthanide ion can be described by Equation 1.7: 
𝐶𝐽 =  𝑔
2𝐽(𝐽 + 1)(2𝐽 − 1)(2𝐽 + 3)⟨𝐽|𝛼|𝐽⟩ (1.7) 
where ⟨𝐽|𝛼|𝐽⟩ is a numerical coefficient specific to a particular fn configuration, g is the 
electron g-factor (Landé) and J the total angular momentum quantum number.54 The 
pseudocontact shift can therefore be more simply expressed by Equation 1.8: 





(3 cos2 𝜃 − 1)
𝑟3
𝐵0
2 +  




The pseudocontact shift is then proportional to the Bleaney constant, which varies 
with the electronic configuration of the lanthanide ion. Thus, the direction (sign) and 
magnitude of 𝛿𝑃𝐶𝑆 can be manipulated through lanthanide selection (Table 1.1).  
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Table 1.1   Overview of parameters affecting the pseudocontact shift for the ground states of 








































































a The normalised (to Dy3+ = -100) values of CJ are typically quoted. 
b The ground state of Eu3+ exhibits no angular momentum however thermal population of low 
lying excited states sees anisotropy arising from J=1 and J=2 states.54 
Bleaney’s theory has proved to be a useful approximation for estimating the 
pseudocontact shifts of nuclei within a paramagnetic complex. However, several 
assumptions are made that should be considered and scrutinised.  
Firstly, in both Equations 1.2 and 1.8, the dipole of the unpaired electrons of the 
lanthanide ion is considered to be located at a single point on the lanthanide nucleus. 
The metal-centred point-dipole approximation fails to accurately evaluate the spatial 
distribution of the electron spin. The approximation has the greatest impact on nuclei 
in close proximity to the lanthanide ion. Recently, numerical methods have been 
utilised to better describe the distribution model of the f-electron density probability 
functions.55–57 The quadrupole approximations of the f-electron charge clouds were 
modelled by Rinehart and Long using the angular dependencies of the 4f orbitals. The 
shape was found to vary between prolate (axially extended) and oblate (equatorially 
expanded) across the lanthanide series.58 The variation across the series explains the 
change in sign seen in the magnetic anisotropy, as predicted by the Bleaney constant, 
CJ. 
Bleaney’s theory relies on the approximation that the ligand field splitting is much less 
than kT (205 cm-1 at 298 K), whilst also ignoring the contribution of higher order ligand 
field parameters. It has been shown that values of 𝐵0
2 can be as high at 1500 cm-1 and 
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typically coordination complexes have 𝐵0
2 values at least double kT.59,60 The higher 
order crystal field terms that contribute to the overall crystal field splittings (e.g. 𝐵0
4, 
𝐵0
6) are completely neglected by Bleaney’s theory. Inclusion of these higher order 
parameters has been shown to result in large disparities from the use of only the 
second order parameters, especially in complexes of lower symmetry.61–64 With larger 
ligand field splitting, the Russell-Saunders coupling scheme may not be appropriate for 
the relatively heavy lanthanide elements. As the ligand field splitting energies become 
of similar magnitude to the spin-orbit coupling energies, J-mixing can occur. The 
uncertainty of the energy levels increases and the quantum number J, used to 
calculate CJ, can no longer be assumed to be a ‘good’ quantum number. 
It was also assumed by Bleaney that within an isostructural series of complexes the 
position of the magnetic axis does not vary with lanthanide. In this case, the 
pseudocontact shift for a given nucleus should only vary linearly with CJ. Recent studies 
have unequivocally demonstrated this assumption to be false.50,60,65–67 Whilst in some 
circumstances the pseudocontact shift variation can be explained by dramatic 
structural variations,68 in many cases there is no obvious explanation for the 
anomalous shift behaviour. 
In complexes with small crystal field splittings it might be expected that the 
assumptions of Bleaney’s were reasonable. However, in the case of a series of 
lanthanide  complexes of a C3-symmetric, 1,4,7-triazacyclononane-based (TACN) 
ligand, [LnLF], the magnitude and sign of the 1H chemical shifts did not correlate with 
Bleaney’s theory (Figure 1.9).69 In particular, for the Dy3+ analogue the observed 
pseudocontact shift was found to be the opposite sign to that expected. Additionally, a 
large solvent dependence of the chemical shifts was observed beyond that expected 
from the diamagnetic Y3+ complex. Through CASSCF-SO and DFT calculations it was 
shown that a small change in angle (1°) of the three axial oxygen donors could induce 
significant variation to the magnetic susceptibility. The donor atom angle was found to 
vary between lanthanides and was hypersensitive even to solvent polarity. 
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Figure 1.9   (Top) Structure of [LnLF] and pyridine assignments. (Bottom) Variation of the 1H 
pseudocontact shifts of the three pyridyl resonances of [LnLF] as a function of the Bleaney 
constant, CJ (D2O, 295 K).69 
1.4.2 Employing Paramagnetic Shift  
Due to the large chemical shifts induced by the anisotropy of the magnetic 
susceptibility and predictable coordination chemistry of the trivalent lanthanides, they 
offer a great deal of potential as paramagnetic ions for NMR applications. The early 
1970s saw an increased interest in the systematic application of paramagnetic shift 
reagents as tools for the organic chemist to elucidate NMR spectra of molecules with a 
large number of overlapping resonances,70,71 and enantiomerically pure lanthanide 
complexes have since been used as chiral shift reagents.72,73 Paramagnetic shift agents 
have also been employed for solid state protein structural elucidation,74,75 and have 
been investigated as potential in vivo shift agents for 23Na+.76 
Paramagnetically shifted proton signals, such as nuclei in the local chelating ligand 
structure of a paramagnetic metal centre, can resonate at frequencies significantly 
shifted away from the usual diamagnetic range, enabling PARAmagnetically SHIFTed 
MRI probes, coined ‘PARASHIFT’ probes, to be imaged in vivo.77 Paramagnetic-induced 
hyperfine shifts have also been exploited in the field of Chemical Exchange Saturation 
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Transfer (CEST) imaging over the last 20 years,78–80 although the long scan times, 
continual irradiation with saturating frequencies, and problems associated with 
inhomogeneities in the field, limit the potential use of ‘PARACEST’ in humans.  
1.5 The effect of paramagnetism on nuclear relaxation 
In addition to the hyperfine shift, paramagnetic centres can also enhance the 
relaxation rates of surrounding nuclei, which can be exploited to enhance sensitivity. 
The unpaired electrons provide addition relaxation mechanisms compared to 
analogous diamagnetic systems. In paramagnetic lanthanide complexes there are two 
dominant relaxation mechanisms; commonly referred to as the dipolar and Curie 
terms. These contributions both originate from the through-space interactions of the 
electronic and nuclear magnetic moment dipoles.  
The dipolar mechanism describes the dipolar interactions between the magnetic 
moment of the resonating nucleus and fluctuating electronic magnetic moment of the 
lanthanide(III) ion. The unpaired electron spins produce fluctuating magnetic fields 
that can induce nuclear spin transitions as a relaxation pathway. It is dependent on the 
electronic relaxation rate of the metal ion and rotational correlation time of the 
molecule. 
The Curie term arises from the dipolar coupling between the time-averaged electronic 
magnetic moment and the nuclear magnetic moment. This time-averaged moment 
arises from a small difference in the population of energy spin levels according to a 
Boltzmann distribution. This interaction is not dependent on electronic relaxation as it 
is already time averaged but does have a dependency on molecular tumbling and the 
effective magnetic moment. 
The paramagnetic relaxation enhancement have classically been described by the 
Solomon-Bloembergen-Morgan (SBM) equations (Equations 1.9 and 1.10) which are 
derived from Bloch-Redfield-Wangsness (BRW) theory81,82 and give a summation of the 
dipolar and Curie term for both R1 and R2.83–86 
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where μ0 is the vacuum permeability, γN is the gyromagnetic ratio of the nucleus 
relaxing, r is the electron- nuclear distance, τr is the rotational correlation time of the 
molecule, ωN is the nuclear Larmor frequency, ωe is the electron Larmor frequency, μeff 
is the effective magnetic moment of the lanthanide(III) ion (Equation 1.11) and τc is the 
total correlation time in the absence of chemical exchange (Equation 1.12). 
𝜇𝑒𝑓𝑓
2 =  𝑔𝐿𝑛
2𝜇𝐵
2𝐽(𝐽 + 1) (1.11) 
𝜏𝑐
−1 =  𝜏𝑟
−1 +  𝜏𝑒
−1 (1.12) 
in which 𝑔𝐿𝑛 is the Landé factor of the fundamental multiplet J of the free Ln
3+ ion and  
τe is the relaxation time of the electron spin.  
Both the longitudinal and transverse relaxation rates are governed by the same 
parameters and are proportional to the magnetic field strength. At lower fields, the 
dipolar term dominates. However, with increasing field strengths the Curie term is 
dominant. Whilst there is a geometric dependence within the SBM relaxation 
equations, both the dipolar and Curie relaxation mechanisms are assumed to depend 
only on the nucleus-lanthanide distance and have no angular dependency. However, 
during the course of the work undertaken in this thesis it has been demonstrated 
experimentally that this assumption is inadequate and there is a strong angular 
dependence of both the dipolar and Curie nuclear relaxation rates.87 This analysis has 
led to a reappraisal of the key equations used to define paramagnetic relaxation. 
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1.6 PARASHIFT probes for imaging 
In order to be employed as in vivo imaging probes, PARASHIFT agents need to be water 
soluble, stable in solution, and non-toxic at the appropriate imaging concentrations. 
Compared with other imaging techniques (radionuclear imaging, luminescence 
imaging) MRI is insensitive and maximising the SNR is integral to probe design. Ideally, 
the reporting proton resonance must be shifted as far away as possible from the 
endogenous protons, so that a large excitation bandwidth can be used to allow the use 
of fast imaging sequences.77 In addition to the hyperfine shift, paramagnetic centres 
can also enhance the relaxation rates of surrounding nuclei, which can be exploited to 
enhance sensitivity. The paramagnetic induced nuclear relaxation gives rise to rapid 
longitudinal relaxation rates, R1, facilitating fast-pulsed NMR techniques. An ideal rate 
is in the region of 100 s-1, allowing for pulse sequences of the order of milliseconds.33 
The linewidth of the reporting resonance, however, needs to be narrow to avoid SNR 
losses due to T2. 
1.6.1 Lanthanide choice 
The selection of the paramagnetic centre affects both the shift and relaxation 
properties of the PARASHIFT probe. From Equation 1.8 (see Section 1.4.1, page 15) we 
can see that that the Bleaney constant of a metal will affect both the magnitude and 
sign of the pseudocontact shift (Table 1.2). Of the lanthanides, the ions Dy3+ and Tb3+ 
have the largest negative Bleaney constants, -87 and -100 respectively. The lanthanide 
ion with largest positive Bleaney constant is Tm3+, +53. The same proton within the 
Tm3+ complex of an isostructural ligand is expected to experience a pseudocontact 
shift of the opposite sign and smaller magnitude than that of Dy3+ and Tb3+.  
Lanthanide ion choice also affects the nuclear longitudinal and transverse relaxation 
rates through variations in the magnetic moment, μeff, and electronic relaxation time, 
τe. It is clear from Equations 1.9 and 1.10 (see Section 1.5, page 20) that an increase in 
μeff will result in an increased relaxation rate so the lanthanide ion must be chosen 
with this in mind. Tb3+, Dy3+, Ho3+, Er3+ exhibit the largest magnetic moments (9.4 to 
10.4 BM) and Tm3+ has a marginally smaller moment (7.6 BM), (Table 1.2). However, 
whilst at higher field strengths the magnetic moment is important due to the 
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dominance of the Curie term, most current clinical MRI instruments operate at 1.5 or 
3 T. At these lower field strengths the dipolar term has the major influence on the 
relaxation rates and hence the size of τe has an increased impact. The electronic 
relaxation time is a function of both the lanthanide ion and the local ligand field; values 
of τe for lanthanide(III) complexes typically fall within the range of 10-12 to 10-13 s-1.88 
Upon inspection of the reported electronic relaxation rates of the hydrated lanthanide 
ions, Ho3+ and Tb3+ appear to be less favourable candidates due to their slightly shorter 
electronic relaxation time. However, the size of τe cannot yet be predicted for novel 
lanthanide coordination complexes.  
Whilst a fast longitudinal relaxation rate, R1, allows the use of fast pulse NMR 
techniques, it should be noted that the transverse relaxation rate, R2, should not be 
too fast. The linewidth of NMR signals are proportional to the transverse relaxation 
rate and hence when R2 is increased the sensitivity is limited. Intrinsically the 
transverse relaxation rate must always be equal or larger than longitudinal relaxation 
rate (R2 ≥ R1). Therefore, a balance must be sought in order to maximise R1. A shorter 
T2 results in increased line broadening and hence an R1/R2 as close to unity is 
desired.33,77,88 
Table 1.2   Magnetic and relaxation properties of selected lanthanide(III) ions. 



































(a) Taken from reference.89 (b) As aqua ion, 2.1 T, from references.90–92 
1.6.2 Ligand design 
It is imperative that PARASHIFT probes are kinetically and thermodynamically stable 
with respect to metal ion dissociation, as much like Gd3+, other free Ln3+ ions are highly 
toxic and unstable complexes can trans-metallate in the body.93 Kinetic and 
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thermodynamic stability with respect to the dissociation of the metal ion are required. 
As with Gd3+-based MRI contrast agents, macrocyclic ligands possessing both oxygen 
and nitrogen donors are most commonly utilised in PARASHIFT probes.  Such probes 
are typically functionalised derivatives of cyclen. The additional chelating groups 
typically are amides, carboxylates or phosphinates. In order to maximise signal 
intensity and minimise exchange broadening of a reporter signal it is preferred that a 
metal complex exists as one major conformation. Therefore, it is important to consider 
the symmetry, assess the possibility of forming diastereoisomers, and study the 
exchange dynamics of potential imaging resonances.94 In complexes based on cyclen, 
at least two different forms of chirality arise, as illustrated by [LnDOTA(H2O)]- in Figure 
1.10. The torsion angle of the NCCN link in the macrocyclic ring can have either a 
positive of negative sign, which define a δ or λ conformation, respectively. 
Additionally, the NCCX (X = O in the case of [LnDOTA(H2O)]-) torsion angle of the 
exocyclic pendant arms can be described as either positive or negative, which 
describes the Δ or Λ helicity, respectively, of the complex. The two modes of chirality 
result in four potential stereoisomers of two enantiomeric pairs. Existing as square 
antiprisms, the conformations can be described as twisted square antiprismatic (TSAP) 
or square antiprismatic (SAP). Typically in slow exchange on the NMR timescale, both 
diastereoisomers are often observed by NMR, however the ratio of SAP to TSAP varies 
between ligand structures and even across a set of lanthanide complexes of the same 
ligand. 
In complexes containing chiral phosphinate chelators, the additional centre of chirality 
at the P atom introduces many more potential diastereoisomers.  
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Figure 1.10   Schematic representation of the coordination geometries of [LnDOTA(H2O)]- and 
those typically adopted by octadentate cyclen-based complexes. The bound water molecule 
has been omitted for clarity. 
In order to achieve a single, sharp resonance, as needed to maximise the SNR, the 
number of magnetically equivalent nuclei of the reporter resonance should be as large 
as possible. This can be achieved through increasing symmetry, as well as the use of 
homotopic reporter groups such as methyl groups (3 equivalent protons) or tert-butyl 
groups (9 equivalent protons). 
Additionally, and perhaps most importantly, the geometry of the reporter with respect 
to the lanthanide ion and magnetic axis should be carefully considered. It has been 
shown in Equations 1.2 and 1.8 (see Section 1.4.1, pages 13 and 15) that the 
pseudocontact shift has a dependence on the internuclear distance of r-3. Therefore, in 
order to induce the maximum chemical shift, the nucleus should be placed as close as 
possible to the lanthanide ion. However, the relaxation rate is also dependent on the 
internuclear distance with both longitudinal and transverse relaxation rates (Equations 
1.9 and 1.10, see Section 1.5, page 20) containing an r-6 dependence. A balance must 
be achieved in which R1 is enhanced sufficiently without increasing R2 drastically. An R2 
value above approximately 300 s-1 results in the NMR signal being prohibitively 
broadened. Simulations of the relaxation rates against internuclear distance show that 
R2 reaches this limit at ~5.8 Å. Hence, the reporter nucleus should not be found closer 
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to the lanthanide than this, in order to reduce losses in sensitivity due to line 
broadening (Figure 1.11). 
 
Figure 1.11   Simulated variation using SBM theory of 1H longitudinal, R1, (red) and transverse, 
R2, (blue) relaxation rates with the Ln3+-1H internuclear distance, r (295K, B = 7 T, μeff = 10.4 BM, 
τe = 0.45 ps, τr = 350 ps). 
The angular dependence is harder to model. Predicting the optimum geometry of the 
reporter group with respect to the principal magnetic axis is very challenging as the 
orientation of the major component of the susceptibility tensor cannot be determined 
ab initio. 
An additional parameter that affects the relaxation rate is the rotational correlation 
time, τr, which describes the tumbling motion of molecules in solution. If this tumbling 
occurs at a similar frequency to the energy gap between the nuclear spin states, the 
rate of transitions between them can be increased. The motion is dependent on the 
size, shape and dynamics of the molecule and the properties of the solvent. The effect 
of the variation of the rotational correlation time on both R1 and R2 as modelled using 
SBM theory is shown in Figure 1.12. As the energy gap of spin states is field strength 
dependent, the modulation of τr varies with the magnetic field. At 7 T, R2 increases 
much more rapidly than R1, especially when τr > 250 ps. This suggests that in order to 
maintain R1/R2 as close to unity as possible we may want to minimise molecular 
volume. However, at lower, clinically relevant, field strengths there is little variation 
between R1 and R2. 
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Figure 1.12   Simulated variation using SBM theory of 1H longitudinal, R1, (red) and transverse, 
R2, (blue) relaxation rates with the Ln3+-1H internuclear distance, τr at three different fields (7 T 
– solid, 3 T – dashed, 1.5 T – dotted) (295 K, B = 7 T, μeff = 10.4 BM, τe = 0.45 ps, r = 6.6 Å). 
1.7 Existing 1H PARASHIFT probes 
1.7.1 Lanthanide based MRS probes 
One of the first examples of chemical shift selective imaging with a paramagnetic 
complex was published in 1996 by Aime, Botta and co-workers, using the complex 
[YbLG]-, known as [YbDOTMA]- (Figure 1.13).95 The intense C4-symmetric methyl 1H 
signal, at -14 ppm (300 K, 4.7 T, R1 = 15 s-1, R2 ~ 30 s-1), was imaged selectively in 
phantoms at 4.7 T. This first proof-of-concept study successfully demonstrated that 
paramagnetic complexes could be imaged selectively in the presence of water at 
physiologically relevant concentrations (LD50 = 10.5 mmol/kg) (Figure 1.13). However, 
the 2D single slice imaging experiment took over 6 h to observe the signal from a 
3 mM solution.  
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Figure 1.13   (Left) Structure of [LnLG]. (Right) 2D spin echo chemical shift selective image of a 
phantom containing a series of aqueous solutions of [YbLG]- from 0 - 100 mM. Slice thickness 
4.5 mm, TE = 23 ms, relaxation delay = 150 ms, nt = 2048 (voxel size 1.8 mm3).95 
The NMR properties of other [LnLG]- complexes were investigated by Bansal and 
co-workers, and [TmLG]- was deemed the most suited to chemical shift selective 
imaging, with its sharp methyl resonance at -100 ppm (308 K).96 In 2014, Faber and 
co-workers successfully employed [TmLG]- in cell-labelling studies in vivo; the complex 
was internalised into HT-1080 (human fibrosarcoma) cells prior to injection, and 
tracked by MRI in mice for 8 days, at an equivalent dose of 1.6 mmol/kg.97 
In 2013, Parker and co-workers began to investigate the optimisation of a series of 
proton PARASHIFT lanthanide complexes, analysing both shift and relaxation 
properties, to inform judicious design of imaging probes.77 As the imaging sensitivity 
relies on the reporter group structure, its shift and relaxation properties,98 PARASHIFT 
probes were designed with a tert-butyl reporter group placed around 6.6 Å from the 
lanthanide(III) ion enclosed within a cyclen-based macrocycle ([LnLH] and [LnLI]+, Figure 
1.14) to optimise fast longitudinal relaxation, whilst negating SNR losses to T2.60,77 The 
tert-butyl group provides nine, in [LnLH], or eighteen, in [LnLI]+, magnetically equivalent 
1H nuclei, giving a relatively intense resonance found between -20.5 and +10.8 ppm 
(295 K) depending on the lanthanide ion and complex.77 Preliminary in vivo PARASHIFT 
imaging was performed on renally intact mice administered with clinically relevant 
doses (0.03 mmol/kg) of [DyLI]+ by intravenous injection, at 7 T. Short echo times 
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(4 ms) and a narrow excitation bandwidth of 5 kHz were used, to observe [DyLI]+ 
within skeletal muscles.77  
 
Figure 1.14   Structures of carboxylate Ln PARASHIFT probes optimised for imaging. 
In pursuit of better sensitivity, Parker and co-workers developed better PARASHIFT 
agents with reporter groups shifted much further and > 70 ppm from the water and fat 
signals so that shorter excitation pulses (i.e. wider excitation bandwidths) could be 
used. It was hypothesised that increasing the excitation bandwidth to 20 kHz would 
significantly speed up image acquisition.33 The structural modification from 
carboxylate ([LnLH]) to methylphosphinate ([LnLJ], Figures 1.14 and 1.15) chelating 
pendants was found to have a dramatic effect on the tert-butyl resonance frequency 
(Figure 1.15).60  
 
Figure 1.15   Schematic representation of the experimentally measured 1H chemical shifts of 
tert-butyl signals in [LnLH] (top) and [LnLJ] (bottom) (D2O, 295 K) (yellow – Tm, green – Er, 
magenta – Yb, black – Ho, red- Dy, blue –Tb). 
The chemical shift range of the tert-butyl resonances in [LnLJ], 140 ppm 
(+67 to -77 ppm), is significantly larger than the range of [LnLH], 32 ppm 
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(+11 to -21 ppm). The loss of the axially coordinating water molecule in the [LnLJ] 
complexes (with respect to [LnLH]) is the cause of this drastic increase in both shift and 
relaxation. The increase arises from a change in the size and orientation of the major 
axial component of the magnetic susceptibility tensor which points directly toward the 
reporting tert-butyl group (Figure 1.16).94,98,99 Further detailed studies of the hyperfine 
shift and relaxation properties of a range of tricarboxylate and triphosphinate cyclen 
macrocyclic lanthanide complexes have shown that even small ligand variations can 
induce very large changes in the magnetic anisotropy.60,99 
 
Figure 1.16   Pseudocontact shift field reconstructed using the best fit susceptibility tensor for 
[YbLH] (top) and [YbLJ] (bottom) created in Spinach.94 
The tert-butyl proton signal of [DyLJ] (Figures 1.15 and 1.17) resonates at -75 ppm 
(295 K), > 20 kHz away from the water signal at 7 T and is therefore suitable for fast 
imaging sequences.  
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Figure 1.17   1H NMR spectrum and structure of [DyLJ] (D2O, 9.4 T, 295 K).60 
The anionic bismethylphosphinate complex, [DyLK]-, (Figure 1.18), introduced a 
thiol-linked carboxylate onto the pyridine ring in order to improve its biodistribution 
with respect to the cationic, dimethylphosphinate analogue, [LnLI] (Figure 1.14).100 The 
anionic Dy3+ complex was imaged in vivo with an optimised 3D gradient echo (3DGE) 
sequence at 7 T. The 18 proton tert-butyl NMR signal was excited at -60 ppm using a 
20 kHz excitation bandwidth and much shorter echo times (TE = 1.45 ms, TR = 2.87 ms) 
and the image acquisition time was reduced to 60 s per 3D image (of 16 slices). An 
impressive detection limit of 23 μmol/dm3 was achieved at this temporal resolution, 
which allowed dynamic time series of images to be implemented to follow the kinetics 
of the molecular probe within the body, following a tail-vein injection of a single 
0.04 mmol/kg dose of [DyLK]- (Figure 1.18). 





Figure 1.18   (Top left) Time series analysis of PARASHIFT concentration from selected regions 
of interest in six mice. In vivo 3DGE imaging of renally intact mice administered with 
0.04 mmol/kg [DyLK]- by intravenous tail vein injection. Imaged using 7 T preclinical MRI 
system with a 39 mm birdcage RF coil, TE = 1.45 ms, TR = 2.87 ms, 20 kHz excitation 
bandwidth, voxel sixe = 32 mm3, 62s per 3D image set (of 16 slices). (Top right) Structure of 
[DyLK]-. (Bottom) PARASHIFT signal from [DyLK]- (colour scale) overlaid onto conventional 
structural MRI scans. Each column represents a different time point post injection. Within each 
column the data represent different spatial axial slices through the mouse.100 
Over the last 20 years several examples of PARASHIFT imaging have been reported 
using symmetrical cyclen-based macrocyclic lanthanide complexes that are relatively 
simple to synthesise, mainly by the groups of Hyder101–105 and Bansal,96,106,107 as well as 
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several optimised imaging probes synthesised by Parker and co-workers.100 The 
magnitude of the paramagnetic shift is sensitive to physiological conditions including 
temperature, and efforts to convey functionality to these imaging probes has been 
exploited in spectroscopic imaging techniques, leading to sensing applications in vivo.  
1.7.2 Temperature sensing 
MRSI can be performed with responsive contrast agents, using the chemical shift of a 
probe in order to map physiological parameters, such as temperature. The 
paramagnetic hyperfine shifts of PARASHIFT nuclei are inherently temperature 
dependent because the magnetic anisotropy derives from the Boltzmann population of 
the mJ energy states. Therefore, the chemical shifts of protons within PARASHIFT 
complexes vary with temperature as shown in Equation 1.8 (page 15). Bleaney’s theory 
indicates that the pseudocontact shift has a 1/T2 dependence. However, over small 
(physiological) temperature ranges an approximate linear dependence is observed and 
thus linear temperature coefficients are often quoted. 
The clinical temperature measurement of deep tissue requires the use of invasive 
probes. The rise of non-invasive thermal therapies for diseases, such as cancer, has 
increased the demand for an accurate deep tissue temperature measurement method. 
A number of non-invasive temperature monitoring MRI techniques have been 
developed.108 Currently, the most widely applied MRS thermometry method in the 
literature is the ‘proton resonance frequency’ technique, which exploits the 
temperature-dependent hydrogen-bonding of water protons; the proton resonance 
exhibits a linear shift response to temperature, with a very small temperature 
coefficient of 0.01 ppm/K.109,110 This low thermal sensitivity limits the error of 
temperature measurements to approximately 2 K,111 requires fat-suppression 
techniques, and is impractical for measuring small temperature differences in vivo. 
The intrinsic temperature sensitivity of paramagnetically shifted resonances has 
enabled the development of a new method for in vivo temperature measurement. 
Accurate thermometry requires the temperature coefficient to be significant enough 
for high temperature resolution, without being too large to cause spatial distortion in 
the frequency encoding dimension. It is important that the reporter signal has a 
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narrow linewidth, to ensure that chemical shift data can be readily extracted, and that 
it responds to temperature only, without shifting due to modulation of other external 
variables. 
In 1996, the complex [YbLG]- (Figure 1.13, pages 26 and 27) was proposed as a 
temperature-sensitive MRS probe and in vitro spectroscopic investigations of the 
methyl resonance revealed a linear 0.04 ppm/K temperature coefficient, four-times 
greater than that of water.95  
Meanwhile, Frenzel, Weinmann and co-workers began to investigate the thermometry 
properties of [PrLP] (Figure 1.19);112,113 the methoxy group at -24.1 ppm (295 K, relative 
to the water signal) was selectively imaged in 10 mM phantoms, and a linear shift 
dependence with temperature of 0.13 ppm/K was observed. 
 
Figure 1.19   Structures of selected temperature responsive MRS probes. 
The methoxy shift was shown to be independent of pH and was used to measure the 
absolute temperature of the liver in a rat model, and verified by a rectal thermocouple 
(deviation <±1 K), although a high dose was required for this study (1 mmol/kg). It was 
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later confirmed that the complex could be used to map temperature through the 2D 
spin echo spectroscopic imaging of phantoms.114–116  
A comparison of the NMR properties of [YbLG]- with the analogous Pr3+, Tb3+, Dy3+ and 
Tm3+ complexes showed that [TmLG]- had the greatest temperature coefficient, 
0.57 ppm/K, and its chemical shift was found to be insensitive to complex 
concentration, pH and the presence of Ca2+ ions.96 [TmLG]- was successfully employed 
for temperature mapping in rats with millimetre resolution, using a frequency selective 
pulse.102,106,107 However, these studies required surgical renal ligation and high doses 
of 1-2 mmol/kg in order to supress the fast clearance of [TmLG]- via the kidneys. 
Despite the remarkably short half-life of [TmLG]- in the blood (approximately 7 min), 
Sled and co-workers managed to measure the internal temperatures of the aorta, 
inferior vena cava and kidney within this time window at 11.7 T, following a single 
bolus injections of 0.7 mmol/kg within physiologically intact mice.117 
Zuo et al. investigated the Tm3+ complex of the tetraphosphonate ligand, known as 
DOTP ([TmLQ]5-, Figure 1.19) as a potential probe for MR thermometry.118 The Ln3+ 
complexes of DOTP had been originally studied as MR probes to distinguish intra- and 
extracellular concentrations of Na+ in vivo, by 23Na and 31P MR imaging.76,119  
The H6 proton signal of [TmLQ]5- (Figure 1.19) resonates at -142 ppm (310 K) with a 
relatively narrow line width (~300 s-1 at 7 T) and a significant linear temperature 
dependence of 0.89 ppm/K, allowing greater thermal resolution than with [TmLG]-. 
Similarly to [TmLG]-, the chemical shift of the [TmLQ]5- proton resonance is unaffected 
by pH (between 6.5 and 8.5), and in vivo thermometry was demonstrated in renally 
ligated rats, dosed with 1 mmol/kg of [TmLQ]5-.118 However, the sensitivity of the 
complex to variations in local Ca2+ concentration reduces the accuracy of the 
temperature measurement in vivo. 
Complexes of the C4 symmetric DOTA ligand, [LnLR]-, (i.e. analogous lanthanide 
complexes of the commercial gadolinium contrast agent Dotarem,1 Figure 1.19) have 
also been employed successfully as MSRI thermometry probes.120,121 The H5 resonance 
of the Tm complex, [TmLR]-, was observed at -227 ppm (310 K) and has a temperature 
coefficient of 0.91 ppm/K, and is insensitive to both pH and [Ca2+]. In vivo temperature 
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measurements were performed, at 9.4 T, on tumour-bearing mice infused with 1-2 
mmol/kg of [TmLR]- and with scan times of 4 min.121 Such a dose is generally regarded 
as being well beyond the safe dose for analogous Gd3+ MRI contract agents, and the 
ability to obtain fast temperature changes is limited by the acquisition time.  
The magnitude and temperature dependence of a paramagnetically shifted proton 
resonance is a property of both the lanthanide ion and the ligand structure. As 
demonstrated by the examples discussed above, complexes of Tm3+, with ligands of 
square antiprism based geometries, often have larger pseudocontact shifts and 
temperature sensitivities than predicted. This behaviour can be rationalised by 
considering the relative thermal population and anisotropy of the individual 
lanthanide(III) ion mJ states. Each mJ level will have different magnetic anisotropy, and 
the relative order and energy separation of the states is determined by the local ligand 
field. It is the weighted population of these states that determines the overall 
anisotropy, and therefore the pseudocontact shift and temperature dependence of a 
particular complex.50,64  
Caravan and co-workers investigated the use of the Yb3+ complex of DOTA, [YbLR]-, for 
potential multiplex imaging by encapsulating the complex inside liposomal nano-
carriers alongside a number of diamagnetic 1H chemical shift imaging probes for 
MRS.122 The liposomes contained a 1.2 M concentration of equivalent protons 
resonances of the diamagnetic probes and H2 of [YbLR]- and all resonances were 
acquired simultaneously. Phantom imaging revealed highly sensitive detection, 
liposome concentrations as low as 57 pM were observable. The addition of 
diamagnetic MRS probes, however, meant long repetition times were required, 
although the inclusion of a traditional T1 contrast agent into the liposome could be 
used to decrease this. 
Tetra-amide based lanthanide(III) complexes have been thoroughly investigated for 
use in PARACEST imaging, and in 2011 Hyder,123,124 Sherry and co-workers investigated 
the possibility of dual modality MRI by combining both the PARACEST and PARASHIFT 
imaging techniques to detect the Eu3+ complex of the carboxylate-appended tetra-
amide ligand ([EuLS]-, Figure 1.19) in phantom solutions.125 In vitro experiments of 
20 mM phantoms were performed, using MRSI to detect the non-exchangeable cyclen 
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proton H4, which has the largest temperature coefficient of 0.13 ppm/K. Direct MRSI of 
[EuLS]- revealed the concentration of the probe and temperature information for each 
voxel. CEST experiments generally rely on the local tissue quantity of the probe being 
known as the PARACEST molecule is imaged indirectly. However the MRSI data allowed 
for quantitative information to be gained from the subsequent CEST images as probe 
concentration was known. The in vitro experiment was performed at 11.7 T and 
required relatively high saturation powers for the CEST imaging, with long scan times 
for both techniques, MRSI (4.5 min) and CEST (7 min).  
Parker and co-workers have successfully used MRSI of PARASHIFT agents to map 
temperature information.77,100,126 MRSI was performed in vivo on renally intact mice, 
following intravenous injection of 0.04 mmol/kg of the dimethylphosphinate complex 
[DyLK]- shown in Figure 1.22 (temperature coefficient of the tert-butyl resonance was 
0.28 ppm/K in mouse plasma). A shift in the tert-butyl frequency between the bladder 
and the kidney was observed, indicating a 4 K difference in temperature between 
these organs, and imaging was performed at relatively high temporal resolution (63 s 
per image set).100 
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Figure 1.20   In vivo spectroscopic imaging of renally intact mice administered with 
0.04 mmol/kg of [DyLK]- by intravenous tail vein injection. (Top) Spectral grids for three of the 
MRSI slices acquired 1 minute after intravenous injection (Bottom left) Reconstructed 
PARASHIFT tissue distribution (derived from peak area for each voxel in 3DSI experiment) at 
1 minute and 25 minutes post injection.  (Bottom right) Spectra extracted from selected 
regions of interest. Imaged using 7 T preclinical MRI system with a 39 mm birdcage RF coil, TE = 
0.73 ms, TR = 7.69 ms, 20 kHz spectral width, 63s per data set.100 
1.7.3 Important considerations for in vivo imaging 
Many examples of responsive molecular PARASHIFT probes have been employed 
successfully in imaging experiments, mainly with the C4-symmetric DOTA-type 
lanthanide complexes [TmLG]- and [TmLQ]5-, and with certain tert-butyl labelled Dy3+ 
and Tm3+ macrocyclic complexes. In order for PARASHIFT imaging to have clinical 
relevance however, it is important to consider the dose and method of administration 
required to produce adequate image sensitivity, as well as the 
pharmacokinetics/biodistribution of the molecular probe, and their interactions with 
other physiological species e.g. proteins and endogenous cations.  
Most PARASHIFT agents studied to date suffer from a fast rate of clearance in the 
body, limiting the time-frame in which to image the molecular probe in organs other 
than the bladder to tens of minutes using a standard mouse model. Many early 
imaging studies were limited by the use of large doses (>0.1 mmol/kg, the clinical dose 
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advised for DOTAREM), the need for renally ligated animals to eliminate clearance 
pathways, or the application of continuous infusion of the PARASHIFT probe to 
maintain sufficient signal intensity.  
Hyder and co-workers encapsulated the complex [TmLQ]5- (Figure 1.19) in 
1,2-dipalmitoyl-sn-glycerophosphocholine (DPPC) liposomes in order to enhance local 
concentrations.127 In vitro MRSI experiments suggested signal amplification could be 
achieved using nanomolar amounts of liposomes, compared to free [TmLQ]5-. Recently, 
investigation of the co-infusion of [TmLQ]5- with an anionic transport inhibitor showed 
enhanced probe concentrations, albeit with high infusion doses of 1 mmol/kg.105  
Other approaches that can be employed to alter the pharmacokinetics involve 
changing the chemistry of the molecular probe; Parker found that anionic PARASHIFT 
complexes cleared slightly more slowly than structurally similar cationic 
complexes.77,100  Both Parker and Hyder have sought to reduce clearance rates by 
increasing the size of the molecular probe by conjugation to biopolymers37 or 
developing dendrimers containing [TmLR]-.128 Unfortunately, Hyder and co-workers 
found that the loss of the C4 structural symmetry resulted in the loss of sharp 
resonances and severe signal broadening was observed as the dendrimers increased in 
size.  
1.7.4 Transition metal probes 
Whilst the paramagnetic NMR properties of lanthanide complexes are better explored 
and understood, there have been some safety concerns about the use of lanthanide 
probes in patients with impaired kidney function. The medical community routinely 
use Gd3+-based contrast agents for MRI, but in 2006 links to the rare but severe illness 
nephrogenic systemic fibrosis were found.129 The European Medicines Agency has 
documented gadolinium accumulation in patients’ brain tissue, leading to restrictions 
in the use of one of the most commonly used contrast agents, [GdDTPA]-.130 There has 
been an impetus to look towards d-block metals to replace gadolinium contrast 
agents,131–133 and more recently the search for new PARASHIFT agents based on 
paramagnetic transition metal systems.  
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Morrow and co-workers have synthesised Fe2+ and Co2+ complexes using TACN and 
cyclen based ligands appended with 6-methyl-2-picolyl groups (Figure 1.21). These six-
coordinate aza-macrocyclic based ligands were found to stabilise the high-spin forms 
of Fe2+ and Co2+, due to the weaker ligand field produced as a result of the steric 
demand of the 6-methyl substituted pyridines. The cationic complexes are 
paramagnetic with an anisotropic magnetic susceptibility that gives rise to a large 
hyperfine shift.134–136 The transition metal complexes [MLL]2+ and [MLM]2+ were found 
to be kinetically inert in biological media and the chemical shifts are insensitive to 
variation of both pH (within physiological range) and the concentration of biological 
ions (HPO33-, HCO3-, Zn2+, Ca2+). A linear temperature dependence was observed for all 
complexes and the largest temperature coefficient was 0.52 ppm/K for [CoLM]2+.  
 
 
Figure 1.21   Structures of TACN and cyclen transition metal based PARASHIFT probes. 
More recently, the spectral behaviour of the reporter methyl groups in the di-picolyl 
complexes [MLN]2+ and [MLO]2+ has been investigated (Figures 1.21 and 1.22).136 The 
di-picolyl complex [MLN]2+ exhibited similar MR properties to the tetra-picolyl 
analogue, [MLM]2+. The picolyl-methyl shifts of each complex were shifted well outside 
the diamagnetic region, between -22 and -113 ppm (298 K). The additional methyl 
groups in [MLO]2+ were found to shift in the opposite direction to the picolyl methyl 
groups (Figure 1.22). The presence of two highly shifted resonances could allow for 
more accurate temperature measurements and the temperature coefficients ranged 
from 0.1 to 0.58 ppm/K. However, for both Co2+ complexes the linewidths of the 
methyl resonances were extremely broad reducing the potential for use in vivo. The 
linewidths of the analogous Fe complexes were significantly narrower, however they 
were less shifted. To date, no animal studies have been reported for these systems. 
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Figure 1.22   1H NMR of [FeLO]2+ at (10 mM complex, 100 mM NaCl, D2O, pD 7.2, 298 K). The 
proton resonances of pyridine and N-methyl groups on 12-N4 are labelled CH3-Pyr and CH3-N, 
respectively. Solvent peak is labelled “S”. Inset shows the effect of increasing temperature on 
the 1H resonance of N-CH3.136 
New and co-workers have also developed a Co2+ based PARASHIFT complex that 
exhibits a distinctive NMR response to the presence of certain anions in aqueous 
solution.137 The paramagnetically shifted N-Me resonance of CoMe6TrenCl was 
observed to give a distinctive spectral profile within the +180 - +130 ppm region 
following reversible binding of fluoride, citrate, lactate and acetate.  
Despite these in vitro spectroscopic studies with d-block PARASHIFT complexes, 
currently no imaging studies in vivo have been reported and optimised probes for 
imaging have not yet been designed. Little has been done in terms of modelling the 
shift and relaxation properties of paramagnetic d-block systems, where the contact 
shift is much more significant due to an increase in spin delocalisation onto the ligand 
in these coordination systems.138–141 
1.8 Project Aims 
The aim of this project is to synthesise and characterise novel paramagnetic lanthanide 
complexes for use as responsive 1H PARASHIFT probes. The research in this thesis will 
focus on the modification of the PARASHIFT probes developed in Durham to 
incorporate varying functionalities, seeking to optimise the chemical shift and 
relaxation behaviour of the complexes.  
The presence of a pH responsive, phosphonate group in close proximity to the tert-
butyl group will give the pseudocontact chemical shift of the reporter pH dependence 
in addition to the inherent temperature dependence. In vitro experiments have been 
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undertaken in order to investigate and calibrate the pH and temperature sensitivities. 
In vivo experiments on a mouse model demonstrate the ability of the probe for non-
invasive measurement by MRS. Structural modification of the ligand backbone is 
explored through the variation of the methylphosphinate groups to benzyl 
phosphinates and an increase in symmetry. In vitro experiments will be undertaken to 
explore the effects of these ligand modifications on the MR properties of the 
complexes. In vivo experiments will indicate how the biodistribution profile changes 
through ligand structure permutation in order to guide ligand design in the future.  
In order to further probe how ligand structure affects the paramagnetic NMR 
properties of such probes in-depth NMR investigations will be undertaken on 
analogous complexes with no pH responsive behaviour.  
Finally, a Zn2+ responsive probe will be sought through the incorporation of a specific 
Zn2+ chelating group (dipicolylamine). The Zn2+ chelating properties will be investigated 
using luminescence, solid state analysis, mass spectrometry and NMR methods. 
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2. Development of pH responsive PARASHIFT probes 
Whilst the hyperfine shifts of PARASHIFT agents have an inherent dependence upon 
temperature, the chemical shift may also be sensitive to other external variables, such 
as pH, which can be exploited for MRI sensing. 
Altered extracellular pH in vivo is associated with certain chronic diseases.1,2 There are 
very few clinical non-invasive methods to quantify pH in vivo. Preclinical studies have 
utilised heteronuclear 31P MRS to measure the chemical shift of pH sensitive, 
phosphorus-containing metabolites3 or probes.4 pH responsive 1H PARASHIFT 
molecular probes offer an alternative non-invasive MR technique that can be 
performed on existing clinical scanners with increased sensitivity.  
 
Figure 2.1   Structures of selected pH responsive 1H PARASHIFT probes. 
The complex [TmLQ]5- (Figure 2.1) has been used as a temperature responsive probe 
for MRS (see Section 1.7.3, pages 33 and 34). Additionally, each phosphonate group 
can protonate stepwise, giving rise to a pronounced pH dependence of the proton 
resonance frequencies.5 The chemical shift separation between selected pairs of 1H 
resonances was found to have a linear dependence that was negligibly affected by 
complex concentration, ionic strength and, most crucially, temperature; allowing for 
ratiometric measurement of pH. NMR measurements of pH were similarly achieved by 
Zuo and Sherry using [TmLQ]5-, where it was found that H6 (Figure 2.1) has a linear pH 
dependence of -3.27 ppm/pH unit in the pH range 5.5 to 7.5, albeit with a marked 
temperature dependence.6 A deconvolution of variables was therefore necessary to 
unravel the dependences, monitoring the chemical shifts of two different proton 
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signals with different response coefficients to each variable using simultaneous 
equations (Equations 2.1 and 2.2):  
∆𝛿(𝑖) = 𝐶𝑇(𝑖)∆𝑇 + 𝐶𝑝𝐻(𝑖)∆𝑝𝐻 
(2.1) 
∆𝛿(𝑗) = 𝐶𝑇(𝑗)∆𝑇 + 𝐶𝑝𝐻(𝑗)∆𝑝𝐻 (2.2) 
where CT(i), CpH(i), CT(j), CpH(j) are the linear coefficients of the temperature and pH 
dependence of the chemical shifts in [TmLQ]5-, as measured in vitro for protons i and j 
respectively. This technique was used to simultaneously measure the temperature and 
pH changes in live rats undergoing ultrasonic hyperthermia treatment, following 
intra-peritoneal injection of 0.15 mmol/kg of [TmLQ]5- (2 T).7 Analysis of the chemical 
shifts of H2 and H6 (Figure 2.1) allowed the measurement of temperature and pH that 
was concurrent with inserted pH electrode and thermocouple readings. Hyder and co-
workers used a similar method to measure the brain temperature and pH of rats by 
focusing on two pairs of proton resonances shifted either side of the water 
resonance.8,9 Animals were renally ligated and injected with 1.5 mmol/kg of [TmLQ]5- 
and each pair of resonances were acquired separately. Additional animal studies 
reduced the dose of complex to 1 mmol/kg and 2D CSI images of the brain (voxel size 
10.2 μL) were obtained in 6 minutes (11.7 T).10 The efficiency of the 2D and 3D 
mapping was further improved using spherical spatial encoding, which reduced the 
[TmLQ]5- dose to 0.5 mmol/kg, and increased the resolution (voxel size 1 μL) with 
5 minute scan times (11.7 T).11 Extracellular pH maps of rat brains were generated in 
animals bearing 9L and RG2 tumours,12 and the extracellular pH within tumours (7.0) 
was found to be lower than that in normal brain tissue (7.4) (Figure 2.2). 
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Figure 2.2   Representative extracellular pH maps of rats bearing (A) 9L and (B) RG2 tumours. 
(i)  T2-weighted image showing tumour localization (tumour = blue outline; brain = orange 
outline). (ii) A portion of the 3D chemical shift imaging (CSI) data for the slice in (i). (iii) 
Examples of spectra from intra-tumoural and peri-tumoural voxels. (iv) Quantitative maps of 
the extracellular pH were obtained using multiple [TmLQ]5- peaks and their respective pH 
sensitivities. Imaged using a 11.7 T horizontal-bore spectrometer, TR = 5 ms, SW = 35 kHz.12 
The complex [TmLQ]5- was also used to map the effectiveness of temozolomide 
treatment (a chemotherapy drug) on U251 tumours by monitoring the pH of the 
tumour and brain,13 and demonstrated that the pH of both tumour and brain tissue 
was higher in treated rats. Although these studies demonstrated the successful use of 
[TmLQ]5- to map temperature and pH in vivo, high doses of the probe were required 
together with renal ligation to supress rapid elimination of the hydrophilic complex.  
The phosphonate-appended tetra-amide complex [GdLT]5- (Figure 2.1) has been 
studied as a pH responsive T1 contrast agent because the relaxivity of the complex is 
pH dependent.14–16 Additionally, the Yb3+ and Tm3+ complexes have been investigated 
as dual PARACEST and PARASHIFT probes.17 The chemical shifts of the non-
exchangeable resonances were pH dependent, with the most sensitive measurement, 
5.2 ppm/pH unit (308 K), arising from the difference between H6 and H8 in [TmLT]5-. 
The chemical shift difference also varied with temperature, 0.3 ppm/K (308 K). 
Determination of pH and T simultaneously required two pairs of chemical shifts, H6-H8 
and H2-H3, each with different pH/T sensitivities. Phantom studies were used to 
compare the use of PARASHIFT and PARACEST in pH mapping which demonstrated 
that although CEST experiments could provide better spatial resolution PARASHIFT 
experiments had much higher pH sensitivities. High resolution pH mapping of [LnLT]5- 
may be feasible using a combination of PARACEST and PARASHIFT techniques. 
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However, further in vitro experiments are required to determine any sensitivity to 
biological cations, e.g. Ca2+ and Mg2+, before in vivo capability can be realised.  
In order for PARASHIFT imaging to have clinical relevance it is important to consider 
the dose and method of administration required to produce adequate image 
sensitivity. The pharmacokinetics/biodistribution of the molecular probe, and their 
interactions with other physiological species e.g. proteins and endogenous cations 
must also be considered. The in vivo experiments described above required high doses 
of probe (>0.1 mmol/kg) coupled with surgical renal ligation of the animal to reduce 
clearance rates, which inhibits the clinical application of such probes. 
The phosphonate groups in compounds such as [LnLQ]5- and [LnLT]5- are known to bind 
divalent metal ions, often forming stable adducts, and interferences from interactions 
with Ca2+ ions within the body may pose a problem for in vivo imaging.18 Although 
some studies have considered the effect of Ca2+ concentration,10 absolute 
determination of pH and/or T in vivo is impractical using these probes.  
 
Figure 2.3   Structures of selected pH responsive 19F PARASHIFT probes. 
Several pH responsive 19F PARASHIFT probes have been developed by Parker and 
co-workers (Figure 2.3).19–21 The use of aryl CF3 reporter groups in each complex 
results in three magnetically equivalent 19F nuclei in order to increase signal 
Chapter 2: Development of pH responsive PARASHIFT probes 
51 
intensity.19,20 The pH responsive behaviour of the complexes [LnLU] and [LnLV] was 
achieved through incorporation of a sulphonamide moiety that coordinates reversibly 
to the lanthanide(III) ion. Protonation of the sulphonamide N atom occurs around pH 
5.5, resulting in the breaking of the N-Ln bond. Exchange between the bound and 
unbound complexes is slow on the NMR timescale. As a result, pH could be measured 
with the complex [HoLV] by monitoring the ratio integrals of the 19F resonance of both 
species. Modification of the pH responsive group to an amide resulted in fast exchange 
between the protonated and deprotonated species and hence only one 19F resonance 
was observed (Figure 2.3 - [LnLW] and [LnLX]).20,21 The chemical shift of this resonance 
corresponded to the weighted average of the two species. Varying the aryl 
substituents was found to regulate the acidity of the amide hydrogen and therefore 
the pH sensitivity and pKa of the complex. The most promising results were found for 
the cyano-functionalised complex, [HoLX]. The complex was found to exist as two 
isomers due to restricted rotation of the amide C-N bond and a large change in the 19F 
chemical shift was observed between pH 5 and 9. Furthermore, the two isomers’ shifts 
exhibited different pH dependencies allowing potential use as a ratiometric pH probe 
removing the need for calibration. However, the requirement of specialised dual 1H 
and 19F MRI coils still limits the clinical applications of these probes. 
2.1 Trimethylphosphinate pH responsive PARASHIFT probe [LnL1]- 
The optimised PARASHIFT probes discussed previously in Section 1.7.1 (pages 27-31) 
show that in vivo PARASHIFT imaging can be achieved on renally intact mice 
administered via tail vein injection with clinically relevant doses (<0.1 mmol/kg). In 
order to introduce pH responsive behaviour to the highly shifted, previously described 
PARASHIFT, trimethylphosphinate probe [LnLJ] (see Section 1.7.1, pages 28-30), the 
incorporation of a phosphonate group adjacent to the tert-butyl reporter group was 
proposed (Figure 2.4). The arylphosphonate group has a pKa in the region of 7, similar 
to phenylphosphonate and is placed in close proximity to the reporter group in order 
that the protonation of this functional group will have an effect on the reporter 
chemical shift. 
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Figure 2.4   Structure of the trimethylphosphinate pH PARASHIFT probe, [LnL1]-. 
2.1.1 Synthesis of [LnL1]- 
The synthesis of [LnL1]- was carried out using a modification of reported procedures.22 
The synthesis of the trimethylphosphinate cyclen macrocycle intermediate, 5, is 
described in Scheme 2.1 and uses simple protecting group chemistry. Firstly, three of 
the cyclen amine sites were protected using benzyl chloroformate and triethylamine to 
create the tri-substituted carbamate, 1. The macrocyclic product was purified on silica 
gel to ensure separation from di- and tetra-substituted analogues. The remaining 
secondary amine group was protected using di-tert-butyl dicarbonate to yield the fully 
substituted macrocycle, 2. The benzyl carbamate protecting groups were then 
removed selectively via high-pressure hydrogenation, catalysed by Pd(OH)2/C, to 
afford the mono-tert-butyloxycarbonyl (BOC) protected cyclen product, 3. 
Condensation of 3 with paraformaldehyde in tetrahydrofuran led to the formation of 
an imine which was subsequently trapped by diethyl methylphosphonite to yield, via 
an Arbuzov reaction, the tri-phosphinate mono-BOC macrocycle, 4. The macrocycle 
was purified by alumina gel column chromatography. The BOC group was deprotected 
with trifluoroacetic acid (TFA) to give the trimethylphosphinate macrocycle, 5.  
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Scheme 2.1   The synthetic route to the trimethylphosphinate cyclen macrocycle, 5. 
The tert-butyl pyridine reporter moiety with a pH responsive phosphonate substituent 
in the 4-position was prepared as described in Scheme 2.2. The first step involved the 
introduction of the reporter tert-butyl group onto the pyridine ring, using a copper(I) 
cyanide catalysed Grignard alkylation, adapted from literature procedure.23,24 The yield 
of this reaction is rather low (~50%) as the tert-butyl alkylated product, 6, is produced 
in similar yield to the proton substituted by-product 2-methylpyridine. The tert-butyl 
product is volatile and column chromatography was avoided to reduce loss. Oxidation   
of the crude mixture of pyridines proceeded with meta-chloroperbenzoic acid 
(mCPBA). The 2-methylpyridine N-oxide produced from reaction of the by-product 
from the previous step and the mCPBA by-products were both removed by aqueous 
base washing to yield the N-oxide, 7. The pyridine 4-position was nitrated using a 
mixture of concentrated HNO3 and H2SO4 to form the 4-nitro product, 8. Reduction of 
the nitro group to the amine, 9, was achieved under high-pressure hydrogenation 
conditions, catalysed by Pd/C. A Sandmeyer reaction was used to generate the 
iodo-N-oxide pyridine compound, 10. The diazotisation step was achieved by reaction 
with nitrous acid, generated in situ using sodium nitrite and fluoroboric acid. Upon 
addition of potassium iodide, the aryl iodide, 10, was formed.  The iodo group was 
chosen due to the weak carbon-halogen bond and its enhanced ability to undergo 
oxidative addition, in order to encourage the subsequent cross coupling reaction. A 
Boekelheide rearrangement occurred upon heating 10 in acetic anhydride. The 
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phosphonate species, 12, was made via a palladium catalysed Arbusov-type reaction. 
Sodium ethoxide, formed by sodium metal in ethanol in situ, was used to cleave the 
acetate ester selectively, to yield the alcohol 13. The reactive mesylate, 14, was 
synthesised by reaction of the alcohol with triethylamine and methanesulfonyl 
chloride. 
Scheme 2.2   Synthetic route to the phosphonate tert-butyl pyridyl moiety. 
The alkylation of macrocycle 5 with the mesylate 14 proceeded as shown in Scheme 
2.3 to give the ethyl protected ligand, L1. The deprotection of both the phosphinate 
and phosphonate ethyl esters was achieved by stirring at 70 °C with 6 M HCl. Finally, 
the deprotected macrocycle was complexed with the appropriate hydrated 
lanthanide(III) chloride salt in water, maintaining the pH at 5.5. The complexes were 
purified by reverse-phase preparative HPLC yielding [LnL1]-, where Ln = Tb, Ho, Dy and 
Tm. High-resolution mass spectrometry and bulk magnetic susceptibility 
measurements were used to characterise each complex.  
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Scheme 2.3   General procedure for the synthesis of trimethylphosphinate pH PARASHIFT 
probe, [LnL1]-. 
The luminescence lifetimes of the Eu3+ and Tb3+ excited states were measured in both 
H2O and D2O in order to calculate the metal hydration state of the complex, q. Inner 
sphere water molecules are able to quench lanthanide excited states due to the similar 
energy of the high vibrational levels of O-H oscillators. The vibronic quenching is much 
poorer in D2O compared to H2O due to the poorer energy overlap of O-D vibrational 
levels. Hence, the number of bound water molecules may be estimated using 
Equations 2.3 and 2.4.25 
𝑞𝐸𝑢 = 1.2(𝑘𝐻2𝑂 −  𝑘𝐷2𝑂 − 0.25) (2.3) 
𝑞𝑇𝑏 = 5(𝑘𝐻2𝑂 − 𝑘𝐷2𝑂 − 0.06) (2.4) 
where 𝑘𝐻2𝑂 and 𝑘𝐷2𝑂 are the rate constants for luminescence decay. The q values for 
both [TbL1] and [EuL1] were both 0, consistent with the behaviour of the parent 
triphosphinate complex [LnLJ].  
2.1.2 Paramagnetic NMR studies of [LnL1]-: shift and relaxation 
The shift and relaxation properties of [LnL1]- were investigated using 1H NMR 
spectroscopy. Studies of [LnL1]- where Ln = Tb, Dy, Er and Tm were completed by Dr 
Katie-Louise Finney and are discussed here for comparison. 
Chemical shift data of [LnL1]- shows that the paramagnetic shifts of the tert-butyl 
reporter resonance are greater than those of the parent complex lacking a 
phosphonate group, [LnLJ] (Figure 2.5). The PARASHIFT tert-butyl resonance of the 
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probe resonated well beyond the diamagnetic region, and was observed at +74 ppm 
for the Tm complex and -78 and -83 ppm for the Dy and Tb complexes respectively.  
 
Figure 2.5   Schematic representation of the experimentally measured 1H chemical shifts of the 
major tert-butyl signals in [LnLJ] (top) and [LnL1]- (bottom) (D2O, 11.7 T, 295 K, pD 7.4) (yellow - 
Tm, green - Er, black - Ho, red - Dy, blue - Tb).  
As seen with previous triphosphinate species the complex exists in two main TSAP 
conformers that are in slow exchange on the NMR timescale.26 The isomer ratio 
observed by integration (7:1) for the major and minor species of [LnL1]- was larger than 
that of the parent triphosphinate complex [LnLJ] (5:1). Parker and co-workers found 
that phosphonate functionalisation does not drastically alter the rate of 
interconversion between the two TSAP isomers. Measurements of the 1H and 31P 
forward and reverse exchange rates using exchange spectroscopy (EXSY) spectroscopy 
allowed estimates of the equilibrium constant that were in agreement with those 
determined by direct integration.  
A plot of the paramagnetic shift of the major tert-butyl resonance peak against the 
associated Bleaney constant reveals a poor agreement for the expected linear fit 
(Figure 2.6). The chemical shifts of the Tm3+ and Ho3+ complexes particularly are not 
adequately explained by Bleaney theory; such deviant behaviour has been observed 
previously.23,27  
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Figure 2.6   Variation of the paramagnetic 1H NMR shift of the major tert-butyl resonance of 
[LnL1]- with the Bleaney constant, CJ (D2O, 295 K, pD 7.4) R2 = 0.599. 
The longitudinal relaxation rate, R1, was measured at six fields over the range 1 to 
16.4 T (Table 2.1). The relaxation rates for each lanthanide complex of [LnL1]- were 
found to be increased when compared to the behaviour of the unsubstituted 
trimethylphosphinate [LnLJ]. The high longitudinal relaxation rates at clinically relevant 
field strengths (1 to 7 T) demonstrate that [LnL1]- is an attractive candidate for MRS 
imaging.  
Table 2.1   1H NMR longitudinal relaxation rate data for the tert-butyl resonance of [LnL1]- as a 
function of magnetic field (D2O, 295 K, pD 7.4). 
Ln3+ R1 / s-1 (± error) 




































The longitudinal relaxation rate data from all five complexes of [LnL1]- were analysed 
by global minimisation methods, assuming classical BRW theory (Equation 1.9, page 
20) (Figure 2.7). The average internuclear distance, r, between the lanthanide ion and 
the tert-butyl protons was assumed to be 6.6 Å, as found in the X-ray studies of the 
unsubstituted trimethylphosphinate complex [LnLJ].26 The fitting procedure worked 
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well for Er3+, Tb3+ and Dy3+, but not for Tm3+ at low field or Ho3+ at higher fields. 
However, this fitting method relies upon the approximation that the electronic-nuclear 
interaction is simply distance dependent (r-6) and does not take into account the 
angular dependence of lanthanide-induced relaxation.  
 
Figure 2.7   1H NMR relaxation rates (R1 / s-1) for the major tert-butyl resonance of [LnL1]- as a 
function of magnetic field, showing the global fits (line) to the experimental data points (D2O, 
295K, pD 7.4, fixed r = 6.6 Å, minimizes to r = 345(9) ps). 
This minimisation process gives a common value for the rotational correlation time, τr, 
of 345 (±9) ps, and also predicts the effective magnetic moment for each lanthanide 
(Table 2.2). The value of τr is larger than that calculated for the non-phosphonated 
analogue [LnLJ] (249 ps).28 Such behaviour is expected due to the increase in molecular 
volume and polarity conferred by the phosphonate group. The ‘best-fit’ values of the 
electronic relaxation rate, τe, and magnetic moment, μeff, are given in Table 2.2. 
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Table 2.2   Estimated ‘best-fit’ values for 1H NMR relaxation parameters of [LnL1]- following 
global fitting with fixed r = 6.6 Å (D2O, 295 K, pD 7.4).a 
Ln3+ τe / ps μeff / BMa 
Tb 0.44 (3) 9.89 (2) 
Dy 0.46 (5) 10.65 (2) 
Ho 0.34 (5) 10.99 (2) 
Er 0.79 (9) 10.80 (4) 
Tm 0.30 (4) 10.46 (3) 
a Theoretical values for the magnetic moments of the lanthanide(III) ions are: Tb, 9.7; Dy, 10.6; 
Ho, 10.6; Er, 9.6; Tm, 7.6 BM. 
Erbium(III) displays the highest value of τe, as expected from its high relaxation rates at 
low fields. The estimated magnetic moments show reasonable agreement with the 
classical values, except for Tm3+ which exhibits a significantly higher μeff value (+38%) 
than the theoretical one.  
2.1.3 Paramagnetic NMR studies of [LnL1]-: temperature response 
The temperature sensitivity of the tert-butyl chemical shift was investigated from 
290 to 315 K and a linear dependence was observed against both T-2 and T (Figure 2.8).  
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Figure 2.8   Variation in the chemical shift of the major tert-butyl resonance of [LnL1]- as a 
function of temperature (D2O, 11.7 T, pD 7.4): Tm (yellow) R2 = 0.996; Er (green) R2 = 0.996; Ho 
(black) R2 = 0.999; Dy (red) R2 = 0.998; Tb (blue) R2 = 0.999.  
The linear temperature dependences were generally proportional to the magnitude of 
the chemical shift (Table 2.3). The temperature sensitivity was found to be 
independent of pH, over the range 4.5 to 8.5.  
Table 2.3   Comparison of the total shift and temperature sensitivities of the major tert-butyl 
resonance of [LnL1]- (D2O, 11.7 T, pD 7.4) 
Ln3+ 





Tb -83 +0.52 
Dy -78 +0.41 
Ho -32 +0.17 
Er +42 -0.24 
Tm +74 -0.44 
2.1.4 Paramagnetic NMR studies of [LnL1]-: pH response 
The pH responsive chemical shift behaviour of the tert-butyl reporter group of [LnL1]- 
was investigated by pD titration. The pD was altered using D2O solutions of NaOD and 
DCl, and measured before and after each NMR using a pre-calibrated pH meter. The 1H 
NMR spectra were acquired at different pD values, where pD = pH + 0.41 (Figure 2.9). 
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Figure 2.9   Stacked 1H NMR spectra of the tert-butyl resonances of [DyL1] as a function of pD 
(D2O, 11.7 T, 295 K) and the corresponding pH equilibrium. 
Chemical exchange between the protonated and deprotonated complex occurs fast 
relative to the NMR timescale and hence a single tert-butyl resonance is observed, that 
is a population weighted average of the two species. The 1H chemical shift of the tert-
butyl reporter group therefore varies as a sigmoidal function of pD, allowing the pKa of 
the phosphonate protonation to be determined by non-linear least square iterative 
analysis to a Boltzmann function (Figure 2.10). The pseudocontact shift of the reporter 
group increases with decreasing pD for each lanthanide. 31P NMR analysis of [DyL1] 
demonstrated that the phosphonate pseudocontact chemical shift is also dependent 
on pD, as expected (Figure 2.10). 





Figure 2.10   (Top Left) Variation in the 31P phosphonate chemical shift of [DyL1] as a function 
of pD. (Remaining) Variation in the 1H chemical shift of the major tert-butyl resonance of 
[LnL1]- as a function of pD (D2O, 11.7 T, 295 K). 
The pKa values averaged 7.16 in D2O at zero ionic strength (I = 0), in close agreement to 
that of phenylphosphonate (7.09) indicating that the close proximity of the large tert-
butyl group to the phosphonate does not drastically alter the protonation equilibrium. 
The longitudinal relaxation rate, R1, of the tert-butyl reporter resonance was found to 
be unchanged with pH over the range measured (4.5 – 8.5). However, the transverse 
relaxation rate, R2, was generally found to increase around the pKa. If the R2 of the 
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reporter resonance is too large, then the extent of line-broadening caused by this can 
inhibit signal detection. Equilibrium between two species in exchange can result in 
additional line broadening. The linewidth is greatest at the pKa when the complex 
exists as a 50:50 mixture of both species. The full width half maximum (FWHM) of the 
tert-butyl resonance was measured as a function of pD, revealing that at the pKa the 
linewidth was approximately doubled. The ratio of R1/R2 was also calculated around 
the pKa; a value as close as possible to unity is ideal for optimal signal detection (Table 
2.4). 
Table 2.4   Linewidths and calculated ratios of R1/R2 of the major tert-butyl resonance of [LnL1]- 
at the relevant pKa value (D2O, 11.7 T, pD 7.2). 
Ln3+ FWHM / s-1 R1/R2 
Tb 214 0.20 
Dy 164 0.35 
Ho 181 0.34 
Er 133 0.47 
Tm 123 0.41 
pD/pH titrations of [DyL1] were also undertaken in 0.1 M NaCl and a 50:50 murine 
plamsa:H2O, giving pKa values of 6.71 and 6.80 respectively. The decrease in pKa 
demonstrated the expected effect of ionic strength on the protonation equilibrium and 
the small variance in plasma indicates that the presence of serum proteins has 
relatively little impact on the protonation equilibrium. 
The total chemical shift change (Δδ) between high and low pD ranged from 0.7 ppm for 
[ErL1] to 1.4 ppm for [TbL1]. Interestingly, unlike the variation with temperature, Δδ 
was not proportional to the initial chemical shift of the tert-butyl resonance. 
Proportionally, the tert-butyl resonance of [HoL1] is most affected by the change of pD 
and [TmL1] the least. It can be assumed that there is no structural change of the ligand 
and that r remains approximately constant upon change in pH, as suggested by the 
consistent longitudinal relaxation rates above and below the pKa.  
A recent study of [DyL1] and a series of trimethylphosphinate Dy3+ complexes with 
variation of the para-substituent of the single pyridine donor (Figure 2.11) suggested 
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that small changes in ligand structure can significantly alter the magnetic susceptibility 
anisotropy.28 
 
Figure 2.11   Structure of Dy3+ trimethylphosphinate complexes with variants of the 4-position 
of the pyridine studied.28 
Emission and relaxation analysis demonstrated that the anisotropy is surprisingly 
sensitive to remote ligand substitution and the polarisability of one pyridine donor 
within the octadentate ligand. In 2018, similar studies on a series of C3 symmetric 
TACN complexes highlighted the sensitivity of the ligand field to solvent 
polarisability.29 
The protonation of the phosphonate group of [LnL1]- will lead to a change in 
polarisability of the pyridine group. It is likely that the magnetic susceptibility 
anisotropy difference between the two species is the cause of the chemical shift 
variation of the tert-butyl reporter resonance frequency. 
One assumption arising from Bleaney’s theory is that the principal axis of 
magnetisation is constant for each lanthanide ion, within the same ligand structure. It 
was originally demonstrated by Sessoli and co-workers that, in the solid state at 2 K, 
the position of this axis varies in C4 symmetric [LnDOTA(H2O)]- complexes.30 In the case 
of [DyDOTA(H2O)]- it was calculated that the presence of an axial bound water rotated 
the axis by about 90°.31 More recently, Parker and co-workers revealed, with the aid of 
ab initio calculations, that the orientation of the major component of the magnetic 
susceptibility tensor differs significantly between complexes of different lanthanides 
for the same trimethylphosphinate complex, [LnLJ].27 This variation of angle may give 
rise to the differing pH sensitivities between the lanthanides for [LnL1]- although more 
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detailed analysis of the both species above and below the pKa is required to fully 
describe the magnetic susceptibility anisotropy.  
2.1.5 Triple imaging phantom and in vivo studies of [LnL1]- 
The dual temperature and pH sensitivity of the reporter chemical shift requires the 
presence of two different lanthanide complexes of [LnL1]-, in order to observe two shift 
values concurrently. The use of simultaneous equations allows the T and pH of the 
region of interest to be calculated.  
The complexes [DyL1]- and [TmL1]- were chosen for imaging studies as a suitable pair of 
complexes, due to their fast and similar relaxation rates around 7 T, large chemical 
shifts and favourable pH/T sensitivities (Table 2.5).  
Table 2.5   Overview of properties of [DyL1]- and [TmL1]-. 
Ln3+ 
δH tBu / 
ppm 






















A pulse sequence was developed by Dr Dara O’Hogain and Prof. Andrew M. Blamire at 
Newcastle University to enable the simultaneous acquisition of the three resonances; 
the water and the two well-separated tert-butyl signals. The similar relaxation rates of 
the two complexes allowed for the frequency, shape, duration and power of the two 
excitation pulses to remain the same, with only a modified offset frequency. No 
specific excitation pulse was applied to the water signal as there was sufficient 
excitation within the bandwidth of the two RF pulses. The spectral width was increased 
to ~60 kHz to encompass signal from all three chemical shifts. Phantoms were created 
and imaged to test the pulse sequence and demonstrate the practicability of MRS in 
vivo studies (Figure 2.12). A 2D-MRSI acquisition was applied to generate a matrix of 
voxels, each of which can be inspected to show the full spectral range. Individual peaks 
from both complexes and water are clearly observed in the mixed solutions in the 
lower vial. A 3DGE triple image method was used for imaging the basic spatial 
distribution of the resonances. The triple imaging experiment allows sampling across 
the whole frequency range of all the signals allowing for acquisition of three entirely 
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independent, but simultaneously acquired MRI images offset by the frequency of the 
resonance. This method does not affect the signal to noise ratio of the scan in 
comparison to acquiring individual images of each component as the noise bandwidth 
per pixel is unchanged. 
 
Figure 2.12   (Left) A 2D-MRSI spectral imaging sequence applied to a phantom set-up of [LnL1]- 
with a TR of 19.5 ms, TE1 of 0.95 ms, TE2 of 0.45 ms and a spectral width SW = 54 kHz, 
32 averages, scan time = 100 s. (Right) A 3DGE pulse sequence with a TR = 4.28 ms, TE1 (Dy) = 
0.87 ms, TE2 (Tm) = 1.37 ms, SW = 60 kHz, 80 averages, scan time = 354 s. The phantom 
contains 1.2 mM [TmL1], [DyL1], a 1.2 mM equimolar mix of the complexes or water. 
In vivo studies were performed by Dr. Dara O’Hogain and Ian Wilson (Newcastle 
University) on CD1 healthy mice (n=3) following a tail-vein injection with 
0.05 mmoles/kg of an equimolar mixture of the Tm3+/Dy3+ complexes in saline. 
Selected spectra from the MRSI were extracted to show the change in shift of each 
complex in different tissues (Figure 2.13).  
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Figure 2.13   In vivo examples of MRSI acquisition in a healthy mouse following injection of a 
1:1 mix of [DyL1]- and [TmL1]-. (Left) Selected spectra from a time series of 2DSI acquisitions. 
The stacked spectra show the Tm3+ (left) and Dy3+ (right) spectral regions from voxels sampling 
liver, kidney, bladder and an external reference phantom.  MRSI acquisition parameters were 
TR = 19.5 ms, TE1 (Dy) = 0.45 ms, TE2 (Tm) = 0.95 ms, SW = 54 kHz, 32 averages, scan time 
100 s. (Right)  A 3DGE triple image taken 40 minutes post injection using a pulse sequence with 
TR = 10.66 ms, TE1 = 1.58 ms, TE2 = 2.08 ms, SW= 54 kHz, 100 averages, scan time = 1092 s.   
There are clear differences in the frequencies between tissues, most significantly in the 
bladder. The pH and temperature were calculated using simultaneous equations that 
define the frequency versus the sigmoidal pH and linear T dependence for each 
complex (developed by Dr. Dara O’Hogain).32 
The pH values for the selected ROIs in the liver, kidney and bladder were measured to 
be 7.14, 6.92 and 6.80 respectively, which is consistent with the expected range of 
values for healthy ‘wild-type’ animals. The temperature in the bladder was found to be 
3.5 K lower than core body temperature, which was the main cause of the large 
frequency difference in shift relative to the other tissues. This is consistent with the 
previously reported temperature difference between bladder and core of 4 K from in 
vivo studies of the dimethylphosphinate complex [DyLK]-.33 
In the spectra extracted from both the in vitro and in vivo scans the peak picking of the 
[DyL1]- tert-butyl resonance was more challenging than that of [TmL1]-. The linewidth 
of the Dy3+ complex was rather broad at 7 T, inhibiting the use of automatic peak 
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detection, and hence in future, complexes with narrower linewidths should be chosen 
for such imaging studies.  
An additional challenge for the in vivo studies arose from the rather rapid clearance of 
the complex and its fast accumulation in the bladder (Figure 2.14). The majority of 
PARASHIFT signal was lost from the kidneys and the liver within 5 minutes of injection. 
The tissue retention and lipophilicity of the complex must be improved, to to more 
image other tissues more effectively, at least in this mouse model. 
 
Figure 2.14   Relative concentration of [DyL1]- as a function of time in an intact, healthy mouse 
following single i.v. injection of 0.05 mmol/kg of a 1:1 mixture of the Tm/Dy complexes of 
[LnL1]. 
2.2 Tribenzylphosphinate pH responsive PARASHIFT probe [LnL2]- 
The structure of [LnL1]- must be modified in order to lengthen the tissue retention time 
and increase lipophilicity, whilst maintaining favourable shift and relaxation properties. 
Manipulation of the R group on the phosphinate arms can be used to enhance 
lipophilicity. Several tetraphosphinate lanthanide complexes have made previously by 
Parker and co-workers, including a series of lanthanide tetrabenzylphosphinate 
complexes.34 It was hoped that changing the phosphorus substituent from methyl to a 
bulkier, non-polar benzyl group would increase the tissue retention time of the 
complex, [LnL2]- (Figure 2.15), particularly in the liver as the presence of organic anion 
transporters in the hepatocytes may encourage clearance via the liver. The pyridine 
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moiety will remain unchanged to minimise changes to pH dependence, shift and 
relaxation. 
 
Figure 2.15   Structure of tribenzylphosphinate pH PARASHIFT probe, [LnL2]-. 
2.2.1 Synthesis of [LnL2]- 
The synthesis for the tribenzylphosphinate cyclen macrocycle is analogous to that of 
the methyl variant (Scheme 2.4). The mono-BOC protected macrocycle, 3, was reacted 
instead with anhydrous paraformaldehyde and diethyl benzylphosphonite (synthesised 
by Dr. P. Kanthi Senanayake) to yield the ethyl ester-protected tribenzylphosphinate 
mono-BOC macrocycle, 15. The BOC group was similarly deprotected with 
trifluoroacetic acid at room temperature to yield the macrocycle, 16, ready for 
alkylation. 
 
Scheme 2.4   Procedure for the synthesis of the tri-benzylphosphinate 12-N4 macrocycle, 16. 
The alkylation of the macrocycle, 16, with the mesylate, 14, proceeded in the presence 
of caesium carbonate and the tetra-alkylated ligand, L2 was purified on alumina 
column chromatography (Scheme 2.5). The phosphinate esters were hydrolysed in 6 M 
HCl before complexation with the appropriate lanthanide(III) chloride. The complex 
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[DyL2]- was synthesised by Dr. P. Kanthi Senanayake, and complexes [TbL2]- and [ErL2]- 
were synthesised by Olga Tyurina. 
Scheme 2.5   Procedure for the alkylation and complexation of the tri-benzylphosphinate 
complex, [LnL2]. 
The luminescence lifetimes of the Tb3+ excited state were measured in both H2O and 
D2O in order to calculate the metal hydration state of the complex. The q value for 
[TbL2]- was found to be 0, consistent with the behaviour of the trimethylphosphinate 
complex, [LnL1]-.  
2.2.2 Paramagnetic NMR studies of [LnL2]-: shift and relaxation 
Initial 1H NMR studies of [LnL2]- showed that the tert-butyl resonances were even 
further shifted (8 - 15%) than analogous [LnL1]- complexes (Figure 2.16). The Tb3+, Dy3+ 
and Tm3+ complexes were shifted to -90, -86 and +85 ppm respectively. 
 
Figure 2.16   Schematic representation of the experimentally measured 1H chemical shifts of 
the major tert-butyl signals in [LnL1]- (top) and [LnL2]- (bottom) (D2O, 295 K, pD 7.4) (yellow - 
Tm, green - Er, red - Dy, blue - Tb).  
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Similarly to [LnL1]-, a major and minor tert-butyl resonance of [LnL2]- was observed, 
deemed to be the two TSAP diastereoisomers in solution. However, the observed 
signal intensity of the major isomer was found in a slightly higher ratio (9:1) than in the 
methylphosphinate analogue. The additional steric bulk of the benzyl group may cause 
the preferential destabilisation of the minor isomer.  
The longitudinal relaxation rate, R1, was measured at six fields, over the range 1 to 
16.4 T (Table 2.6). The general trend found for the relaxation rates was in general 
agreement with that of [LnL1]- although the [ErL2]- complex exhibited significantly 
faster relaxation, particularly at low fields. The longitudinal relaxation rate of [TmL2]- 
was higher at every field, compared to [TmL1]-. 
Table 2.6   Longitudinal relaxation rate data for the major tert-butyl resonance of [LnL2]- at 
different magnetic field strengths (D2O, pD 7.4, 295 K). 
Ln3+ R1 / s-1 (± error) 






























The relaxation data of the four complexes were again analysed by global minimisation 
methods assuming the internuclear distance, r, remains 6.6 Å (Figure 2.17). The fit for 
[ErL2]- and [TmL2]- is notably poor at low fields. 
 
Figure 2.17   1H NMR relaxation rates (R1 / s-1) for the major tert-butyl resonance of [LnL2]- as a 
function of magnetic field, showing the global fits (line) to the experimental data points (D2O, 
295K, pD 7.4, fixed r = 6.6 Å, minimizes to r = 400 (15) ps). 
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The minimisation process gave a common rotational correlation time, τr, of 
400 (±15) ps, and also predicts the effective magnetic moment, μeff, and electronic 
relaxation time, τe, for each lanthanide ion (Table 2.7). The calculated value of τr is 
larger than that for the methylphosphinate analogue [LnL1]- (345 ps). Rotational 
correlation time is generally proportional to molecular volume and hence molecular 
weight, so the increase in τr is explained by the increase in mass associated with the 
three benzyl groups.  
Table 2.7   Estimated ‘best-fit’ values for 1H NMR relaxation parameters of [LnL1]- and [LnL2]- 
following global fitting with fixed r = 6.6 Å (D2O, 295 K, pD 7.4).a 
 
a Theoretical values for the magnetic moments of the lanthanide(III) ions are: Tb, 9.7; Dy, 10.6; 
Ho, 10.6; Er, 9.6; Tm, 7.6 BM. 
The electronic relaxation times of the Tb3+, Dy3+ and Tm3+ ions are close to those 
estimated for [LnL1]-, whilst [ErL2]- shows a significant increase. However, the high 
value may be a result of the poor fit of the relaxation rates at low field. The ‘best-fit’ 
values of μeff have increased for each [LnL2]- compared to [LnL1]-, most significantly 
demonstrated by [TmL2]- which now has the largest magnetic moment of all the 
lanthanide ions and is 43% larger than the theoretical value. Evidently, these values 
must be treated with considerable caution as the paramagnetic relaxation induced by 
the electron-nuclear dipolar interaction is anisotropic, whereas the theory applied 
here assumes it is isotropic. 
2.2.3 Paramagnetic NMR studies of [LnL2]-: temperature response 
The chemical shift of the tert-butyl resonance was linearly dependent on both T-2 and 
over the range measured directly on T. The temperature sensitivities of [LnL2]- were 
calculated from the linear fit (Figure 2.18 and Table 2.8). 
Ln3+ 
τe / ps μeff / BMa 
[LnL1]- [LnL2]- [LnL1]- [LnL2]- 
Tb 0.44 (3) 0.43 (5) 9.89 (2) 9.77 (3) 
Dy 0.46 (5) 0.44 (6) 10.65 (2) 10.68 (3) 
Er 0.79 (9) 0.99 (12) 10.80 (4) 10.89 (4) 
Tm 0.30 (4) 0.35 (3) 10.46 (3) 10.90 (5) 
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Figure 2.18   Variation in the chemical shift of the major tert-butyl resonance of [LnL2]- as a 
function of temperature (D2O, 11.7 T, pD 7.4): Tm (yellow) R2 = 0.999; Er (green) R2 = 0.997; Dy 
(red) R2 = 0.998; Tb (blue) R2 = 0.997. 
Table 2.8   Comparison of the temperature sensitivities of the major tert-butyl resonance of 
[LnL1]- and [LnL2]- (D2O, 11.7 T, pD 7.4). 
Ln3+ 
T sensitivity / ppm/K 
[LnL1]- [LnL2]- 
Tb +0.52 +0.45 
Dy +0.41 +0.37 
Er -0.24 -0.24 
Tm -0.44 -0.45 
As the tert-butyl chemical shifts of [LnL2]- are greater than [LnL1]-, it would be expected 
that the temperature dependences would be larger. However, whilst the sensitivities 
of the Er3+ and Tm3+ complexes are comparable, [TbL2]- and [DyL2]- have actually 
reduced slightly in magnitude. 
2.2.4 Paramagnetic NMR studies of [LnL2]-: pH response 
The behaviour of [LnL2]- in response to changing pH was similar to the behaviour 
observed with [LnL1]-. The protonated and deprotonated species are in fast exchange 
on the NMR timescale, and the pseudocontact shift is greatest at low pD. Plots of the 
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chemical shift of the tert-butyl resonance against pD were again iteratively fitted to a 
sigmoidal curve to calculate the associated pKa values (Figure 2.19). 
  
  
Figure 2.19   Variation in the 1H chemical shift of the major tert-butyl resonance of [LnL2]- as a 
function of pD (D2O, 11.7 T, 295 K). 
Inspection of the pKa curves of [LnL2]- shows that the change from methyl- to 
benzylphosphinate has increased the pKa (Table 2.9). The overall solvation of the 
complex is likely to be affected by the introduction of the more hydrophobic, larger 
benzylphosphinate groups. Disproportional destabilisation of the doubly negatively 
charged conjugate base, resulting from reduced overall hydration, would cause an 
increase in pKa. The pKa of [TmL2]- is also remarkably high, and the explanation for this 
is not obvious although the same trend is also observed in [LnL1]-. The ionic radius of 
Tm3+ is the smallest of the lanthanide ions studied, which may result in a slight 
geometric change that alters the Ln-Npy bond strength, influencing the polarisability. 
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Table 2.9   Comparison of the pH sensitivities of the major tert-butyl resonance of [LnL1]- and 
[LnL2]- (D2O, 11.7 T, 295 K). 
Ln3+ 
pKa Δδ / ppm 
[LnL1] [LnL2] [LnL1] [LnL2] 
Tb 7.20 7.33 1.4 2.9 
Dy 7.11 7.22 1.9 3.5 
Er 7.11 7.26 0.7 1.3 
Tm 7.26 7.65 1.1 2.4 
As with [LnL1]-, the values of Δδ were not proportional to the initial chemical shift. 
Comparison of the pH responses of [LnL1]- and [LnL2]- reveals that the order of Δδ is 
the same across the Ln3+ ions for both series of complexes (Table 2.9). The tert-butyl 
resonance of [DyL2]- shifts most upon the change of pH. However, the magnitude of Δδ 
in the benzylphosphinate is significantly increased, effectively doubling in the cases of 
the Tb3+, Er3+ and Tm3+ complexes. This behaviour may be as a consequence of the 
differential degree of hydration of the protonated and deprotonated species. As a 
consequence, the change in solvation, albeit a second sphere effect, may influence the 
ligand field and hence change anisotropy of the lanthanide ion resulting in a larger 
chemical shift change. A larger chemical shift range of pH sensitivity, should lead to an 
increase in accuracy in the measurement of pH. 
2.2.5 In vivo studies of [LnL2]- 
In order to establish if the modification from methyl to benzyl phosphinates had 
improved the clearance profile of [LnL2]-, a series of standard contrast enhanced 1H 
MRI experiments were undertaken using [GdL2]-. These scans revealed no real 
improvement in the biodistribution profile from [LnL1]- (Figure 2.20); the complex 
predominantly clears via the kidneys, accumulating rapidly in the bladder. Due to these 
results further in vitro and in vivo PARASHIFT imaging experiments were not pursued, 
and a further modification of the complex was sought in order to increase retention. 
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Figure 2.20   Relative concentration of [GdL2]- as a function of time in an intact, healthy mouse 
following single i.v. injection of 0.05 mmoles/kg. 
2.3 Dibenzylphosphinate pH responsive PARASHIFT probe [LnL3]- 
Previous in vivo studies by Parker and co-workers on the temperature sensitive 
PARASHIFT probe dimethylphosphinate probe [DyLK]- showed a slightly more 
favourable biodistribution (see Section 1.7.1 and 1.73, pages 30-31 and 36-37).33 It was 
proposed that modification of the tribenzylphosphinate complex [LnL2]- to a 
dibenzylphosphinate complex [LnL3]- (Figure 2.21) could result in decreased clearance 
rates which, when coupled with an increase in the number of magnetically equivalent 
nuclei as a result of the C2 symmetry, will increase the observed signal intensity.  
 
Figure 2.21   Structure of diphosphinate PARASHIFT probes, (left) the temperature responsive 
dimethylphosphinate complex [DyLK]- and (right) the pH and temperature responsive 
dibenzylphosphinate complex [LnL3]-. 
The complexes of [LnL3]- (Ln= Tb, Dy, Er, Tm and Gd) were synthesised by Dr P. Kanthi 
Senanayake and the NMR and relaxation properties of the tert-butyl reporter group 
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were subsequently studied. The metal hydration state of [TbL3]- was found to be 0, by 
luminescence lifetime analysis in H2O and D2O. 
2.3.1 Paramagnetic NMR studies of [LnL3]-: shift and relaxation 
The chemical shift of the major tert-butyl resonances of [LnL3]- are the least shifted of 
the three classes of probes discussed. However, whilst the shifts are decreased in 
comparison to [LnL2]-, they remain far beyond the diamagnetic region of water and fat 
(Figure 2.22). The chemical shift of [TbL3]- is least affected by the change from 
tribenzylphosphinate to dibenzylphosphinate (-9%) compared to other lanthanides (-
24 to -33%).  
 
Figure 2.22   Schematic representation of the experimentally measured 1H chemical shifts of 
the major tert-butyl signals in [LnL2]- (top) and [LnL3]- (bottom) (D2O, 11.7 T, 295 K, pD 7.4) 
(yellow - Tm, green - Er, red - Dy, blue - Tb). 
A single major tert-butyl resonance demonstrates the presence of a C2 symmetric 
species that renders both reporter groups magnetically equivalent. However, whereas 
only two diastereoisomers were observed for [LnL1]- and [LnL2]-, up to four tert-butyl 
resonances were identified for all [LnL3]- (Figure 2.23). These tert-butyl peaks were 
identified by comparison of integrals, linewidths and their longitudinal relaxation rates. 
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Figure 2.23   1H NMR spectra of the tert-butyl resonances observed for [LnL3]- (D2O, 11.7 T, 
295 K, pD 7.4). 
For each [LnL3]- complex, at least two diastereoisomers were observed and the major 
tert-butyl resonance was the least furthest shifted of these species in every complex 
except [TbL3]-. The presence of multiple isomers in slow exchange on the NMR 
timescale suggests that the dibenzylphosphinate macrocycle is more flexible than in 
the tri-substituted species. The relative stabilities of the minor diastereoisomers have 
increased and are now closer in energy to the major conformation. Although the 
presence of additional minor isomers reduces the signal intensity of the major isomer, 
in each case the major species accounted for >66% of the tert-butyl signal, and thus 
[LnL3]- affords an increase in overall signal intensity in comparison to [LnL2]-.  
The longitudinal relaxation rate of the major tert-butyl resonance was measured at six 
fields over the range 1 to 16.4 T (Table 2.10). 
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Table 2.10   Longitudinal relaxation rate data for the major tert-butyl resonance of [LnL3]- at 
different magnetic field strengths (D2O, pD 7.4, 295 K). 
Ln3+ R1 / s-1 (± error) 






























Whereas the modification from methyl- to benzylphosphinate resulted in only small 
changes to longitudinal relaxation rates, the change from tri- to diphosphinate gives 
rise to a much more marked variation, especially for [TbL3]- and [TmL3]-. The value of 
R1 for the Tb3+ complex is increased and the rate for the Tm3+ complex is dramatically 
decreased. This effect occurs at all field strengths but is proportionally largest at 1 T. 
Structural modification from tri- to di- has little impact on the relaxation rate of [DyL3]-; 
the rates of [ErL3]- decrease, although less notably than [TmL3]-. The longitudinal 
relaxation rates of [LnL3]- are not all decreased in a similar manner to the chemical 
shift, and this behaviour indicates that the internuclear distance between reporter 
protons and lanthanide ion is unlikely to be dramatically changed from [LnL2]-. 
Notwithstanding the intrinsic limitations of the approach, the relaxation data were 
analysed by global minimisation methods assuming classical BRW theory and an r of 
6.6 Å as previously (Figure 2.24). 
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Figure 2.24   1H NMR relaxation rates (R1 / s-1) for the major tert-butyl resonance of [LnL2]- 
(dashed) and [LnL3]- (solid) as a function of magnetic field, showing the global fits (line) to the 
experimental data points (D2O, 295K, pD 7.4, fixed r = 6.6 Å, minimizes to r = 418 (8) ps). 
Similarly to [LnL2]- the fit is least good for [TmL3]- at low fields. The rotational 
correlation time was estimated to be 418 (±8) ps, and such an increase is in line with 
the increase in molecular mass. The minimisation process gave ‘best-fit’ values for μeff 
and τe, shown in Table 2.11. 
Table 2.11   Estimated ‘best-fit’ values for 1H NMR relaxation parameters of [LnL2]- and [LnL3]- 




a Theoretical values for the magnetic moments of the lanthanide(III) ions are: Tb, 9.7; Dy, 10.6; 
Ho, 10.6; Er, 9.6; Tm, 7.6 BM. 
Analysis of the magnetic moments and electronic relaxation rates of [LnL3]- shows vast 
deviation from both the theoretical lanthanide(III) values and from the behaviour of 
[LnL2]-. A dramatic increase in τe for [TbL3]- can tentatively be used to rationalise the 
increased R1 rates. The size of the magnetic moment of Tb3+ is now significantly higher 
than the predicted theoretical value. Conversely, the decrease in the measured 
Ln3+ 
τe / ps μeff / BMa 
[LnL2]- [LnL3]- [LnL2]- [LnL3]- 
Tb 0.43 (5) 0.85 (5) 9.77 (3) 10.45 (2) 
Dy 0.44 (6) 0.50 (7) 10.68 (3) 10.72 (1) 
Er 0.99 (12) 0.92 (8) 10.89 (4) 10.52 (2) 
Tm 0.35 (3) 0.18 (3) 10.90 (5) 10.05 (4) 
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relaxation rate of [TmL2]- at low field (<4.7 T) results in large reductions in the 
estimated values of τe.  
2.3.2 Paramagnetic NMR studies of [LnL3]: temperature response 
As demonstrated with the earlier series of complexes, the tert-butyl chemical shift of 
[LnL3]- varies linearly with T-2 and T, over the measured temperature range (Figure 
2.25). 
 
Figure 2.25   Variation in the chemical shift of the major tert-butyl resonance of [LnL3]- as a 
function of temperature (D2O, 11.7 T, pD 7.4): Tm (yellow) R2 = 0.999; Er (green) R2 = 0.997; Dy 
(red) R2 = 0.997; Tb (blue) R2 = 0.997. 
The temperature sensitivities of [LnL3]- were calculated from the linear fit (Table 2.12).  
Table 2.12   Comparison of the temperature sensitivities of the major tert-butyl resonance of 
[LnL2]- and [LnL3]- (D2O, 11.7 T, pD 7.4). 
Ln3+ 
T sensitivity / ppm/K 
[LnL2]- [LnL3]- 
Tb +0.45 +0.38 
Dy +0.37 +0.23 
Er -0.24 -0.13 
Tm -0.45 -0.32 
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The temperature sensitivity of [LnL3]- decreases in comparison to [LnL2]-. The decrease 
is in line with the reduced chemical shifts of the tert-butyl reporter group. 
Additionally, to explore the exchange between the additional diastereoisomers of 
[LnL3]-, the linewidths of the tert-butyl resonance were measured as a function of 
temperature. It is expected that the linewidth of the tert-butyl resonance will reduce 
with increasing temperature as BRW theory predicts a T-2 dependence of R2. However, 
at higher temperatures (>315 K) the linewidths were observed to increase due to 
chemical exchange, although no coalescence of the tert-butyl resonances was 
observed. 
2.3.3 Paramagnetic NMR studies of [LnL3]: pH response 
The chemical shifts of the tert-butyl resonances of [LnL3]- were measured as a function 
of pH, in order to probe the effect of the structural change from the tri- to the 
diphosphinate series. Due to the distance between the two phosphonate groups, they 
were assumed to protonate independently and simultaneously, resulting in a single pKa 
value for each tert-butyl resonance. As previously observed for [LnL1]- and [LnL2]-, the 
size of the paramagnetic shift increased at low pD (Figure 2.26). 
 




Figure 2.26   Variation in the 1H chemical shift of the major tert-butyl resonance of [LnL3]- as a 
function of pD (D2O, 11.7 T, 295 K). 
Comparison of the fitted pKa values of [LnL3]- with those of [LnL2]- shows that the 
protonation equilibrium of the two phosphonates is broadly unchanged (Table 2.13). 
The average pKa value (7.30) decreased from that found for [LnL2]- (7.37), although this 
behaviour can largely be related to the pKa decreases found for [TmL3]- and [ErL3]-. The 
total pH sensitivities of the Tb3+ and Dy3+ complexes of [LnL3]- remained similar to 
those of the analogous [LnL2]- complexes (Table 2.13). However, the Δδ values of 
[ErL3]- and [TmL3]- decreased greatly, and this change was not proportional to the 
decrease in the tert-butyl chemical shifts. 
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Table 2.13   Comparison of the pH sensitivities of the major tert-butyl resonance of [LnL1]- and 
[LnL2]- (D2O, 11.7 T, 295 K). 
Ln3+ 
pKa Δδ / ppm 
[LnL2]- [LnL3]- [LnL2]- [LnL3]- 
Tb 7.33 7.31 2.9 2.7 
Dy 7.22 7.29 3.5 3.5 
Er 7.26 7.12 1.3 0.6 
Tm 7.65 7.48 2.4 1.4 
The pH response of the identified tert-butyl resonances of the minor isomers were also 
analysed (Figure 2.27). Unexpectedly, the different diastereoisomers showed very 
different sensitivities to pD. The total shift change, Δδ, was particularly different in 
[TbL3]- and [DyL3]-.  For example, one of the minor isomers of the Dy3+ complex shifted 
5.4 ppm from high to low pD, significantly further than the major isomer 
(Δδ = 3.5 ppm). Conversely, both minor species of the Tb3+ complex were found to shift 
significantly less (Δδ = 0.4 and 1.0 ppm) compared to that of the major species 
(Δδ = 2.7 ppm). 
The pKa values were also found to slightly vary between diastereoisomers, each 
lanthanide complex spanning a similar range. The inclusion of the minor pKa values 
also increased the total range of values (7.12 - 7.71) and the order of pKa values was 
Tm3+>Tb3+>Dy3+>Er3+. This trend was also observed for the triphosphinate complexes 
[LnL1]- and [LnL2]-, for which the Tm3+ and Tb3+ complexes have the highest pKa values.  
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Figure 2.27   Variation in the 1H chemical shift of the tert-butyl resonances of [LnL3]- as a 
function of pD (D2O, 11.7 T, 295 K). 
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The linewidths of the Dy3+ and Tb3+ complexes of L3 were considered to be rather 
broad, restricting their use in imaging experiments. Hence, [TmL3]- and [ErL3]- were 
chosen to be the pair of lanthanides used for the in vivo studies. In order to probe the 
effects of ionic strength on the pKa and pD response of the diphosphinate complexes, a 
pD titration was performed in 0.1 M NaCl in D2O. The titration was performed on a 1:1 
mixture of the Er3+ and Tm3+ complexes. Such an experiment also confirms that the 
presence of the two different lanthanide complexes in solution has no adverse effect 
on shift or relaxation behaviour (Figure 2.28). 
 
 
Figure 2.28   Variation in the 1H chemical shift of the major tert-butyl resonance of [ErL3]- and 
[TmL3]- as a function of pD (D2O, 0.1 M NaCl, 11.7 T, 295 K). 
It was expected that an increase in ionic strength would decrease the pKa, as observed 
for [DyL1]-. However, whilst the pKa of major tert-butyl resonance of [TmL3]- was found 
to decrease slightly to 7.42, the pKa of [ErL3]- actually increased to 7.38, the two pKa 
values for the two complexes now lie within the experimental error (Figure 2.28).  
The presence of NaCl in solution was found to have no effect on the chemical shift and 
the longitudinal relaxation rate of the major tert-butyl resonance (Table 2.14). 
Table 2.14   Overview of the properties the major tert-butyl resonance of [ErL3]- and [TmL3]- in 
an equimolar mixture in 0.1 M NaCl (D2O, 11.7 T, 295 K). 
Ln3+ 
δH tBu / 
ppm 
R1 / s-1 (± error) 
11.7 T 
Δδ / ppm pKa 
Er +32 173 (2) 0.7 7.38 
Tm +65 126 (1) 1.5 7.42 
The effect of endogenous metal cations (Mg2+ and Ca2+) on the chemical shift of [LnL3]- 
was also explored. It was found that addition of the chloride salts of Mg2+ and Ca2+ at 
millimolar concentrations had no discernible effect (Figure 2.29 and Figure 2.30). 
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Figure 2.29   Stacked 1H NMR spectra of [ErL3]- and [TmL3]- (bottom) and after addition of 
excess Mg2+ (centre) or Ca2+ (top). (D2O, pD 7.4, 11.7 T, 295 K). 
 
 
Figure 2.30   Chemical shifts of the tert-butyl resonances of [ErL3]- (green) and [TmL3]- (yellow) 
as a function of the number of added equivalents of Ca2+ (black) and Mg2+ (red) (D2O, pD 7.4, 
11.7 T, 295 K). 
2.3.4 In vivo studies of [LnL3]- 
Standard contrast enhanced 1H MRI was undertaken in intact, healthy mice following 
tail-vein injection with 0.05 mmol/kg of [GdL3]-. These scans showed that the 
dibenzylphosphinate complex was still found to accumulate rapidly in the bladder 
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(Figure 2.31). However, the relative concentrations in the liver and kidneys within the 
initial 5 minutes post-injection were improved. The higher local concentration of the 
probe and increased signal intensity suggest that imaging these organs may be 
enhanced at early time points.  
 
Figure 2.31   Relative average in vivo concentration of [GdL3]- as a function of time in intact, 
healthy mice (n = 3) following single i.v. injection of 0.05 mmol/kg. 
1H PARASHIFT experiments were performed on intact, healthy mice following a tail-
vein injection with 0.05 mmoles/kg of an equimolar mix of the Er3+ and Tm3+ 
complexes in saline. 3DGE triple imaging sequences were utilised, demonstrating that 
this technique can be used to image simultaneously signals from [ErL3]-, [TmL3]- and 
water. Figure 2.32 shows a triple image of a 10 mM phantom of both Tm/Er 
complexes, and a mouse 120 min post-injection; at this time, renal clearance of the 
probe results in a strong signal from the bladder only (Figure 2.33). A large spectral 
width of 60 kHz allowed for the use fast pulse sequences. The frequency offset of the 
tert-butyl signals in the bladder compared to that of the external phantom arises due 
to the different temperature and pH within the mouse. 
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Figure 2.32 A 3DGE triple image taken 120 minutes post-injection of an equimolar 
0.05 mmoles/kg solution of [ErL3]- and [TmL3]- in saline. TR = 4.08 ms, TE = 0.77 ms, SW= 60 
kHz, 50 averages, scan time = 209 s.   
 
Figure 2.33 Relative average in vivo concentration of [ErL3] and [TmL3] as a function of time in 
an intact, healthy mouse following single i.v. injection of an equimolar 0.05 mmol/kg solution 
of [ErL3]- and [TmL3]- in saline. 
In vivo MRSI acquisitions were also performed and the presence of both complexes 
was observed within the liver, kidneys (Figure 2.34) and bladder. The linewidths were 
reduced compared to that of [DyL1]- enabling simpler peak identification. 
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Figure 2.34   (Right) T1-weighted image highlighting kidney of the mouse and two external 
phantoms containing; a 10 mM equimolar solution of [ErL3]- and [TmL3]- in saline for pH 
calibration and a solution of ethylene glycol for temperature calibration. (Left) Selected spectra 
from 2DSI acquisition of the Er3+/Tm3+ containing phantom (top) and of the kidney (bottom). 
MRSI acquisition parameters were TR = 14.1 ms, TE = 0.45 ms, SW = 56 kHz. 
Further in vivo studies are ongoing in order to gain more detailed frequency 
information from the acquired spectra. This will allow for automation of the processing 
procedure and enable 2D pH and temperature maps to be readily constructed. 
2.4 Conclusions and Future Work 
A series of novel pH and temperature responsive 1H PARASHIFT probes, [LnL1-3]-, for 
MRS have been synthesised and characterised. The complexes exist as one major 
diastereoisomer in aqueous solution so that one major signal of the tert-butyl reporter 
group is observed. The reporter signal of each complex resonates outside the 
diamagnetic range, well away from the signals of water and fat, allowing for near zero-
background imaging. Furthermore, longitudinal relaxation rates of the complexes at 
clinically relevant fields allow for very short repetition times allowing fast data 
acquisition per unit time. The highly-shifted signals exhibit large, linear dependence on 
temperature. The presence of a pH sensitive phosphonate group with a pKa in a 
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biologically relevant range (7.16 - 7.37) allows for the measurement of pH by 
perturbation of the reporter resonance frequency. The dual temperature and pH 
dependence requires the co-injection of two different lanthanide complexes. A 
number of parameters must be considered in the selection of these complexes, 
including their chemical shift and relaxation properties (Figure 2.35).  
Initial in vivo studies of [LnL1]- demonstrated that non-invasive measurement of pH 
and temperature could be achieved using mice with no surgical renal ligation. 
However, temporal resolution in the liver and kidneys was hindered by the relatively 
fast clearance and rapid accumulation of the complex into the bladder of the mice 
studied. It was found that whilst Dy3+ and Tb3+ complexes demonstrate extremely 
shifted tert-butyl resonances the linewidths of the signals are rather broad, inhibiting 
imaging in vivo. 
Structural adaptation was sought in order to increase the lipophilicity of the probe.  
Modification of the phosphinate R groups from methyl to benzyl resulted in an 
increase in the chemical shift of the tert-butyl resonance. The tribenzylphosphinate 
complex, [LnL2]-, maintained fast relaxation rates and high temperature sensitivity. The 
pKa was found to increase slightly as a result of the increase in hydrophobicity of the 
complex. Moreover, there was an increase in the total chemical shift of the tert-butyl 
resonance upon pH variation, increasing the potential accuracy of pH measurements. 
Unfortunately, in vivo experiments revealed no improvement in the biodistribution so 
further structural modification was required. 
The change in structure from the tri- to the dibenzylphosphinate resulted in a number 
of changes to the NMR properties that are not yet well understood. The longitudinal 
relaxation rate profiles of [TmL3]- and [TbL3]- were remarkably different from their 
related tribenzylphosphinate complexes. Whilst the favourable pH sensitivities were 
maintained, the paramagnetic shift of the reporter group decreased, but remained 
well outside the diamagnetic region for all complexes. 






R1 / s-1 (± error) T sensitivity / 
ppm/K 
Δδ / ppm pKa 
1 T 4.7 T 7 Ta 9.4 T 
Tb -83 42 (3) 73 (1) 95  122 (1) +0.52 1.4 7.20 
Dy -78 54 (5) 88 (3) 121 156 (1) +0.41 1.9 7.11 
Ho -32 44 (4) 89 (5) 125 160 (2) +0.17 1.1 7.16   
Er +42 92 (10) 117 (7) 144 173 (3) -0.24 0.7 7.11 




δH tBu / 
ppm 





1 T 4.7 T 7 Ta 9.4 T 
Tb -90 45 (1) 69 (1) 92 111 (1) +0.44 2.9 7.33 
Dy -86 56 (1) 94 (1) 124 143 (1) +0.37 3.5 7.22 
Er +48 113 (3) 145 (1) 155 183 (1) -0.24 1.3 7.26 






R1 / s-1 (± error) T sensitivity / 
ppm/K 
Δδ / ppm pKa 
1 T 4.7 T 7 Ta 9.4 T 
Tb -82 91 (1) 121 (1) 139 157 (1) +0.38 2.7 7.31 
Dy -62 59 (1) 103 (1) 136 160 (1) +0.23 3.5 7.29 
Er +32 103 (2) 125 (1) 140 155 (1) -0.13 0.6 7.12 
Tm +65 16 (1) 61 (1) 87 112 (1) -0.32 1.4 7.48 
 
Figure 2.35   Overview of selected chemical shift and relaxation properties of the major 
tert-butyl resonances of [LnL1-3]-. aR1 at 7 T is estimated using the fits of R1 against field.  
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In vivo experiments using an equimolar mixture of [TmL3]- and [ErL3]-, demonstrated 
the feasibility of using 3DGE scans to image complexes in which the tert-butyl 
resonance is shifted on the same side of the water resonance. The triple image 
experiment showed a frequency difference of the reporter resonance between a 
phantom and the bladder. The offset demonstrates the pH and temperature difference 
within these locations. 
Further in vivo work is ongoing in order to construct pH and temperature maps and 
optimise the sequence parameters to achieve the best quality spectra. Triple imaging 
experiments should be undertaken on animal models of human disease to assess the 
change of tissue pH and temperature in these pathologies. 
Although development of the dibenzylphosphinate pH probe, [LnL3]-, has resulted in an 
improved biodistribution, particularly in the liver and kidneys, clearance is still rather 
fast in a mouse model. Larger animals with reduced metabolic rates will likely have 
slower clearance rates and may provide better models for temporal imaging of organs 
such as the liver. Conjugation of the complex to targeting vectors would also reduce 
clearance rates as the molecular weight of the probe increases. The additional benefit 
of targeting vectors would increase the local concentration of the probe and allow for 
non-invasive pH measurement in various pathologies.  
In order to design future PARASHIFT probes, the effect of ligand modification should 
be properly investigated. The vast differences seen in the NMR properties of [LnL1-3]- 
should be explored, so that the ideal ligand structure can be selected.  
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3. Comparison of tri- and dibenzylphosphinate 
complexes 
It has been shown previously that small changes to the metal ion coordination sphere 
can have a dramatic impact on the paramagnetic NMR properties of lanthanide ions, in 
marked contrast to the behaviour expected from simple ligand field interpretations 
based on Bleaney’s theory of magnetic anisotropy.1–5  
An in-depth analysis of both the diamagnetic and paramagnetic NMR data of the 
trimethylphosphinate complexes [YLJ] and [YbLJ] and the tricarboxylate complex [YLH] 
and [YbLH] (see Section 1.7.1, pages 27-30) revealed that whilst the geometries of the 
two complexes was generally similar, their NMR behaviour was quite different.6 It was 
demonstrated that the markedly different NMR behaviour of the complexes arises 
from the change in the orientation of the magnetic susceptibility tensor rather than 
the degree of anisotropy or a change in geometry of the reporter group within the 
ligand.  
Further experimental and theoretical analysis of the isostructural series of 
paramagnetic complexes, [LnLJ], demonstrated that several of the assumptions made 
in both Bleaney’s theory and BRW relaxation theory are incorrect.7,8 Analysis of the 
chemical shift data of the trimethylphosphinate complexes (Tb – Yb) enabled the 
fitting of the individual magnetic susceptibility tensors.7 Significant variations in the 
amplitude, shape and orientation of the PCS fields across the series were revealed. The 
application of Bleaney’s theory suggests that only the amplitude and sign should vary 
between lanthanides and fails to account for changes in ligand field within the series. 
The implicit assumption that the ligand field splitting is smaller than kT was also 
demonstrated to fail for [LnLJ].  
Analysis of the low field (1 T) relaxation rates of the proton resonances for the 
trimethylphosphinate series (Tb – Yb) demonstrated that both the Curie and dipolar 
mechanisms should be treated as anisotropic.8 By measuring the relaxation rates of 
every proton within the complex, it was found that the relaxation rate depends not 
only on the distance of the observed nucleus to the lanthanide, but also the angle of 
Ln-H vector. These results demonstrated that the chemical shift and relaxation 
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properties of potential PARASHIFT probes are not predictable, as the long-standing 
theories suggest. To design new probes for MR successfully, the nature of these effects 
must be better understood.  
In order to explore the variations in chemical shift and relaxation described for the pH 
probes described in Chapter 2, [LnL1-3], it was decided to study the non-phosphonated 
tri- and di-benzylphosphinate complexes, [LnL4] and [LnL5]+ (Figure 3.1). The use of the 
non-phosphonate substituted pyridine moiety allows for direct comparisons to be 
made to the trimethylphosphinate complexes, [LnLJ], which have been extensively 
studied.6–8  
 
Figure 3.1   Structures of the parent benzylphosphinate complexes [LnL4] and [LnL5]+. 
3.1 Synthesis of [LnL4] and [LnL5]+ 
The tert-butyl appended pyridine was synthesised using literature procedures (Scheme 
3.1).9 The N-oxide, 7, was converted to the alcohol, 17, via a Boekelheide reaction with 
trifluoroacetic anhydride (TFAA) and subsequent hydrolysis of the resulting 
trifluoroacetate ester with ethanol and water. Mesylation of the hydroxyl group gave 
the required mesylate, 18. 
 
Scheme 3.1   Boekelheide rearrangement reaction followed by mesylation. 
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The synthesis of the tribenzylphosphinate macrocycle, 16, was described in Section 
2.2.1 (page 68). The dibenzylphosphinate macrocycle was synthesised via an analogous 
route (Scheme 3.2). Alkylation of cyclen with three equivalents of benzyl 
chloroformate at pH 2.5 yielded a major product of the trans- di-substituted 
carbamate, 19, that was purified by recrystallisation. The final amine sites were 
protected with BOC groups, 20, before hydrogenation removed the benzyl carbamates 
to yield the di-BOC macrocycle, 21. Reaction of 21 with diethyl benzylphosphonite and 
anhydrous paraformaldehyde yielded the benzylphosphinate ester, 22, before 
deprotection of the BOC groups was achieved to give the desired trans-substituted 
dibenzylphosphinate macrocycle, 23. 
Scheme 3.2   Synthetic route to di-benzylphosphinate cyclen macrocycle, 23. 
The final secondary amines of the tri- and dibenzylphosphinate macrocycles, 16 and 
23, were alkylated with the mesylate, 18, using caesium carbonate as a base (Scheme 
3.3). Deprotection of the phosphinate esters proceeded under acidic conditions, 
before complexation was achieved using the appropriate lanthanide(III) chloride salt. 
The complexes [LnL4] and [LnL5]+ were purified by reverse-phase HPLC. 
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Scheme 3.3   Procedure for the alkylation and complexation of the tribenzylphosphinate 
complex [LnL4] (top) and dibenzylphosphinate complex [LnL5]+ (bottom). 
As [LnL5]+ contains only two anionic oxygen donors the overall complex is cationic, the 
complex exists was isolated as its chloride salt. 
The luminescence lifetimes of the Eu3+ and Tb3+ complexes of [LnL4] and [LnL5]Cl were 
measured in both H2O and D2O and the metal hydration states were calculated (Table 
3.1). 
Table 3.1   Luminescence lifetime measurements and the calculated q values for the Eu3+ and 
Tb3+ complexes, [LnL4] and [LnL5]Cl (295 K, λex = 270 nm). 
[LnLx] 𝝉𝐇𝟐𝐎 (ms) 𝝉𝐃𝟐𝐎 (ms) q 
[EuL4] 1.03 1.67 0.15 
[TbL4] 3.23 3.70 0 
[EuL5]Cl 0.49 0.65 0.30 
[TbL5]Cl 2.56 2.63 0 
As expected, both [LnL4] and [LnL5]Cl have no inner sphere water molecule, consistent 
with the behaviour of the phosphonate-substituted species, [LnL2] and [LnL3] (Sections 
2.2.1 and 2.3, pages 69 and 76). 
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3.2 Structure elucidation 
3.2.1 Solid state structure analysis 
Crystals of the Yb3+ complex of [LnL4] were grown by diffusion of diethyl ether into a 
methanol solution of the complex (Figure 3.2). The complex crystallised in the 
centrosymmetric space group P21/c, both enantiomers were present within the crystal 
and were symmetry related. The asymmetric unit contained two molecules of the 
same enantiomer, with four of these within the unit cell (Z = 8). However, only one will 
be referred to in this thesis, as both exhibited near identical structures. There was no 
solvent coordinated to the lanthanide ion, however hydrogen bonding was observed 
between methanol in the lattice and two of the phosphinate oxygen atoms. 
 
Figure 3.2   Molecular structure of (SSS)-Δ-(δδδδ)-[YbL4], viewed from the top (left) and the 
side (right). H atoms are omitted for clarity. 
In order to grow a suitable crystal for X-ray diffraction of [LnL5]+ the Cl- counterion was 
substituted for the larger PF6- anion by salt metathesis. Crystals of [YbL5]PF6 were 
grown using the same method as [YbL4] (Figure 3.3). Similarly to [YbL4], the 
dibenzylphosphinate complex crystallised in a centrosymmetric space group, P1̅. Only 
one complex enantiomer was present in the asymmetric unit, and both phosphinate 
oxygens act as hydrogen bond acceptors to solvent methanol. 
Chapter 3: Comparison of tri- and dibenzylphosphinate complexes 
100 
 
Figure 3.3   Molecular structure of (RR)-Λ-(λλλλ)-[YbL5]PF6, viewed from the top (left) and the 
side (right). H atoms are omitted for clarity. The position of the molecule within the unit cell 
was found to be disordered within 4% of the crystal lattice as indicated by the position of Yb1. 
The coordination number of Yb3+ was 8 in each complex. Both exhibit a twisted-
square-antiprismatic (TSAP) coordination geometry with all phosphinate chiral centres 
exhibiting the same configuration (SSS-[YbL4] and RR-[YbL5]PF6). The Yb3+ ion of [YbL4] 
was bound to the four ring nitrogen atoms, the pyridine nitrogen atom and the three 
anionic, phosphinate oxygen atoms, N5O3. The coordination sphere of the Yb3+ ion of 
[YbL5]+ is N6O2, coordinated by the four ring nitrogen atoms as one square plane and 
the two pyridine nitrogen atoms and two anionic oxygen atoms in a trans arrangement 
as the other plane. It was expected that [YbL5]+ would be C2 symmetric, however this 
was not found to be the case in the solid state. 
Due to the isomerism observed in the phosphonate-substituted dibenzylphosphinate 
complex [LnL3], the solid state structure of [TbL5]+ was also sought. The Yb3+ ion is the 
smallest and Tb3+ the largest of the later paramagnetic lanthanides discussed in this 
thesis. Examination and comparison of the crystal structures of both complexes will 
indicate whether the complexes are isostructural or if large geometry changes occur 
across the lanthanide series.  
Crystals of [TbL5]PF6 were grown using the same method as [YbL5]PF6 (Figure 3.4). 
Similarly to [YbL5]PF6, the terbium complex crystallised in the centrosymmetric space 
group, P1̅. In contrast to the Yb3+ complex, the asymmetric unit contained the two 
enantiomeric forms of the Tb3+ complex as two different molecules. The two 
dibenzylphosphinate complexes are comparable, with the same coordination sphere, 
N6O2. 
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Figure 3.4   Molecular structure of (RR)-Λ-(λλλλ)-[TbL5]PF6, viewed from the top (left) and the 
side (right). H atoms are omitted for clarity.  
Bond distances between Ln3+ and the anionic oxygen donors were shorter than those 
to the neutral nitrogen donors (Table 3.2). The bond distances of the metal ion to the 
cyclen nitrogen atoms varied alternatingly in [LnL5]PF6: N1 and N3, which are alkylated 
with the tert-butyl pyridine moiety, had shorter bonds to Ln3+ compared to the 
nitrogen donors alkylated with phosphinates. The Ln-X bond lengths of [TbL5]PF6 are 
longer than those of [YbL5]PF6, as expected due to the larger ionic radius of Tb3+. 
The average distance of the two tert-butyl reporter group protons to the Yb3+ ion of 
[YbL5]PF6 was 6.76 Å, and this was slightly longer than the corresponding distance in 
[YbL4] which was found to be 6.62 Å in the solid state. The average distance r of the 
tert-butyl hydrogen atoms in each enantiomers of [TbL5]PF6 was measured to be 
6.74 Å, very similar to that of the analogous Yb3+ complex. The similarity of the 
internuclear distance in the solid state suggests that any variations in the NMR 
properties of the tert-butyl reporter group are independent of r.   
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Table 3.2   Bond distances in the N5O3 or N6O2 coordination sphere of [YbL4] and [LnL5]PF6. 
bond 
bond lengths (Å) 
[YbL4] [YbL5]PF6 [TbL5]PF6 (Λ) [TbL5]PF6 (Δ) 
Yb-N1 2.549 (3) 2.532 (5) 2.565(2) 2.564(2) 
Yb-N2 2.590(3) 2.629 (4) 2.661(2) 2.668(2) 
Yb-N3 2.570 (3) 2.524 (4) 2.572(2) 2.588(2) 
Yb-N4 2.678 (3) 2.605 (3) 2.646(2) 2.654(2) 
Yb-N5py 2.472 (3) 2.515 (5) 2.533(2) 2.541(2) 
Yb-O1 2.216 (2) 2.194 (4) 2.226(2) 2.234(2) 
Yb-O2/N6py 2.217 (2) 2.508 (4) 2.543(2) 2.535(2) 
Yb-O3 2.232 (2) 2.173 (3) 2.242(2) 2.253(2) 
The four NCCN torsion angles of the cyclen macrocycle ring, which define the λ/δ 
configurations, are reported in Table 3.3. They were all found to be the same sign, 
positive or negative, respectively for the δδδδ and λλλλ enantiomers. 
Table 3.3   Torsion angles in the cyclen macrocyclic ring for [YbL4] and [LnL5]PF6. 
Torsion Chain 
Torsion angle (deg) 
[YbL4] [YbL5]PF6 [TbL5]PF6 (Λ) [TbL5]PF6 (Δ) 
N1-C1-C2-N2 ±59.0(4) ±59.0(6) -58.7(3) +59.8(3) 
N2-C3-C4-N3 ±58.6(4) ±57.3(5) -60.7(3) +59.9(3) 
N3-C5-C6-N4 ±56.8(3) ±59.6(6) -58.3(3) +57.6(3) 
N4-C7-C8-N1 ±58.9(4) ±58.8(6) -59.8(3) +60.4(3) 
The torsion angles of the macrocyclic ring of each complex are similar to each other 
and also comparable to those found for the analogous trimethylphosphinate complex, 
[LnLJ].6 
Similarly, the torsion angles of the exocyclic groups, NCCNpy or NCCO, can be either 
positive or negative (Table 3.4). These angles define the overall Δ or Λ helicity, 
respectively, of the complex.  
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Table 3.4   Torsion angles around the exocyclic groups for [YbL4] and [LnL5]PF6. 
Torsion Chain 
Torsion angle (deg) 
[YbL4] [YbL5]PF6 [TbL5]PF6 (Λ) [TbL5]PF6 (Δ) 
N1-C10-C11-N5py ±28.5(4) ±21.5(7)  -21.8(3)  +22.8(3) 
N2-C20-P1-O1 ±26.9(3) ±43.6(4) -43.9(2)  +42.7(2) 
N3-C30-P2-O2 or 
N3-C30-C31-N6py 
±30.5(2) ±27.1(6) -27.1(3) +29.0(3) 
N4-C30-P3-O3 ±40.6(2) ±43.3(4) -44.1(2) +48.2(2) 
The tribenzylphosphinate complex exhibits similar torsion angles to those of the 
trimethylphosphinate complex.6 However, the exocyclic torsion angles of the 
phosphinate chelate arms are larger for [LnL5]PF6.  
Cyclen-based, 8-coordinate lanthanide complexes typically exist as a form of square 
antiprism, with the 4 cyclen nitrogen atoms (N4) and the arm donor atoms (O3N or 
O2N2) making up two planar and parallel square bases. The twist angles, α and γ, of the 
two square planes are 0° for an idealised square prism and 45° for an antiprism. The 
twist angles for [YbL4], [YbL5]PF6 and [TbL5]PF6 are described and shown in Scheme 3.4 
and Table 3.5. 
 
Scheme 3.4   Schematic representation of the twist angles found in octadentate square 
prismatic lanthanide complexes such as [YbL4] and [LnL5]PF6. 
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5]PF6 (Λ) [TbL5]PF6 (Δ) 
N1-Yb-N3 vs O1-Yb-O3 δ 64.1 70.4 70.6 71.3 
N1-Yb-N3 vs O2-Yb-N5py 
or N5py-Yb-N6py 
α  24.9 18.1 18.4 17.9 
N2-Yb-N4 vs O1-Yb-O3 γ  28.0 18.9 18.5 17.8 
N2-Yb-N4 vs O2-Yb-N5py 
or N5py-Yb-N6py 
β 65.4 72.6 72.5 73.0 
The average observed twist angle for [YbL4] was 26.4°, near identical to that of [YbLJ].6 
The structural modification from the tri- to the dibenzylphosphinate complex however, 
has a more significant impact on the twist angle, reducing it to 18.5° and 18.2° for 
[YbL5]Cl and [TbL5]Cl respectively, indicating the coordination geometry of [LnL5]PF6 is 
somewhat closer to that of an ideal square prism. 
3.2.2 DFT studies 
In order to probe the solution structures of [LnL4] and [LnL5]+, DFT computational 
studies, using the Yb3+ complex crystal structures as a basis to optimise the 
geometries, were conducted by Dr Mark A. Fox (Figure 3.5). Paramagnetic 
Yb3+complexes are difficult to model computationally so the structures were optimised 
as the diamagnetic Y3+ complexes using the hybrid-DFT B3LYP functional and 3-21G* 
basis set which has been previously demonstrated to be appropriate for such 
complexes.10  







Figure 3.5   DFT calculated TSAP structures (Λ-(λλλλ) (left) and Δ-(δδδδ) (right)) of [YL4] (top) 
and [YL5]+ (bottom). 
The relative free energies of the possible isomeric Y3+ complexes of [LnL4] and [LnL5]+ 
are shown in Table 3.6. The lowest energy structures for both complexes are both 
TSAP isomers. In the case of [YL4], the lowest energy structure was calculated to be 
(RRR)-Λ-(λλλλ) as observed by crystallography. However, the TSAP isomer 
(RR)-Δ-(δδδδ) was found to be the lowest energy structure for [YL5]+, although the 
(RR)-Λ-(λλλλ) TSAP diastereoisomer as found in the solid state is of comparable energy.  
Table 3.6   Calculated relative energies for the diastereoisomers of [YL4] and [YL5]+. 
Complex Isomer 
Relative Energy / kJmol-1 
[YL4] [YL5]+ 
(R)-Λ-(λλλλ) TSAP 0.0 1.2 
(R)-Δ-(δδδδ) TSAP 33.4 0.0 
(R)-Λ-(δδδδ) SAP 33.8 25.5 
(R)-Δ-(λλλλ) SAP 64.0 13.9 
The relative energy of the conformations of the dibenzylphosphinate complex [YL5]+, 
are smaller compared to those of the tribenzylphosphinate analogue. This suggests 
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that multiple isomers may be observed in the solution state NMR of [LnL5]+, which is 
consistent with the multiple tert-butyl resonances observed for the phosphonated 
dibenzylphosphinate complex, [LnL3]. 
3.3 Diamagnetic NMR studies of [YL4] and [YL5]Cl 
The solution 1H, 13C and 31P NMR spectra of the diamagnetic complexes, [YL4] and 
[YL5]Cl, were analysed in detail. Complexes of L4 proved sparingly soluble in D2O, so all 
NMR analyses were conducted in CD3OD for each complex.  
Full assignment of the observed 1H, 13C and 31P resonances was achieved for both of 
the major diastereoisomers of [YL4] and [YL5]Cl. The labelling scheme used for [LnL4] is 
shown in Figure 3.6 and an analogous scheme was used for [LnL5]+. The assignment of 
all resonances for the major isomer of both complexes can be found in Section 5.9 
(pages 215-216 and 223-224).  
 
Figure 3.6   Atom labels of [LnL4]: (A) the full structure of [YbL4] showing the donor atoms (B) 
fragment of the same structure labelling the axial (ax) and equatorial (eq) protons of the cyclen 
ring; (C) fragment showing the aromatic (py), axial (apax) and equatorial (apeq) protons of the 
pyridine arm; (D) fragment labelling the axial (a1ax) and equatorial (a1eq) diastereotopic 
protons of the phosphinate arms, the benzylic axial (r1ax) and equatorial (r1eq) diastereotopic 
protons and the ortho- (ph1o), meta- (ph1m) and para- (ph1p) benzylic protons. 
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3.3.1 NMR Assignment of [YL4] 
The 31P NMR spectra of [YL4] showed the presence of three major, distinct phosphorus 
environments (Figure 3.7). Through-bond J coupling to the Y3+ ion (89Y, I = 1/2) was 
observed in each case (2JYP ≈ 6 Hz). The presence of a minor diastereoisomer can also 
be observed, as previously seen for the analogous trimethylphosphinate complex 
[YLJ].6 The ratio of the minor isomer decreased from [YLJ] (5:1) to [YL4] (10:1), a trend 
also observed in the triphosphinate pH probe upon the structural modification from 
methyl to benzylphosphinate groups. 
 
Figure 3.7   31P NMR spectrum of [YL4] showing the phosphinate resonances of both major and 
minor isomers, with small 89Y-31P couplings (3JYP ~ 6 Hz) (14.1 T, 298 K, CD3OD). 
The complex [YL4] contains 43 chemically distinct proton environments and 34 carbon 
environments. The tert-butyl resonance was readily identified from the 1H NMR 
spectrum and the carbon and proton resonances of the aromatic pyridine were 
assigned from this resonance using the 2D 1H-1H COSY, 1H-13C HMBC and 1H-13C HSQC 
spectra. The remaining aromatic signals belong to the phosphinate benzyl groups. Due 
to the number of overlapping resonances, analysis of the 1H-13C HSQC spectra was 
required to identify each of the 9 1H aromatic benzyl resonances. The number of 1H 
signals means that in solution at room temperature there is fast rotation of the 
aromatic rings on the NMR timescale. Proton-phosphorus HMBC (Figure 3.8) and 1H-1H 
COSY spectra were employed to identify the connectivity of the aromatic proton and 
phosphorus resonances. 
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Figure 3.8   1H-31P HMBC NMR spectrum of [YL4] showing the proton-phosphorus correlations 
in the aromatic and aliphatic regions (14.1 T, 298 K, CD3OD). 
The aliphatic region (4.8 – 2.2 ppm) of the 1H spectra of [YL4] contained many 
overlapping multiplets coupled to phosphorus and/or other protons, which made 
assignment challenging. Simplification of the spectra was achieved through the use of 
‘pure shift’ 1H NMR techniques (Dr Juan A. Aguilar), which removes both proton and 
phosphorus coupling. The 1H-1H splitting is removed using the PSYCHE pulse sequence 
and 1H-31P couplings were removed by standard 31P decoupling methods 
(Figure 3.9).11,12 
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Figure 3.9   1H (top), 1H{1H decoupled} (centre) and 1H{1H and 31P decoupled} (bottom) NMR 
spectra of [YL4], in the shift range 2.3 – 4.2 ppm (14.1 T, 298 K, CD3OD). 
In each aliphatic CH2 group, the protons are diastereotopic. A general assignment was 
achieved by analysis of the 2D 1H-13C HSQC spectrum, in which the coupled pairs of 
diastereotopic protons (2JHH ~ 16 Hz) can be readily identified. Proton-proton(2JHH) and 
carbon-phosphorus (1JCP) J coupling can be observed in the 1H-13C HSQC spectrum 
(Figure 3.10) of the identified benzylic-CH2 resonances. The complete connectivity of 
these resonances was aided by inspection of the 2D 1H-31P HMBC spectrum (Figure 3.8) 
which enabled the resonances to be linked to the correct phosphorus atom and 
associated aromatic group.  
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Figure 3.10   1H-13C HSQC NMR spectrum of the aliphatic region of [YL4] showing the PCH2Ar 
(orange) resonances (14.1 T, 298 K, CD3OD). 
The exocyclic arm CH2 protons and carbons of the phosphinate groups and pyridine 
moiety were identified from the 1H-13C HSQC spectrum (Figure 3.11). The phosphinate-
CH2 resonances were correlated to a phosphorus resonance, and therefore the 1H-31P 
HMBC spectrum was used to connect the exocyclic CH2 protons to the correct benzylic 
group (Figure 3.8). 
 
Figure 3.11   1H-13C HSQC NMR spectrum of the aliphatic region of [YL4] showing the cyclen-
CH2 (green), NCH2P (red) and NCH2py (blue) resonances (14.1 T, 298 K, CD3OD). 
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The 1H-13C HSQC spectrum (Figure 3.11) also allowed for the identification of the 
cyclen CH2 protons and carbons. The order of the cyclen carbon resonances around the 
ring was then determined using 1H-13C HMBC and 1H-1H TOtal Correlated SpectroscopY 
(TOCSY) (Figure 3.12). TOCSY is similar to 1H-1H COSY; however, correlations are 
observed for every proton within a given spin system, not just those that are directly 
coupled. This allowed for each NCH2CH2N to be identified and gave the connectivity of 
carbon resonances, around the macrocyclic ring.  Analysis of the 1H-13C HMBC spectra, 
utilising the known assignment of the exocyclic pyridine CH2 protons, allowed for the 
complete assignment of all proton, carbon and phosphorus resonances.  
 
Figure 3.12   Aliphatic region of the 1H-1H TOCSY NMR spectrum of [YL4] (14.1 T, 298 K, CD3OD). 
The groups of four J-coupled cyclen protons are shown with rectangles and solid lines, 
exocyclic CH2 pairs are shown with ovals and dashed lines and benzylic pairs are shown with 
rounded rectangles and dot and dashed lines. 
Carbon-phosphorus coupling was seen in three of the cyclen carbon resonances 
(Figure 3.13).  
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Figure 3.13   13C NMR spectrum of the cyclen region of [YL4] showing the 3JCP coupling (14.1 T, 
298 K, CD3OD). 
Measurement of the torsion angles between the cyclen carbons and the phosphorus 
atoms of the crystal structure of [YbL4] revealed that the coupling arises in those 
carbons with a larger torsion angle (Table 3.7). The size of the coupling follows a 
Karplus-type relationship, so the carbons C2, C4 and C6 exhibit no coupling to 
phosphorus as the torsion angle (~70°) is close to 90°, where the magnitude of 
coupling is a minimum.  
Table 3.7   Torsion angles between the carbons of the cyclen macrocyclic ring and the 





C2-N2-C20-P1 70.7 (3) - 
C3-N2-C20-P1 169.0 (2) 14 
C4-N3-C30-P2 67.7 (3) - 
C5-N3-C30-P2 174.1 (2) 13 
C6-N4-C40-P3 75.9 (3) - 
C7-N4-C40-P3 165.8 (2) 14 
3.3.2 NMR Assignment of [YL5]Cl 
Although the crystal structures of [YbL5]PF6 and [TbL5]PF6 did not show C2 symmetry, 
analysis of the 1H and 31P NMR spectra of [YL5]Cl showed that the major isomer 
exhibits time-averaged C2 symmetry in solution. The presence of C2 symmetry meant 
that assignment of the resonances was simplified, as the number of inequivalent 
resonances is halved. 
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The 31P spectrum of [YL5]Cl in CD3OD showed one major isomer, that revealed a 
through-bond J coupling to the Y3+ ion of the same magnitude as seen in [YL4] 
(2JYP ≈ 6 Hz) (Figure 3.14). 
 
Figure 3.14   31P NMR spectrum of [YL5]Cl showing the phosphinate resonances of the major 
and minor isomers and the small 89Y-31P couplings (14.1 T, 298 K, CD3OD). 
Unlike [YL4], in which only phosphorus resonances arising from a major and a single 
minor isomer were observed, the 31P spectrum of [YL5]Cl showed the presence of 
multiple smaller phosphorus signals. Some of the minor resonances displayed Y3+ 
coupling, although other signals were broader and did not show any splitting. 
The 1- and 2-dimensional 1H NMR spectra confirmed the presence of multiple 
diastereoisomers and their presence was best visualised in the aromatic region of the 
1H-13C HSQC spectrum (Figure 3.15). At least three minor isomers were seen for each 
of the three pyridine resonances. However, the major diastereoisomer accounted for 
~70% of the signal, as calculated by integration.  
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Figure 3.15   1H-13C HSQC NMR spectrum of the aromatic region of [YL5]Cl highlighting the 
major and minor pyridine ((py6 – blue), (py4 – green) and (py3 – orange)) and aromatic benzyl 
(red) resonances (14.1 T, 298 K, CD3OD). 
The 1H-1H COSY spectrum of the aromatic pyridine region was used to assign the minor 
pyridine resonances (Figure 3.16). However, the pyridine proton resonances were the 
only minor signals that could be identified, and only the assignment of the major 
isomer will be discussed henceforth.  
 
Figure 3.16   1H-1H COSY NMR spectrum of the aromatic region of [YL5]Cl highlighting the 
correlations between pyridine resonances (14.1 T, 298 K, CD3OD). Each colour highlights a 
different spin system and stereoisomer. 
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The major tert-butyl and pyridine resonances were assigned similarly to those of [YL4], 
utilising 2D 1H-1H COSY, 1H-13C HMBC and 1H-13C HSQC spectra.  
Proton-phosphorus HMBC (Figure 3.17) was used to identify the major benzylic and 
exocyclic phosphinate CH2 protons. The 2D spectrum also showed the presence of 
phosphorus-proton correlations for the minor isomers. 
 
Figure 3.17   1H-31P HMBC NMR spectrum of [YL5]Cl (14.1 T, 298 K, CD3OD). 
Although the aliphatic region of the 1H spectrum of [YL5]Cl was generally simpler than 
that of [YL4], due to the reduced number of major resonances, decoupling techniques 
still aided assignment (Figure 3.18). 
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Figure 3.18   1H (top), 1H{1H decoupled} (centre) and 1H{1H and 31P decoupled} (bottom) NMR 
spectra of [YL5]Cl, in the shift range 2.3 – 5.3 ppm (14.1 T, 298 K, CD3OD). 
The aliphatic diastereotopic proton pairs were identified using the corresponding 2D 
1H-13C HSQC spectrum (Figure 3.19).  
 
Figure 3.19   1H-13C HSQC NMR spectrum of the aliphatic region of [YL4] showing the cyclen-
CH2 (green), NCH2P (red), NCH2py (blue) and PCH2Ar (orange) resonances (14.1 T, 298 K, 
CD3OD). 
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Full assignment of the cyclen protons was achieved using the 1H-1H TOCSY spectrum 
(Figure 3.20) and 1H-13C HMBC spectra. Similarly to [YL4], carbon phosphorus splitting 
was observed for C3 of the cyclen ring (~14 Hz). Analysis of the crystal structure of 
[YbL5]PF6 showed that the torsion angle between this carbon and the phosphorus 
atom was ~163.5°. 
 
Figure 3.20   Aliphatic region of the 1H-1H TOCSY NMR spectrum of [YL4] (14.1 T, 298 K, CD3OD). 
The two groups of four J-coupled cyclen protons are shown with rectangles and solid lines 
(blue and green), exocyclic CH2 pairs (NCH2P/py) are shown with ovals and dashed lines 
(orange and red) and the benzylic pair (PCH2Ar) are shown with rounded rectangles and dotted 
lines (purple). 
3.3.3 Dynamic NMR analysis of [YL4] and [YL5]Cl 
Whilst the full assignment reveals the connectivity of the complexes, determination of 
the solution structure of [YL4] and [YL5]Cl has not yet been achieved. In the case of the 
trimethylphosphinate complex, [YLJ], 1H-1H NOESY/EXSY NMR was utilised to 
investigate the structure and dynamics of the major isomer.6 The presence of certain 
observed NOE signals was used to identify the TSAP isomer (RRR)-Λ-(λλλλ). Previous 
work has demonstrated that octadentate SAP structures will show two strong NOE 
correlations between exocyclic NCH2P/py protons and the endocyclic, cyclen ring 
protons; whereas only one cross-peak will be present for a TSAP structure.13 In the 
case of [YL4] only one strong NOE correlation with the ring protons was observed, as 
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shown in Figure 3.21. Additionally, the cross-peak observed is between the axial 
exocyclic pyridyl CH2 proton (apax) with the axial endocyclic, cyclen proton of C2 
(c2ax). This correlation is only possible in a TSAP structure indicating that the major 
isomer in solution has a TSAP geometry, in agreement with the outcome of the DFT 
calculations and in accordance with the crystal structure of [YbL4].  
 
Figure 3.21   Aliphatic region of the 1H-1H NOESY NMR spectrum of [YL4] (14.1 T, 298 K, CD3OD, 
300 ms mixing time). The NOE cross-peak highlighted is that of the axial exocyclic pyridyl CH2 
proton (apax) with the axial endocyclic, cyclen proton of C2 (c2ax). This correlation is only 
possible in a TSAP structure. The other NOE cross peak observed for apax is to its 
diastereotopic proton apeq.  
Distinguishing between the two possible TSAP isomers (RRR)-Λ-(λλλλ) and 
(RRR)-Δ-(δδδδ) of the trimethylphosphinate complex [YLJ] relied on the presence of 
correlations between the phosphinate methyl resonances and the exocyclic CH2 
phosphinate protons.6 The absence of cross-peaks between the phosphinate methyl 
groups and the endocyclic ring protons eliminated the possibility of the TSAP structure 
(RRR)-Δ-(δδδδ), as in this conformer the methyl protons would be in closer proximity 
to the cyclen protons than to the exocyclic CH2 protons. Analysis of the DFT structures 
of both TSAP isomers of [YL4] shows that in the minimum energy structure of the 
(RRR)-Δ-(δδδδ) diastereoisomer, the 1H-1H distance between the benzylic CH2 (rax and 
req) and cyclen protons should be ~2 Å. Protons in such close proximity should give 
strong NOE signals. The distance between the benzylic CH2 and the exocyclic 
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phosphinate CH2 protons in the DFT lowest energy structure of the (RRR)-Λ-(λλλλ) 
conformer is much longer at ~2.7 Å. At such an internuclear distance, no or an 
extremely weak NOE signal would be observed. In the NOESY spectrum of [YL4], no 
NOE correlations were observed between the benzylic protons and either the 
endocyclic or exocyclic CH2 resonances (Figure 3.21). Initially, it was thought that 
neither TSAP structure would be able to be conclusively assigned. 
However, upon further inspection, the two benzyl CH2 resonances of phosphinate P3 
do show weak correlations between both the tert-butyl (tBu) and H6 resonance of the 
pyridine, py6, (Figure 3.22). Analysis of the DFT structures showed that this interaction 
between the adjacent phosphinate group and the pyridine resonances can only occur 
in (RRR)-Λ structures. The major solution isomer of [YL4] must be (RRR)-Λ-(λλλλ), as 
expected from the DFT calculations and from the crystal structure of [YbL4]. 
 
Figure 3.22   1H-1H NOESY NMR spectrum of [YL4] (14.1 T, 298 K, CD3OD, 300 ms mixing time). 
The NOE cross-peaks highlighted are those of the P3 phosphinate benzylic CH2 protons with the 
pyridine H6 (py6) and tert-butyl resonance (tBu).  
The aromatic region of the NOESY spectra of [YL4] and [YL5] also revealed chemical 
exchange, as cross-peaks with the same phase as the diagonal were also present, 
consistent with the occurrence of such an exchange process. The major pyridine 
resonances of [YL4] were observed to exchange with the equivalent minor resonances 
(Figure 3.23). Exchange spectroscopy calculations were performed using the 
MestreNova EXSYCalc program using intensity data obtained from two EXSY spectra. 
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The first has a mixing time of 0 ms, which allows for thermal equilibrium, with no 
chemical exchange to be observed. The amplitudes of the diagonal resonance are then 
compared with the diagonals and cross peaks of the second EXSY spectrum. In this 
latter experiment, a mixing time must be chosen that is large enough for 
magnetisation transfer to occur; in this work, that mixing time was found to be 300 ms 
(Figure 3.23). 
Using the H6 pyridine resonance (py6), the rate of exchange between the minor and 
major isomer of [YL4] was found to be 1.27 s-1. The reverse rate was slower (0.12 s-1), 
and the equilibrium constant calculated from these rates (Keq = 10.9) was found to be 
in reasonable agreement with that calculated by integration of the fully relaxed 31P 
NMR spectrum (10:1) (Figure 3.7). Similar exchange rates were found for the 
behaviour of related trimethylphosphinate complexes, [YLJ] and [YL1].6 
 
Figure 3.23   Aromatic region of the 1H-1H NOESY NMR spectrum of [YL4] (14.1 T, 298 K, CD3OD, 
300 ms mixing time). The out of phase (red) cross-peaks indicate through-space NOE 
correlations and the in phase (blue) cross-peaks indicate chemical exchange. 
As with to [YL4], the structure of [YL5]Cl must also be a TSAP, as only one strong NOE 
signal was observed between the exocyclic pyridyl CH2 and the cyclen CH2 protons 
(Figure 3.24). Again, the only NOE correlation seen is between the axial proton on the 
C2 carbon of the cyclen ring (c2ax) and the axial exocyclic pyridyl proton (apax). 
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Figure 3.24   Aliphatic region of the 1H-1H NOESY NMR spectrum of [YL5]Cl (14.1 T, 298 K, 
CD3OD, 300 ms mixing time). The NOE cross-peak highlighted is that of the axial exocyclic 
pyridyl CH2 proton (apax) with the axial, endocyclic proton of C2 (c2ax). This correlation is only 
possible in a TSAP structure. The other NOE cross peak observed for apax is to its 
diastereotopic proton apeq. 
Through-space correlations were also observed between the benzylic protons and 
both H6 of the pyridine (py6) and the tert-butyl resonance (Figure 3.25). As with [YL4], 
the solution structure of the major diastereoisomer of [YL5]Cl must be (RR)-Λ-(λλλλ), as 
revealed in the crystal structure analysis of [YbL5]PF6. DFT calculations predicted that 
the most stable solution structure was the other TSAP diasteroisomer (RR)-Δ-(δδδδ). 
However, the NOE signals observed in the solution NMR spectrum preclude this 
possibility. The DFT calculated relative energy between the two TSAP isomers was 
small (1.2 kJmol-1). 
Chapter 3: Comparison of tri- and dibenzylphosphinate complexes 
122 
 
Figure 3.25   1H-1H NOESY NMR spectrum of [YL5]Cl (14.1 T, 298 K, CD3OD, 300 ms mixing 
time). The NOE cross-peaks highlighted are those of the phosphinate benzylic CH2 protons with 
the pyridine H6 (py6) and tert-butyl (tBu) resonance.  
The previous 1H NMR experiments of [YL5]Cl revealed the presence of multiple 
diastereoisomers within the aromatic pyridine region. The H6 pyridine resonances 
overlapped least, and that enabled at least seven signals to be identified from the 1H 
(Figure 3.26) and 1H-1H COSY spectra (Figure 3.16, page 113).  
 
Figure 3.26   1H NMR spectrum of the pyridine H6 resonances of [YL5]Cl (14.1 T, 298 K, CD3OD). 
The integrals of each peak is shown as a % value. 
1H-1H EXSY spectroscopy at two different mixing times was used to investigate the 
exchange between the observed resonances (Figure 3.27). The experiment showed 
that interconversion between all isomers does not occur on this timescale at 298 K.   
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Figure 3.27   (Top) Forward and reverse reaction rates in s-1 for the isomers of py6 as 
calculated with EXSYCalc. (Bottom) Aromatic region of the 1H-1H NOESY NMR spectrum of 
[YL5]Cl showing the H6 pyridine resonances (14.1 T, 298 K, CD3OD, 300 ms mixing time).   
Analysis of the 2D spectra using EXSYCalc quantified the rate of exchange between the 
diastereoisomers. The forward and reverse rates of the exchange of the isomers were 
broadly similar (k = 0.87 – 1.28 s-1, k-1 = 0.14 – 0.18 s-1) except for the pair A and C. 
Indeed, rates of these exchange processes are similar to those found for both [YL4] and 
[YLJ]. 
 The major isomer, D, was found to exchange with both resonances B and E (Figure 
3.27), which are of similar intensities in the 1H NMR spectrum. A very weak correlation 
was seen between B and E, which may arise via indirect exchange involving the major 
isomer D.  
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3.4 Paramagnetic NMR studies of [YbL4] and [YbL5]Cl 
3.4.1 Pseudocontact shift analysis of [YbL4] and [YbL5]Cl 
The 1H NMR spectrum of [YbL4] revealed the presence of a major and minor isomer in 
a ratio of 13:1 (Figure 3.28). The proton resonances of the major isomer were 
observed between +150 to -75 ppm, with the tert-butyl group resonating at +20 ppm. 
Compared to the chemical shifts of the trimethylphosphinate complex [YbLJ] the 
benzylphosphinate pseudocontact shifts are slightly increased.6 The tert-butyl chemical 
shift of the trimethylphosphinate analogue was observed at +16 ppm. 
 
 
Figure 3.28   1H NMR spectrum of [YbL4] (4.7 T, 295 K, CD3OD). 
Three major phosphorus resonances were observed in the 31P spectrum of [YbL4] 
found to be shifted to lower frequency (-30, -63 and -65 ppm) relative to the 
diamagnetic analogue [YL4] (Figure 3.29). The minor isomer resonances were shifted 
similarly, in a ratio of 12:1, in close agreement with the value obtained from the 
integration of the fully relaxed 1H NMR spectrum. 
Chapter 3: Comparison of tri- and dibenzylphosphinate complexes 
125 
 
Figure 3.29   31P NMR spectrum of [YbL4] (4.7 T, 295 K, CD3OD). 
The spectral range of the 1H chemical shifts of the major isomer of [YbL5]Cl 
(+65 to -50 ppm) was significantly decreased compared to that of [YbL4] (Figure 3.30). 
The tert-butyl chemical shift (+9 ppm) has also decreased from the tri- to the 
dibenzylphosphinate complex. Analysis of the crystal and DFT optimised structures 
does not readily account for the large changes in the pseudocontact shifts as there is 
minimal structural variation between the complexes. 
 
Figure 3.30   1H NMR spectrum of [YbL5]Cl (4.7 T, 295 K, CD3OD). 
Quantifying the proportion of the major isomer from the 1H spectrum was challenging. 
Analysis of the 31P spectrum was simpler, as only five resonances were observed 
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(Figure 3.31). The major resonance represented around 80% of the signal. The two 
largest minor resonances were of equal intensity, as seen previously for py6 in the 1H 
spectrum of [YL5]Cl. Two equal intensity phosphorus resonances will arise from a 
diastereoisomer if it is asymmetric in solution. The phosphorus chemical shifts were all 
negatively shifted, with similar magnitudes to those seen for [YbL4]. 
 
Figure 3.31 31P NMR spectrum of [YbL4] (4.7 T, 295 K, CD3OD). 
In order to construct the PCS fields of [YbL4] and [YbL5]Cl, the chemical shifts, 
linewidths and longitudinal relaxation rates of every proton in each of the Yb3+ 
complexes were measured (4.7 T). A combinatorial assignment and fitting of the NMR 
data, excluding the benzyl resonances was achieved via a semi-automated procedure 
in Spinach 1.9, carried out by Dr Elizaveta A. Suturina (Bath University) using the DFT 
optimised structures of the (RRR)-Λ-(λλλλ) and (RR)-Λ-(λλλλ) complexes (Figure 3.32) 
(See Appendix, Tables S1 and S2). 
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Figure 3.32   Comparison of the observed and ‘best- fit’ PCS values for [YbL4] (left) (R2 = 0.997) 
and [YbL5]Cl (right) (R2 = 0.997). Assignments of selected resonances have been highlighted; a 
full assignment can be found in the Appendix (Tables S1 and S2). 
The ‘best-fit’ susceptibility tensors can be converted to axiality and rhombicity 
parameters together with three Euler angles, with respect to the molecular frame 
(Table 3.8). For each complex, the z axis of the molecular frame goes through the Yb3+ 
ion and the centre of the four nitrogen atoms of cyclen, the x axis points towards 
nitrogen N1 (a more detailed description of this method can be found in Section 5.7, 
pages 193-194).  
Table 3.8   Magnetic susceptibility tensors for [YbLJ], [YbL4] and [YbL5]Cl  expressed in terms of 
axiality (𝝌𝒂𝒙), rhombicity (𝝌𝒓𝒉) and Euler angles.  
Complex 𝝌𝒂𝒙 (Å
3) 𝝌𝒓𝒉 / 𝝌𝒂𝒙 α (deg) β (deg) γ (deg) 
[YbLJ]a 0.11 0.14 185 23 300 
[YbL4] 0.13 0.11 168 22 171 
[YbL5]Cl -0.087 0.10 70 90 269 
a In D2O From reference6 
The pseudocontact shift fields that were constructed from these values are shown in 
Figure 3.33. Comparing the susceptibility tensor fitting results of [YbL4] to the 
trimethylphosphinate complex, [YbLJ], reveals that the structural modification from 
methyl- to benzyl- phosphinates has minimal impact on the amplitude, shape and 
orientation of the PCS fields. The magnitude of the [YbL4] PCS field is slightly increased 
from that of [YbLJ]. The tilt angle of the main anisotropy axis (angle β in Table 3.8) is 
near identical for both of the triphosphinate complexes (22° and 23°). The shape of the 
magnetic susceptibility tensor varies minimally between the complexes, and can be 
described to be between fully axial (𝜒𝑟ℎ / 𝜒𝑎𝑥 = 0) and fully rhombic (𝜒𝑟ℎ / 𝜒𝑎𝑥 = 0.33). 
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However, comparisons between [YbL4] and [YbL5]Cl reveal very large variations in the 
PCS fields. The magnetic anisotropy has changed sign, resulting in the negative PCS 
lobe being larger than the positive one. It would be expected from this result that the 
chemical shifts of the proton resonances in [YbL5]Cl will be opposite in sign to those of 
[YbL4]. However, the change in sign is also accompanied by an extremely large tilt 
angle, β (90°), which results in the negative PCS lobe being orientated in the equatorial 
plane of the molecule, as in [YbL4]. This cooperative effect of the change in sign and 
angle begins to explain the large changes seen between the tri- and 
dibenzylphosphinate species. 
 
Figure 3.33 Pseudocontact shift (PCS) field reconstructed using the best fit susceptibility tensor 
for [YbL4] (left) and [YbL5]+ (right) created in Spinach by Dr Elizaveta A. Suturina. Positive PCS is 
shown in red, negative in blue. 
Comparisons of the fitted magnetic susceptibility tensors of [YbL4] and [YbL5]Cl with 
that of [YbLJ] must regarded with some caution as the NMR data were measured in 
different solvents (D2O vs CD3OD). 
3.5 Luminescence of [EuL4] and [EuL5]Cl in solution 
The emission spectra of the complexes [EuL4] and [EuL5]Cl were measured in methanol 
at room temperature (Figure 3.34).  
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Figure 3.34   Emission spectra of [EuL4] (bottom) and [EuL5]Cl (top) with the splittings (Δ and δ) 
of the ΔJ = 1 manifold highlighted (295 K,  λex = 276 nm, CH3OH). 
The fine structure of the ΔJ = 1 band is controlled by the crystal field splitting of the 
excited 7F1 level, as defined by the nature of the ligand.14 In complexes with C1 or C2 








2, in which the ligand field 
parameters are based on Stevens operators (Figure 3.34). The sign of Δ is positive if the 
singlet component is higher in energy than the doublet component (e.g. [EuL4]). 
Generally, the analysis of emission spectra uses a different formulation of ligand field 
theory, and is described by spherical tensors. Conversion between the two formalisms 
is described by Equations 3.1 and 3.2.14 
𝐵0
2[Spherical Tensors] = 2𝐵0
2[Stevens Operators] (3.1) 
𝐵2




2[Stevens Operators] (3.1) 
The ligand field parameters are given in terms of irreducible spherical tensors in Table 
3.9. The 𝐵0
2 value of [EuL4] and 𝐵2
2 values of both complexes are in good agreement 
with similar complexes previously reported, including that of the trimethylphosphinate 
species (-660 cm-1, H2O).7,9 The very large positive value of the 𝐵0
2 value of [EuL5]Cl is 
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rather unusual but the change in sign is consistent with that seen from the analysis of 
the pseudocontact shift data of [YbL5]Cl (Table 3.8, page 126). 
Table 3.9   Ligand field parameters of [EuL4] and [EuL5]Cl in the spherical operator formalism. 
Complex Δ (cm-1) δ (cm-1) 𝑩𝟎
𝟐 (cm-1) 𝑩𝟐
𝟐 (cm-1) 
[EuL4] 211 82 -703 -167 
[EuL5]Cl -277 75 +923 -153 
3.6 Paramagnetic NMR studies of [LnL4] and [LnL5]Cl 
3.6.1 Pseudocontact shift analysis of [LnL4] and [LnL5]Cl 
After the initial studies on the Yb3+ and Eu3+ complexes of [LnL4] and [LnL5]Cl, the 
investigation was extended to the remaining paramagnetic complexes (where Ln = Tm, 
Dy, Er, Ho, Tm and Yb). The shift and relaxation properties of the tert-butyl resonances 
of each complex were measured in CD3OD. It has been previously shown that changes 
in the solvation of lanthanide complexes can have significant effects on the 
paramagnetic NMR behaviour4 and hence direct comparisons to [LnLJ] must be 
cautious as these measurements were undertaken in D2O. Chemical shift data of the 
major tert-butyl 1H resonances of [LnL4] and [LnL5]Cl (Figure 3.35) showed that the 
change from tri- to dibenzyl phosphinate results in decreased pseudocontact shifts, as 
seen in the pH responsive complexes [LnL2] and [LnL3] (Figure 2.22, page 76). The tert-
butyl reporter resonance is still found outside the diamagnetic region in each complex, 
except [YbL5]Cl (+9.3 ppm). 
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Figure 3.35   Schematic representation of the experimentally measured 1H chemical shifts of 
the major tert-butyl signals in [LnL4] (top) and [LnL5]Cl (bottom) (MeOD, 11.7 T, 295 K, pD 7.4) 
(yellow - Tm, green - Er, magenta - Yb, black – Ho, red - Dy, blue - Tb). 
As observed in the diamagnetic complex [YL4], the paramagnetic complexes of L4 exist 
in solution as two diastereoisomers in slow exchange on the NMR timescale. In each 
case the major isomer represented over 90% of the signal intensity in both the 1H and 
31P spectra, suggesting that the sterically bulky benzyl groups destabilise the minor 
isomer in comparison to the smaller methyl groups of [LnLJ] (See Appendix, Figures S1 
and S2). Similarly to the behaviour of the pH responsive dibenzylphosphinate complex 
[LnL3], multiple diastereoisomers were present in the 1H spectra of [LnL5]Cl (see 
Appendix, Figure S3), as identified by integration, linewidth analysis and longitudinal 
relaxation rates. However, due to the large number of proton resonances, the isomers 
of [LnL5]Cl were best distinguished in the 31P spectra (Figure 3.36). The phosphinate 31P 
resonances for each [LnL5]Cl complex are extremely broad and far shifted, ranging 
from +1350 ppm (Dy3+) to -400 ppm (Tm3+). A major single phosphinate resonance was 
seen for each complex, meaning that the major conformation possesses time-averaged 
C2 symmetry. At least two minor phosphinate resonances were observed for each 
complex. In each case, except [TbL5]Cl, the major diastereoisomer accounted for >50% 
of the phosphorus resonances as calculated by integration.  
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Figure 3.36   31P NMR spectra of the phosphinate resonances observed for [LnL5]Cl (CD3OD, 
4.7 T, 295 K). 
Analysis of the minor isomers found that the two largest of the minor phosphinate 
resonances gave similar integration values in each complex, as found previously in 
both [YL5]Cl and [YbL5]Cl. In the 31P and 1H spectra of [TbL5]Cl the major isomer was 
proportionally smaller. Integration of the fully relaxed 31P and 1H spectra revealed a 
general trend that as the size of the complexed lanthanide(III) ion increases, the 
proportion of minor isomers increases with respect to the major diastereoisomer 
(Figure 3.37). 
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Figure 3.37   Variation in the ratio of the intensities of the 1H tert-butyl and 31P phosphinate 
resonances of the minor and major species of [LnL5]Cl as a function of the lanthanide ionic 
radius (CD3OD, 4.7 T). 
Assignment and fitting of the 1H shift data of the paramagnetic complexes of [LnL4] 
and [LnL5]Cl (excluding Ho3+) with Spinach 1.9 was carried out by Dr Elizaveta A. 
Suturina (Bath University) (See Appendix, Tables S1 and S2). Susceptibility tensor fitting 
results revealed a significant variation in the amplitude, shape and orientation of the 
PCS fields across the series for each complex (Figure 3.38). 
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Figure 3.38 Pseudocontact shift (PCS) field reconstructed using the best fit susceptibility tensor 
for [LnL4] (left) and [LnL5]+ (right) created in Spinach by Dr Elizaveta A. Suturina. Positive PCS is 
shown in red, negative in blue. 
The orientations of the major component of the magnetic susceptibility tensors, β, of 
the tribenzylphosphinate complex, [LnL4], were found to be generally similar to those 
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of the trimethylphosphinate complex, [LnLJ] (Table 3.10).7 The negative lobe of the PCS 
field of [TbL4] points much more directly at the tert-butyl reporter group compared to 
that of [DyL4]. It is this orientation that explains why the chemical shift of the reporter 
group of the Tb3+ complex is as large as the Dy3+ complex despite having a lower 
Bleaney constant.  The shape of the magnetic susceptibility tensors of the [LnL4] varied 
compared to [LnLJ].7 [TbL4] is found to be significantly less rhombic and [TmL4] is less 
axial than their trimethylphosphinate analogues. However, [DyL4] was calculated to be 
almost fully rhombic as found previously with [DyLJ]. 
Table 3.10   Magnetic susceptibility tensors for [LnL4] expressed in terms of axiality (𝝌𝒂𝒙), 
rhombicity (𝝌𝒓𝒉) and Euler angles. 
Ln3+ 𝝌𝒂𝒙 (Å
3) 𝝌𝒓𝒉 / 𝝌𝒂𝒙 α (deg) β (deg) γ (deg) 
Tb -0.83 0.14 30 10 278 
Dy -0.70 0.29 174 16 338 
Er 0.35 0.11 181 13 317 
Tm 0.66 0.11 169 6 162 
Yb 0.13 0.11 168 22 171 
Table 3.11   Magnetic susceptibility tensors for [LnL5]+ expressed in terms of axiality (𝝌𝒂𝒙), 
rhombicity (𝝌𝒓𝒉) and Euler angles. 
Ln3+ 𝝌𝒂𝒙 (Å
3) 𝝌𝒓𝒉 / 𝝌𝒂𝒙 α (deg) β (deg) γ (deg) 
Tb 0.84 0.088 242 90 101 
Dy 0.95 0.015 249 90 76 
Er 0.25 0.30 146 4 178 
Tm 0.53 0.16 140 2 184 
Yb -0.087 0.10 70 90 269 
The shape, amplitude and orientation of the PCS fields of [LnL5]+ vary significantly from 
the tribenzylphosphinate complex (Table 3.11). The complexes [DyL5]+ and [TbL5]+ are 
almost ideally axial whilst [ErL5]+ is almost fully rhombic.  
Additionally, the sign of the PCS field is the opposite of that found with [LnLJ] and 
[LnL4] for the Tb3+, Dy3+ and Yb3+ complexes of L5. In these complexes, the reversal in 
sign is accompanied by a 90° change in the orientation of the major component of the 
susceptibility tensor, β. The result of both of these effects is that the pseudocontact 
chemical shifts of these complexes remain the same sign as those in the triphosphinate 
complexes. These vast changes may be crudely ascribed to the change in symmetry 
from the triphosphinate (C1) to the diphosphinate (C2) complexes, 
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3.6.2 Relaxation rate analysis of [LnL4] and [LnL5]Cl 
The longitudinal relaxation rates of the major tert-butyl resonances of [LnL4] and 
[LnL5]Cl were measured at six fields over the range 1 to 16.4 T (Tables 3.12 and 3.13).  
Table 3.12   1H NMR longitudinal relaxation rate data for the tert-butyl resonance of [LnL4] as a 
function of magnetic field (CD3OD, 295 K). 
Ln3+ R1 / Hz (± error) 











































Table 3.13   1H NMR longitudinal relaxation rate data for the tert-butyl resonance of [LnL5]Cl as 
a function of magnetic field (CD3OD, 295 K). 
Ln3+ R1 / Hz (± error) 











































Comparison of these rates showed that the structural change from tri- to 
dibenzylphosphinate induces very large changes in the relaxation behaviour (Figure 
3.39). The longitudinal relaxation rates of [TbL5]Cl are increased dramatically 
compared to its tribenzylphosphinate analogue, [TbL4]. The effect is largest at lower 
magnetic fields, at 1 and 4.7 T the relaxation rate is increased by 110% and 84% 
respectively. Conversely, the opposite effect is seen for [TmL5]Cl, in which the 
longitudinal relaxation rates are significantly slower, especially at lower fields.  
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Figure 3.39   Variation of the longitudinal rates (R1 / s-1) of the major tert-butyl resonance from 
[LnL4] to [LnL5]Cl expressed as a percentage against the magnetic field for each lanthanide 
(CD3OD, 295 K) (yellow - Tm, green - Er, black – Ho, red - Dy, blue - Tb). 
The dipolar term of the SBM equation, for describing longitudinal relaxation rates 
(Equation 1.9, page 20), dominates the relaxation rate at low fields, and the dramatic 
changes seen at lower fields suggest that it is this term that is most affected by the 
structural change. In order to probe this issue further, the relaxation data were 
analysed by global minimisation methods assuming classical BRW theory (Figure 3.40 
and Figure 3.41), and an average internuclear distance of 6.6 Å was used, as previously 
used in Chapter 1.  
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Figure 3.40   1H NMR relaxation rates (R1 / s-1) for the major tert-butyl resonance of [LnL4] as a 
function of magnetic field, showing the global fits (line) to the experimental data points 
(CD3OD, 295K, pD 7.4, fixed r = 6.6 Å, minimizes to r = 286 (13) ps). 
 
Figure 3.41   1H NMR relaxation rates (R1 / s-1) for the major tert-butyl resonance of [LnL5]Cl as 
a function of magnetic field, showing the global fits (line) to the experimental data points 
(CD3OD, 295K, pD 7.4, fixed r = 6.6 Å, minimizes to r = 240 (19) ps). 
The global fits of [LnL4] and [LnL5]Cl were generally reasonable. However, the data for 
the tribenzylphosphinate complex [TmL4] did not fit well, especially at lower fields. In 
the case of the dibenzylphosphinate complexes, [TbL5]Cl and [ErL5]Cl were found to fit 
poorly; this effect was, yet again, most apparent at lower fields. These results suggest 
that there is an additional factor determining the relaxation rates at lower fields that 
BRW theory fails to account for.  
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The fitting process gave rotational correlation times for [LnL4] and [LnL5]Cl, of 
286 (±13) and 240 (±19) ps respectively. The value of τr is decreased from the 
analogous phosphonated complexes, [LnL2] and [LnL3] (400 (±15) and 418 (±8)). The 
decrease can be rationalised by the reduced mass and smaller solution solvation shell 
of [LnL4] and [LnL5]Cl and the significant reduction in solvent viscosity from water to 
methanol.   
The electronic relaxation times, τe, and effective magnetic moments, μeff, were also 
fitted individually for each lanthanide(III) complex (Table 3.14). The values of μeff for 
[DyL5]Cl, [TbL5]Cl and [HoL5]Cl increase compared to the analogous complexes of 
[LnL4]. In contrast the dibenzylphosphinate complexes of Er3+, Tm3+ and Yb3+, have 
decreased μeff values. As demonstrated by Figure 3.39 the structural change has the 
largest effect at lower fields (> 4.7 T), suggesting the dipolar term and therefore the 
electronic relaxation time is most impacted. The fitted values of τe show this clearly, 
with the estimated values for [TbL5]Cl and [DyL5]Cl increasing, by 94% and 44% 
respectively, compared to the tribenzylphosphinate complex. The decrease in 
relaxation of [ErL5]Cl and [TmL5]Cl is reflected in the decreased τe values. As seen in 
Figure 3.39, the relaxation rate of [HoL4] is faster at fields below 12 T, and this can be 
associated with the modest (-17%) decrease in the value of τe of [HoL5]Cl. However, 
above 12 T this trend is reversed as the increase in μeff becomes dominant. 
Table 3.14   Estimated ‘best-fit’ values for 1H NMR relaxation parameters of [LnL4] and [LnL5]Cl 
following global fitting with fixed r = 6.6 Å (CD3OD, 295 K, pD 7.4).a 
Ln3+ 
τe / ps μeff / BMa 
[LnL4] [LnL5]Cl [LnL4] [LnL5]Cl 
Tb 0.48 0.93 8.68 9.49 
Dy 0.47 0.68 9.27 9.77 
Ho 0.34 0.28 9.61 9.70 
Er 0.91 0.78 9.70 9.30 
Tm 0.36 0.20 9.80 8.93 
Yb 0.55 0.58 4.69 4.27 
a Theoretical values for the magnetic moments of the lanthanide(III) ions are: Tb, 9.7; Dy, 10.6; 
Ho, 10.6; Er, 9.6; Tm, 7.6; Yb, 4.3 BM. 
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3.7 Conclusions and Future Work 
In order to develop and optimise 1H PARASHIFT probes for MRSI in vivo, an 
understanding of the structure, solution dynamics and magnetic anisotropy of existing 
probes is required. The novel lanthanide complexes of the benzylphosphinate 
macrocycles L4 and L5 are prototypical examples of agents that are being developed.  
The solution structure of the major isomers of each complex have been identified by 
studies of the related diamagnetic Y3+ complexes. The major species of complexes [YL4] 
and [YL5]Cl is observed to be the same eight-coordinate TSAP conformation 
(R)-Λ-(λλλλ) in both solution and the solid state. As seen with similar triphosphinate 
complexes,6 [LnL4] undergoes a chemical exchange process with a single minor isomer 
in solution. NMR exchange spectroscopy revealed similar exchange rates compared 
with the previously published trimethylphosphinate complex [LnLJ]. Due to the 
different isomer ratios, [YL4] represents a SNR improvement as the equilibrium 
constant of the major isomer is larger for the benzyl appended complex.  The 
behaviour of the dibenzylphosphinate complex [YL5]Cl is different, and multiple 
isomers are observed in both the 1H and 31P spectra. DFT calculations suggest that the 
different isomers of [LnL5]+ are closer in energy and the overall conformational 
flexibility of the ligand is greater.  
Analysis of the pseudocontact chemical shift behaviour of the tert-butyl resonances of 
the paramagnetic species of L4 and L5 demonstrated that whilst the sign of the shift 
remains the same, the magnitude decreases from tri- to dibenzylphosphinate. The 
reduction in pseudocontact shift was not consistent across the lanthanide series, 
evidence that the degree of anisotropy and orientation of its major component varies 
for the isostructural complexes.  
The paramagnetic 1H NMR spectra of [YbL4] and [YbL5]Cl have been analysed and 
assigned allowing the fitting of the magnetic susceptibility tensors. In the case of the 
tribenzylphosphinate complex, the magnetic anisotropy was observed to be quite 
similar to the trimethylphosphinate complex. In contrast, the magnetic anisotropy of 
the dibenzylphosphinate Yb3+ complex changes sign. However, this dramatic change is 
balanced out by the orientation of the susceptibility rotating by 90°. The result of this 
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is that whilst the negative PCS lobe is now bigger than the positive, it remains 
orientated in the equatorial plane of the molecule. Evidence of the change in sign of 
the magnetic anisotropy of [LnL5]Cl was found from analysis of corresponding Eu3+ 
complex emission spectra. Analysis of the ΔJ = 1 band reveals that the crystal field 
parameter 𝐵0
2 indeed changes sign from the tri- to dibenzylphosphinate complex. 
The fitting procedure was continued for the remaining paramagnetic Ln3+ complexes of 
L4 and L5 (excluding Ho3+), which demonstrated that the shape, sign, orientation and 
magnitude of the magnetic susceptibility tensor varies unpredictably even within an 
isostructural series of complexes. Similarly to [YbL5]Cl, the magnetic anisotropy of the 
dibenzylphosphinate complexes of Dy3+ and Tb3+ were found to be of the opposite 
sign, but orientated by 90° to that fitted for the analogous tribenzylphosphinate 
species. The vast differences between the PCS fields of [LnL4] and [LnL5]Cl could 
possibly arise from the change in symmetry between the complexes. Assignment and 
fitting of the proton resonances of the paramagnetic complexes [HoL4] and [HoL5]Cl 
would enable the construction of the PCS fields across the complete series. The large 
changes to the PCS fields of [LnL4] and [LnL5]Cl, induced by modification from tri- to 
dibenzylphosphinate, were not readily predicted. Similar analysis on a variety of 
complexes, with different geometries and symmetries may enable trends to be 
identified. 
The structural change also induced relaxation rate changes, the longitudinal relaxation 
rates of the Tb3+ and Dy3+ complexes of L5 were observed to be faster than those of L4. 
Conversely, the R1 values of [HoL5]Cl, [ErL5]Cl and [TmL5]Cl, were found to be lower 
than those of the analogous tribenzylphosphinate complexes. In both cases this effect 
was found to be largest at lower fields (< 4.7 T), suggesting that the change in structure 
has a larger impact on the electronic relaxation time, rather than the magnetic 
moment, of the lanthanide ion. More in-depth analysis of the relaxation rates of all the 
proton resonances of [LnL4] and [LnL5]Cl should be explored in order to further 
examine the anisotropy of the paramagnetically induced relaxation rate of different 
lanthanide complexes. This may explain the significant variations of longitudinal 
relaxation rates in the Tb3+ and Tm3+ complexes of [LnL4] and [LnL5]Cl. 
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The results shown in this thesis demonstrate the difficulty in predicting the NMR 
properties of a particular PARASHIFT probe, even when making seemingly minor ligand 
modifications. In the example of modification from a tri- to diphosphinate complex, 
initial analysis of the tert-butyl reporter chemical shifts suggests only a minor change in 
the lanthanide anisotropy. However, in-depth analysis demonstrates that both a 
change in sign and orientation of the PCS field is occurring. When looking only at the 
chemical shift of the reporter resonance these two variations mostly cancel each other 
out but may be causing the dramatic changes in relaxation. 
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4. Development of zinc responsive PARASHIFT probes 
Metal cations are essential for life, are associated with numerous biological signalling 
pathways and are found in countless enzymes and proteins. Zinc (Zn2+) is the second 
most abundant transition metal ion, after iron, in the body. Most biological Zn2+ is 
tightly bound within metalloproteins and plays a key role in enzymatic catalysis and 
structural organisation. However, Zn2+ has also been found to be an important 
signalling ion and relatively high concentrations of free Zn2+ (μM) can be present 
extracellularly in several organs (e.g. the pancreas and prostate gland) in the body.1 
Disruption of normal Zn2+ homeostasis is associated with many diseases, such as 
diabetes and prostate disease. Elevated levels of zinc in the brain have been linked to 
certain neurodegenerative disorders, including Alzheimer’s disease.  
The abundance and importance of Zn2+ in biology has led to the development of many 
chemical sensors, most commonly based on fluorescence detection.2,3 Typically these 
sensors are small molecular probes, such as the cell-permeable probe Zinpyr-1 
described by Lippard and Tsien (Figure 4.1),4 and contain a fluorescent reporting group 
appended with selective Zn2+ chelators. The most frequently used chelator 
incorporated into Zn2+ sensors is bis(2-pyridylmethyl)amine, also known as 
dipicolyamine (DPA). DPA forms an extremely stable complex with Zn2+ (Kd = 158 nM)5 
and has no measurable affinity for other biological, divalent cations, such as Ca2+ and 
Mg2+.6 
 
Figure 4.1   Structure of the fluorescent Zn2+ sensor Zinpyr-1. 
Zn2+ sensors for MRI have also been designed. Typically they are Gd3+-based complexes 
with relaxivity values that vary as a function of Zn2+ concentration.7,8  
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Figure 4.2   Examples of MRI-based Zn2+ sensors. 
Nagano and co-workers designed the first Zn2+ sensing MRI probe, based on a Gd-DTPA 
backbone appended with two DPA moieties, [GdLY] (Figure 4.2).9 Upon addition of up 
to 1 equivalent of Zn2+, the relaxivity of the complex decreased by 33%. In the resulting 
1:1 complex, Zn2+ is coordinated by both DPA units. The hydrophobic pyridine moieties 
sterically limit the access of water to the Gd3+ ion, resulting in a decrease in relaxivity. 
However, this change is reversed upon the further addition of Zn2+ as a less sterically 
demanding 2:1 complex forms at higher concentrations. The replacement of one 
pyridine unit of each DPA moiety by a carboxylate group, [GdLZ] (Figure 4.2) 
circumvented this problem as the 2:1 complex was no longer favoured, meaning the 
30% relaxivity decrease was maintained, even after addition of excess Zn2+.10 Both of 
these sensors displayed high selectivity for Zn2+ as no relaxivity changes were induced 
upon addition of Mg2+ or Ca2+.  
Sherry and co-workers developed an Eu3+ PARACEST probe for the selective sensing of 
Zn2+, based upon a cyclen-tetraamide macrocycle appended with two DPA moieties, 
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[EuLA1] (Figure 4.2).11 Following addition of Zn2+, the CEST magnitude of the exchanging 
inner sphere water molecule decreased and this behaviour was attributed to a faster 
exchange rate. Phantom imaging demonstrated selectivity against Mg2+ and Ca2+. 
However, the loss of the CEST signal was also found to be pH dependent, and a marked 
temperature dependence of the chemical shift of this resonance was also observed. 
The PARACEST probe, [EuLA1], was modified to create a Gd3+-based relaxivity probe, in 
which two of the amides were replaced with carboxylates, [GdLB1] (Figure 4.2).12 A 
modest increase (20%) in relaxivity was observed with the addition of Zn2+ until 
2 equivalents had been added. The increase in relaxivity was suggested be due to the 
presence of the Zn2+ cation promoting faster water exchange rates at the Gd3+ ion. 
When the same addition of Zn2+ was performed in the presence of human serum 
albumin (HSA), a significantly larger increase (165%) in the relaxivity was observed. 
Fluorescent displacement experiments indicated that the 2:1 Zn2+2:[GdLB1] complex 
binds strongly to HSA, whereas the [GdLB1] complex alone binds weakly. The increase 
in relaxivity in the presence of HSA was therefore attributed to an increase in the 
rotational correlation time for the complex when bound to the large protein. In vivo 
studies demonstrated that the complex could be used to monitor the glucose-
stimulated co-release of Zn2+ with insulin from pancreatic β-cells.13 It was shown that 
mice on high-fat diets displayed higher contrast enhancement upon injection of 
glucose and [GdLB1], consistent with pancreatic expansion and concomitant increase in 
β-cell function. More recently the same complex was investigated for the detection of 
the release of Zn2+ in the prostate.14 
GdDO3A-based Zn2+ sensors were investigated by Meade and co-workers, [GdLC1] and 
[GdLD1] (Figure 4.2), in which the relaxivity increased upon the binding of Zn2+.15,16 The 
aminoacetate groups in [GdLC1] were 13C-labeled providing direct evidence of 
carboxylate binding to the paramagnetic centre, in the absence of Zn2+. In the free 
complex, Gd3+ is coordinatively saturated and thus has a low relaxivity. Upon addition 
of Zn2+, the relaxivity increases by over 100%. In vitro phantom images, obtained at 
4.7 T, demonstrated selectivity for Zn2+ over Ca2+ and Mg2+. 
Lippard and co-workers designed a dual-function Mn2+-based probe for MRI and 
fluorescence, [MnLE1] (Figure 4.2).17 The fluorescence and relaxivity of the porphyrin 
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complex was modulated by the presence of Zn2+. The probe shows a 24% decrease in 
relaxivity upon the addition of 1 equivalent of Zn2+ and the near infrared (NIR) 
fluorescence increased by a factor of 10. The water-soluble porphyrin probe was able 
to permeate cell membranes and MR experiments demonstrated that the probe could 
induce lower relaxivity values in cells incubated with Zn2+. The contrast agent was 
shown to effectively penetrate and stain cells in vivo using intracranially injected rats.18 
However, in the regions of the brain with known higher concentrations of Zn2+, the 
contrast enhancement was found to be greater than for regions with lower 
concentration of Zn2+, the opposite of the dependence found with in vitro and cellular 
experiments. 
Unfortunately, all of the contrast agents described above rely on indirect methods of 
detection, which measure the properties of the bulk water, to quantify the Zn2+ 
concentration. It is not possible to determine the Zn2+ concentration without knowing 
the concentration of the probe in each voxel studied. Local concentrations cannot be 
known in vivo without additional efforts or scans to calculate contrast agent 
concentration. The use of PARASHIFT probes provides the opportunity to remove this 
limiting requirement, as the probe itself reports the presence of Zn2+ by modulation of 
a concentration independent parameter.  
A Eu3+-based Zn2+ luminescence sensor has been previously reported by Pope and 
co-workers, which contained a pyridine group appended with a DPA moiety, on a 
DO3A macrocycle, [EuLF1] (Figure 4.3).19 Upon addition of 1 equivalent of ZnCl2, the 
observed europium luminescence emission was quenched. A 1:1 complex formed with 
Zn2+, and the changes to the luminescence spectrum occurred as a result of the 
modulation of the Eu3+ coordination environment.  
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Figure 4.3  Structure of existing luminescent Eu3+-based Zn2+ probe and proposed 
conformational change upon Zn2+ binding (top) and proposed structure of PARASHIFT Zn2+ 
probe (bottom). 
It is proposed in this thesis to modify [EuLF1] by adding a tert-butyl reporter group 
adjacent to the DPA Zn2+ sensing moiety, thereby creating the first metal responsive 
PARASHIFT probe (Figure 4.3).  
4.1 Synthesis of [LnL7] 
The initially proposed synthetic pathway to the tert-butyl and DPA appended Zn2+ 
sensing moiety is shown below in Scheme 4.1.  
Scheme 4.1   Attempted synthetic pathway to the desired tert-butyl and DPA appended 
pyridine intermediate. 
Chapter 4: Development of zinc responsive PARASHIFT probes 
148 
The tert-butyl reporter group was installed first, onto 3-bromo-2,6-dimethylpyridine, 
using a Grignard reaction, by an analogous method to that described previously in 
Section 2.1.1 (pages 52 and 53). The reaction was found to be extremely slow, yielding 
<20% of the desired product after a week of stirring at room temperature. The solvent 
system of the reaction was changed from diethyl ether to tetrahydrofuran, allowing 
heating of the reaction to 50°C and under these conditions completion of the reaction 
was achieved overnight. The desired product, 24, was not volatile, unlike 5-tert-butyl-
2-methylpyridine (6), which allowed purification to be undertaken by silica gel column 
chromatography. The conversion to the corresponding N-oxide, 25, was achieved by 
reaction with mCPBA, before a Boekelheide rearrangement using trifluoroacetic 
anhydride activated the proximate CH bond of the methyl group. It was expected that 
a mixture of both possible trifluoroacetic ester regioisomers from the rearrangement 
(Figure 4.4) would be present.  
 
Figure 4.4   Structures of the two possible trifluoroacetic ester regioisomers from the 
Boekelheide rearrangement of 25. 
However, the crude 1H NMR spectrum of the trifluoroacetic ester indicated only a 
single product was present. After room temperature hydrolysis, the alcohol product, 
26, was purified by silica gel column chromatography. The NOESY 2D NMR spectrum 
was utilised to characterise 26 (Figure 4.5) and two indicative correlations confirmed 
the presence of only the 6-methyl product. Cross-peaks revealed a close spatial 
proximity of the tert-butyl protons and the allylic alcohol protons and also between 
the pyridine H5 and the remaining methyl protons that can only occur in the 6-methyl 
regioisomer.  
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Figure 4.5   1H-1H NOESY NMR spectrum of 26. The NOE correlations of importance are circled 
in green. 
Mesylation of 26 with methanesulfonyl chloride and triethylamine led to the mesylate 
ester 27, before alkylation of DPA was carried out using potassium carbonate as the 
base. The tripicolyl product, 28, was purified using reverse phase HPLC. In order to 
introduce the alcohol functionality, it was necessary to re-oxidise the pyridine 
nitrogen. However, due to the presence of multiple pyridine rings, reaction of 28 with 
one equivalent of mCPBA yielded a mixture of N-oxide products that could not be 
separated or purified.  
Alternative methods to reach the hydroxyl group required in the final pyridine were 
therefore explored. Oxidation of the 6-methyl group of 28 was attempted with 
selenium dioxide, but similarly this could not yield a selective reaction. Bromination, 
via a radical reaction with N-bromosuccinimide also gave a mixture of products. The 
lack of selectivity is due to the presence of multiple picolyl environments at which 
reaction can occur. 
A new synthetic pathway (Scheme 4.2) was proposed in which the N-oxide was 
installed before the alkylation of the DPA moiety.  
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Scheme 4.2   Alternate synthetic pathway to the tert-butyl and DPA appended pyridine 
intermediate. 
The 6-methyl alcohol product, 26, was converted to the N-oxide, 29, with mCPBA and 
the subsequent mesylation of the alcohol was initially attempted with 
methanesulfonyl chloride and triethylamine. Mass spectrometry of the crude reaction 
mixture revealed that, whilst full conversion of the alcohol to the mesylate had 
occurred, the major species had also undergone reduction of the N-oxide. A literature 
search revealed that methanesulfonyl chloride and triethylamine may be used as 
reagents for the reduction for N-oxides, thought to be through the formation of 
SO2.20,21 A change of base from triethylamine to N,N-diisopropylethylamine (DIPEA) 
afforded the mesylated product, 30, in reactions with both methanesulfonyl chloride 
and anhydride, suggesting that a more sterically hindered base prevents the 
production of SO2. The alkylation of DPA proceeded similarly to that previously 
described, and the tripicolyl product, 31, was purified using HPLC. Unfortunately, upon 
reaction with TFAA no desired product was seen to be formed by the either crude 
NMR spectrum or mass spectrometry. It is likely that the deprotonation step of the 
Boekelheide rearrangement occurred on the more acidic 2-picolyl protons, instead of 
the 6-methyl as desired.  
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The conversion of the 6-methyl group to an alcohol was deemed unfeasible after the 
addition of the DPA moiety. Accordingly, a new synthetic route was developed in 
which both methyl groups of 24 are oxidised before the introduction of the Zn2+ 
sensing amine (Scheme 4.3). Oxidation and subsequent esterification of both methyl 
groups of 24 should yield a diester, which may be carefully reduced to two potential 
regioisomers of the monoester, both of which can be intermediates to the desired Zn2+ 
sensing arm. 
 
Scheme 4.3   General strategy for the synthesis of tert-butyl and DPA appended pyridine 
intermediate from 3-tert-butyl-2,6-dimethylpyridine, 24. 
The dimethyl pyridine precursor, 24, was oxidised to the dicarboxylate salt with KMnO4 
(Scheme 4.4). The dicarboxylic acid could not be isolated, so the esterification step was 
performed on the crude dicarboxylate salt. Initial attempts to install methyl esters with 
methanol and catalytic H2SO4 were unsuccessful. The esterification was reattempted, 
similarly on the crude salt, with thionyl chloride and methanol to first form the reactive 
acyl chloride. The 1H NMR spectrum of the reaction mixture revealed two major 
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products which were separated by silica gel column chromatography to yield the 
desired diester, 33, as the minor product (23%) and the monoester, 32, as the major 
product (35%). Only one mono-ester regioisomer was observed. Analysis of the 2D 
1H-13C HMBC NMR spectrum established this to be the 6-ester. Formation of the 
2-ester is expected to be inhibited due to the increased steric hindrance from the 
presence of the adjacent, bulky tert-butyl group. An esterification with the same 
conditions was repeated on the pure monoester product, 32, however no second 
esterification was observed. A Steglich esterification using the carbodiimide 
N,N'-dicyclohexylcarbodiimide (DCC) with 4-dimethylaminopyridine (DMAP) as a 
catalyst yielded the diester, 33, although separation of the product from the excess 
dicyclohexylurea by-product proved challenging. The reaction was repeated with 
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), the aqueous soluble urea 
by-products of which were easily removed through aqueous washing before further 
purification on silica gel. 
 
Scheme 4.4   The synthetic route to dimethyl 3-tert-butyl-2,6-pyridinecarboxylate, 33. 
A test reaction of the mono-reduction of diester, 33, was attempted using sodium 
borohydride at 0°C (Scheme 4.5 and 4.6). The reaction was monitored regularly by thin 
layer chromatography (TLC) to ensure consumption of the starting material and limit 
over reduction to the diol, (2,6-dihydroxymethyl, Scheme 4.5). 
Scheme 4.5   The reduction of 3-tert-butyl-2,6-pyridinecarboxylate, 33, and the possible 
products. 
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However TLC analysis showed complete loss of starting material immediately (<5 min) 
and only a single spot was visible under UV, even after stirring the reaction at room 
temperature for several hours. NMR analysis of the reaction mixture confirmed the 
presence of only one product, indicating the complete regioselectivity of the 
reduction. Purification by silica gel column chromatography yielded a single mono-
reduced regioisomer in near quantitative yield. The 2D NOESY NMR spectrum was 
employed to determine the constitution of this regioisomer (Figure 4.6). Through-
space correlations were found between the tert-butyl group and the methyl protons of 
the ester. The reduction reaction therefore occurred selectively to produce the 6-
hydroxylmethyl pyridine, 34, which was further corroborated by the presence of a 
cross peak between the pyridine H5 and the hydroxymethyl protons. 
 
Figure 4.6   1H-1H NOESY NMR spectrum of 34. The NOE correlations of importance are circled 
in green. 
As indicated in Scheme 4.3, the 6-hydroxylmethyl group must be protected before the 
second ester is reduced so that the DPA group can be alkylated regioselectively. A 
tetrahydropyran (THP) ether was chosen due to the ease of protection and 
deprotection and their known stability under reductive and basic conditions. The 
protection step was achieved by reaction of 34 with 3,4-dihydro-2H-pyran and catalytic 
p-toluenesulfonic acid to yield 35 (Scheme 4.6). The remaining ester was reduced with 
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lithium aluminium hydride to give the alcohol 36. Conversion to the mesylate, 37, 
succeeded using methanesulfonyl chloride and triethylamine, prior to alkylation of 
DPA. Purification of the alkylated product, 38, was achieved with column 
chromatography on alumina.  
 The THP ether was then hydrolysed under acidic conditions with p-toluenesulfonic 
acid to yield the desired novel tert-butyl and DPA appended pyridine, 39. Mesylation of 
the hydroxyl group provided the required reactive pyridine moiety, 40, for alkylation of 
the cyclen macrocycle. 
Scheme 4.6   Synthesis of the tert-butyl and DPA appended pyridine intermediate, 40, from the 
diester, 33. 
The previous work described in Chapter 3 indicated that neutral tribenzylphosphinate 
Ln3+ complexes may have limited water solubility. However, neutral 
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trimethylphosphinate complexes, such as [LnLJ], have demonstrated sufficient 
solubility in water. Hence the macrocycle, 5, was chosen as the ligand backbone of the 
Zn2+ probe. The alkylation step was carried out in anhydrous acetonitrile using caesium 
carbonate as the base (Scheme 4.7), and the crude ligand purified by alumina column 
chromatography. 
 
Scheme 4.7   The alkylation of trimethylphosphinate 5 with mesylate 40 to afford the ligand L6. 
Phosphinate ester hydrolysis of L6 was carried out in aqueous 6 M HCl solution at 70°C 
(Scheme 4.8), and reaction progress was monitored by mass spectrometry. Once the 
ester hydrolysis was complete, the pH of the solution was adjusted to 5.5 and 
dysprosium(III) chloride was added. The reaction was stirred for 7 days at 70°C. 
However, after HPLC, only uncoordinated ligand was observed and no complex could 
be isolated. Several attempts at the complexation reaction yielded similar results 
regardless of solvent and pH. The additional steric bulk of the Zn2+ sensing pyridine 
moiety may have inhibited complex formation in the triphosphinate macrocycle.  
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Scheme 4.8   Attempted hydrolysis and complexation of ligand L6. 
In order to achieve complexation a less sterically hindered macrocyclic derivative was 
sought. The tert-butyl tri-ester of DO3A, 41, was therefore prepared using a literature 
procedure (Scheme 4.9).22 
 
Scheme 4.9   Synthesis of the tert-butyl tri-ester of DO3A. 
Alkylation of the macrocycle, 41, with the mesylate, 40, was achieved in acetonitrile 
using caesium carbonate as the base (Scheme 4.10). Hydrolysis of the tert-butyl esters 
was carried out in trifluoroacetic acid (TFA) and dichloromethane at room temperature 
before complexation in aqueous solution with the appropriate lanthanide(III) chloride 
hexahydrate. The crude complexes were purified by reverse phase HPLC.  
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Scheme 4.10   General procedure for the alkylation, hydrolysis and complexation of [LnL7]. 
The inner sphere hydration state, q, for [LnL7], was calculated by measuring the 
luminescence lifetimes of [EuL7] and [TbL7] in both H2O and D2O (Table 4.1). 
Table 4.1   Luminescence lifetime measurements of [EuL7] and [TbL7] (295 K, λex = 276 nm, 
pH/pD = 7.3). 









A q value of 0 was expected, as the lanthanide has a coordination number of at least 8 
and there is an additional shielding effect from the hydrophobic DPA. The q value of 
zero was observed experimentally, in agreement with the results of Pope and co-
workers.19 
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4.2 NMR studies of [LnL7]: shift and relaxation 
4.2.1 Diamagnetic NMR studies of [YL7]: shift and relaxation 
The diamagnetic complex [YL7] was synthesised in order to compare the NMR 
behaviour with the analogous paramagnetic complexes. 1H NMR analysis revealed a 
mixture of broad and sharp resonances within the aromatic pyridine region 
(Figure 4.7).  
 
 Figure 4.7   1H NMR spectrum of [YL7] (D2O, 16.4 T, 295 K, pD 7.3). 
A general assignment was attempted using the HSQC, COSY and NOESY 2D NMR 
spectra. However, no resonances corresponding to the aromatic or picolyl DPA protons 
could be assigned unequivocally. Whilst the two aromatic proton resonances of the 
tert-butyl pyridine moiety are sharp and readily assignable, several of the aromatic 
DPA resonances are exchange broadened. Such exchange broadening is consistent 
with the presence of more than one conformation or species of the DPA moiety.  
Variable temperature NMR was undertaken in an attempt to explore the origins of the 
broadening of the aromatic resonances (Figure 4.8). Upon cooling, multiple resonances 
appeared within the aromatic region. Above 305 K, these resonances sharpened and 
coalesced to reveal four distinct picolyl environments. The macrocyclic ring protons 
also sharpened at lower temperature but no additional resonances were seen.  
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Figure 4.8   Stacked variable temperature 1H NMR spectra of the aromatic region of [YL7] (D2O, 
11.7 T, pD 7.3), showing a coalescence phenomenon around 300 K.  
 
Figure 4.9   Partial structure of the Zn2+ sensing DPA moiety highlighting C-Namine rotation. 
The variable temperature NMR study demonstrates that at temperatures above 285 K 
the C-Namine bond (Figure 4.9) must be free to rotate sufficiently quickly that the two 
picolyl rings are rendered equivalent on the NMR timescale. As the temperature 
decreases, bond rotation slows and the picolyl rings are inequivalent, which may be 
associated with a weak interaction between the tertiary amine lone pair and the 
lanthanide(III) ion, perhaps mediated by a bridging solvent interaction.   
4.2.2 Paramagnetic NMR studies of [LnL7]: shift and relaxation 
The chemical shifts of the tert-butyl reporter group of the paramagnetic [LnL7] 
complexes were measured in D2O (Figure 4.10). The resonances are significantly less 
shifted than the phosphinate-based complexes described in the previous chapters. 
However, the tert-butyl resonance for the Tm3+, Tb3+ and Dy3+ complexes lies well 
outside the diamagnetic region. 
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Figure 4.10   Schematic showing the superimposed partial 1H NMR spectra of the tert-butyl 
resonance of [LnL7] (D2O, 4.7 T, 295 K, pD 7.3): Tm (yellow); Yb (magenta); Tb (blue); Dy (red). 
When compared to the analogous carboxylate complex without the Zn2+ sensing 
moiety, [LnLH] (see Section 1.7.1, page 27-29), the tert-butyl pseudocontact chemical 
shifts are increased. The increase is most significant for the negatively shifting tert-
butyl resonances. Thus, in [TbLH] and [DyLH] chemical shifts of -10.6 and -20.1 ppm 
respectively are observed, compared to -30.2 and -36.5 ppm in [TbL7] and [DyL7]. It has 
been found previously that the presence of an axially coordinated water molecule can 
have a significant impact on the paramagnetic shift of lanthanide complexes in 
structurally related ligands (see Section 1.7.1, page 27-31), as the orientation and size 
of the principal component of the magnetic susceptibility tensor (the axial component) 
are sensitive to structural perturbation. The larger chemical shifts in [LnL7] are also 
consistent with the loss of the inner sphere water molecule, as established from the 
lifetime analysis of the Eu3+ and Tb3+ complexes (Table 4.1).  
Unlike [LnLH], in which two diastereoisomers are observed, only one tert-butyl 
resonance was present for every [LnL7]. The weak interaction postulated between the 
DPA amine and lanthanide(III) ion is likely to stabilise the complex and reduce the 
flexibility of the macrocyclic backbone.  
The longitudinal relaxation rate, R1, of the tert-butyl resonance of [LnL7] was measured 
at six different field strengths (Table 4.2). The rates are comparable with those of 
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[LnLH],23 indicating that there is no large structural change in the complex that causes 
the increase in the pseudocontact shift of the tert-butyl resonances.  
Table 4.2   1H NMR longitudinal relaxation rates for the tert-butyl resonance of [LnL7] as a 
function of magnetic field (D2O, 295 K, pD 7.3). 
Ln3+ R1 / s-1 (± error) 





























The relaxation data of the four complexes were analysed by global minimisation 
methods assuming the internuclear distance, r, was 6.6 Å (Figure 4.11). The fitting 
yielded generally good results, although both [DyL7] and [TmL7] were less well fitted at 
low fields. 
 
Figure 4.11   1H NMR relaxation rates (R1 / s-1) for the major tert-butyl resonance of [LnL7] as a 
function of magnetic field, showing the global fits (line) to the experimental data points (D2O, 
295K, pD 7.3, fixed r = 6.6 Å, minimizes to r = 237 (7) ps). 
This minimisation process gave a common rotational correlation time, τr, of 
237 (±7) ps, and also predicted values of μeff and τe for each lanthanide ion (Table 4.3). 
The calculated value of τr is slightly increased from the value of the similar 
tricarboxylate complex, [LnLH] (197 (±7) ps), which is consistent with the increase in 
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molecular volume arising from the additional DPA moiety. The predicted μeff values are 
in relatively close agreement to those theoretically calculated. 
Table 4.3 Estimated ‘best-fit’ values for 1H NMR relaxation parameters of [LnL7] following 
global fitting with fixed r = 6.6 Å (D2O, 295 K, pD 7.4)a 
Ln3+ τe / ps μeff / BMa 
Tb 0.49 (5) 9.48 (2) 
Dy 0.65 (6) 10.72 (4) 
Tm 0.34 (12) 8.26 (5) 
Yb 0.44 (3) 4.47 (6) 
a Theoretical values for the magnetic moments of lanthanide(III) ions are: Tb, 9.7; Dy, 10.6; Tm, 
7.6; Yb 4.3 BM. 
The chemical shift of the reporter tert-butyl group was investigated over the 
temperature range 290 K to 325 K and showed a linear dependence (Figure 4.12). The 
magnitudes of the linear sensitivities are significantly decreased in comparison to the 
previously discussed phosphinate complexes; [TbL7] and [DyL7] have the largest 
dependences, 0.25 and 0.27 ppm/K respectively. 
 
Figure 4.12   Variation in the chemical shift of the tert-butyl resonance of [LnL7] as a function 
of temperature (D2O, 11.7 T, pD 7.3): Tm (yellow) R2 = 0.996; Yb (magenta) R2 = 0.998; Tb (blue) 
R2 = 0.994; Dy (red) R2 = 0.995. 
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4.3 pH Responsive behaviour of [LnL7] 
4.3.1 Luminescence studies of [EuL7] and[TbL7]: pH response 
In order to study the pH sensitivity of [LnL7] a pH titration with [EuL7] was carried out. 
The emission spectrum and emission lifetime were recorded as a function of pH. The 
emission spectra showed that the luminescence generally decreases upon decreasing 
pH (Figure 4.13). A sigmoidal fit of the intensity ratio of the largest ΔJ = 2 band against 
a ΔJ = 0 band gave a pKa of 5.70(05).  
 
Figure 4.13   Variation of the emission spectra of [EuL7] (20 μM) as a function of pH (H2O, 
295 K, λex = 276 nm). (Inset) The ratio of emission intensities at 617 nm (ΔJ = 2) / 579.5 nm 
(ΔJ = 0) as a function of pH. 
The luminescence lifetimes of ΔJ = 2 was also measured in D2O and H2O at varying pH 
(Figure 4.14). Interestingly, whilst the lifetime in H2O decreased with decreasing pH, 
the lifetime in D2O increased at lower pH.  
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Figure 4.14   Variation of the lifetime of [EuL7] as a function of pH in H2O and D2O (295 K, 
λex = 276 nm, λem = 617 nm). 
The hydration state of [EuL7] was estimated, from the sigmoidal fit of the variation of 
the observed lifetimes with pH/pD. At high pH q = 0, and at low pH, the apparent q 
value was 0.4. Lifetime measurements of [TbL7] revealed similar q values at high and 
low pH/pD, 0 and 0.3 respectively. Such a variation is most simply explained by the 
quenching effect of the proximate NH vs ND oscillator of the protonated tertiary amine 
nitrogen. It has previously been established that amine NH oscillators are twice as 
effective as OH oscillators at quenching Eu3+ excited states.24 In the complex, [LnL7], 
there may be a bifurcated hydrogen bond shared between the sp3 N atom and the 
pyridyl sp2 N atom that would be within 4Å of the Eu ion and hence able to quench by 
through-space vibrational energy transfer, for which the distance dependence is r-6.   
 A pKa value of 5.7, accompanied by the small change in spectral form, suggests that 
protonation is occurring on the dipicolyl amine nitrogen atom.  The observed pKa value 
is only slightly lower than that reported for the model compound trispicolylamine 
(TPA), for which a value of 6.2 has been found.25 The presence of the sterically bulky 
tert-butyl group and the shielding provided by the three proximate aromatic rings will 
tend to inhibit local solvation and so will not stabilise the protonated form (i.e. the 
conjugate acid), as effectively as normal.   
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4.3.2 Diamagnetic NMR studies of [YL7]: pH response 
The 1H NMR spectra of [YL7] above and below the pKa were acquired (Figure 4.15). At 
low pD (4.5) the aromatic DPA proton resonances are shifted to higher frequency, 
indicative of protonation of the pyridine N. The aromatic resonances are significantly 
sharper at low pD, whilst the macrocyclic region is broader. As there are only 6 distinct 
pyridine environments upon addition of acid, the DPA pyridine protons must be 
equivalent, as was observed at high temperature. The C-Namine must have freedom of 
rotation on an intermediate NMR timescale. The increasing broadness of the 
macrocyclic proton resonances suggests that the rate of exchange between low energy 
conformations of the ligand backbone is accelerated at low pD. This is consistent with 
the luminescence pKa data that suggests it is the DPA amine which becomes 
protonated, as upon protonation the interaction between the metal ion and amine 
lone pair will be lost. The change from 9- to 8- coordination of the metal would result 
in increased flexibility of the macrocyclic backbone.  
 
Figure 4.15   Stacked 1H NMR spectra of [YL7] at different pD values, above (top) and below 
(bottom) the pKa (5.7) (D2O, 9.4 T, 295 K). 
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4.3.3 Paramagnetic NMR studies of [DyL7]: pH response 
A pD titration was carried out on the paramagnetic complex [DyL7] (Figure 4.16). From 
high pD to low pD, the tert-butyl resonance (-36 ppm) broadens and the 
pseudocontact shift increases (chemical shift becomes more negative) before 
sharpening (-47 ppm), whilst there is an additional tert-butyl peak that appears 
(-60 ppm) and sharpens as pD decreases. The presence of two tert-butyl resonances 
below the pKa demonstrates there are two different forms of the protonated complex 
that are in slow exchange.  
 
Figure 4.16   Stacked 1H NMR spectra of the tert-butyl resonances of [DyL7] as a function of pD 
(D2O, 11.7 T, 295 K). 
The longitudinal relaxation rates of the two new tert-butyl peaks at -47 and -60 ppm 
were measured at low pD (295 K, 11.7 T) and were found to be 164 and 163 Hz 
respectively, compared to the high pD rate of 181 Hz. The increase in chemical shift, 
which was also accompanied by an increase in linewidth and hence R2, indicates that 
there is a change in the anisotropy of the pseudocontact shift field. Or, the change may 
arise from a structural change of the complex that brings the Dy3+ centre either closer 
in space to the tert-butyl group, or at a different angle with respect to the main 
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component of the magnetic susceptibility tensor. As the longitudinal relaxation 
actually decreases at higher pD, the change is unlikely to be the result of a decreased 
internuclear distance. The loss of the postulated weak interaction of the DPA amine is 
likely to induce a change in the anisotropy of the pseudocontact shift field as ligand 
changes in the axial position have previously been shown to have drastic effects on the 
ligand field and therefore the anisotropy of lanthanide complexes.26,27 
The presence of two tert-butyl resonances is indicative of the complex exchanging 
between low energy conformations of the macrocyclic ring. In the diamagnetic species 
[YL7] this led to broadening of the macrocyclic region. However, the frequency 
difference of the two species of the paramagnetic complex results in the exchange 
being slower on the NMR timescale.  
4.4 Zn2+ responsive behaviour of [LnL7] 
As [LnL7] has demonstrated pH dependence, it is crucial that any metal ion titrations 
be buffered in order to keep the pH or pD constant within a physiological range above 
the pKa. In order to maintain consistency between luminescence and NMR titrations, it 
was decided that the same buffer system should be used throughout. The buffer ‘TRIS’ 
was selected due to the useful pH range (7-9) and the commercial availability of the 
deuterated analogue. 
4.4.1 Luminescence studies of [EuL7] and[TbL7]: Zn2+ response 
The addition of ZnCl2 to [EuL7] resulted in a significant emission intensity decrease and 
changes to spectral form in the ΔJ = 1, 2 and 4 manifolds (Figure 4.17). Such significant 
changes in spectral form indicate a change in the coordination environment of the Eu3+ 
ion. Analysis of the ΔJ = 2 transitions suggested an extremely strong interaction 
between the complex and Zn2+ (Figure 4.17). The binding curve indicates a 1:1 binding 
stoichiometry with very high affinity. Attempts to fit the binding curves failed, 
suggesting a dissociation constant, Kd, of less than 1 μM. 
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Figure 4.17   Variation of the emission spectra of [EuL7] (20 μM) as a function of equivalents of 
Zn2+. (Inset) Intensity ratio of 613.5 nm / 617 nm as a function of equivalents of Zn2+ (295 K, 
H2O, 0.1 M TRIS, pH/pD = 7.3, λex = 276 nm).  
The europium luminescence lifetime was monitored as a function of the number of 
equivalents of Zn2+ added, both in D2O and H2O (Table 4.4 and Figure 4.18). Upon 
addition of ZnCl2 the lifetime of the lanthanide excited state increased in D2O.  
However, it decreased in H2O. The same result was obtained with [TbL7] (Table 4.4).  
Table 4.4   Luminescence lifetime measurements of [EuL7] and [TbL7] with and without an 




𝝉𝐇𝟐𝐎 (ms) 𝝉𝐃𝟐𝐎 (ms) q 
Eu 0 1.15 1.61 0.00 
 5 0.61 1.96 1.06 
Tb 0 2.55 2.78 -0.14 
 5 1.94 3.19 0.75 
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Figure 4.18   Variation of the lifetime of [EuL7] as a function of equivalents of Zn2+ in H2O and 
D2O (295 K, 0.1 M TRIS/TRIS-d11, pH/pD = 7.3, λex = 276 nm, λem = 617 nm). 
The hydration states of the europium and terbium ions following binding of Zn2+ were 
calculated to be q = 1 (Table 4.4). The coordination of an inner sphere water molecule 
and the observation of the lifetime variation are consistent with a 1:1 binding 
stoichiometry, in which the binding mode is analogous to that originally proposed by 
Pope and co-workers (Figure 4.3). The tert-butyl pyridine is no longer coordinated to 
the lanthanide ion, and the zinc ion is coordinated to all three pyridine nitrogen atoms 
and the tertiary amine N atom (Scheme 4.11).  
 
Scheme 4.11   Proposed structures of [LnL7] without (left) and with Zn2+ (right). It is assumed 
that the Zn2+ ion will be 5-coordinate and that at pH 7.3 the coordination is completed by OH-. 
The selectivity of this probe towards Zn2+ with respect to other biologically relevant, 
divalent cations was explored through titrations of CaCl2 and MgCl2 with [EuL7]. No 
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change in spectral form was observed upon addition of up to 10 equivalents (200 μM) 
of the cations in each case, indicating that no significant interaction was occurring with 
the complex (Figure 4.19).  
 
Figure 4.19   Variation of emission spectral form for [EuL7] (20 μM) as a function of [Mg2+] 
(295 K, H2O, 0.1 M TRIS, pH/pD = 7.3, λex = 276 nm). 
In order to prove that Zn2+ binding is reversible, ligands with a high affinity for Zn2+ 
(ethylenediaminetetraacetic acid (EDTA) and diethylenetriaminepentaacetic acid 
(DTPA)) were titrated into a 1:1 solution of [EuL7] and ZnCl2 (Figure 4.20).  
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Figure 4.20   Stacked emission spectra of [EuL7] (20 μM) (bottom) alone, with one equivalent of 
Zn2+ (centre) and with one equivalent of Zn2+ and 5 equivalents of EDTA (top) (295 K, H2O, 
0.1 M TRIS, pH/pD = 7.3, λex = 276 nm). 
The titrations revealed the restoration of the spectral form of the free complex [EuL7] 
at high concentrations of the competing ligand, demonstrating that the binding of Zn2+ 
is reversible. The stability of complexes of Zn2+ with EDTA and DTPA are known to be 
logKML = 16.5 and 18.7 respectively, and the competitive titrations indeed showed that 
binding to these ligands is stronger than [LnL7]. Binding curves were plotted using the 
ratio of the intensity integrals for the ΔJ = 2 and ΔJ = 1 bands. The binding curve 
constructed for DTPA showed that at a 1:1:1 ratio of Zn2+:[EuL7]:DTPA, almost full 
restoration of the free complex (~87%) could be seen (Figure 4.21). Addition of EDTA 
was found to be slightly less competitive (~85%), as expected from its lower stability 
constant with Zn2+.  
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Figure 4.21   Variation of emission spectra of a 1:1 solution of ZnCl2 (20 μM) and [EuL7] 
(20 μM)as a function of DTPA concentration. (Inset) Ratio of ΔJ = 2 (I610-619 nm) / ΔJ = 1 (I582-610 nm) 
as a function of equivalents of Zn2+ (295 K, H2O, 0.1 M TRIS, pH/pD = 7.3, λex = 276 nm). 
4.4.2 Mass spectrometric analysis of [TbL7]: Zn2+ response 
Mass spectrometry was employed to probe the stoichiometry of the Zn2+ interaction 
with [LnL7]. Electrospray mass spectrometry experiments were conducted using a 1:2 
mixture of [TbL7] and ZnCl2 in H2O (Figure 4.22). A 1:2 ratio of Zn2+:[TbL7] was chosen 
first,  to probe the possibility of the presence of the 1:2 ternary complex,  as a related 
system has exhibited this stoichiometry.28 The Tb complex was chosen in order to 
simplify the isotopic pattern, due to the presence of only one stable isotope of this 
lanthanide. The buffer TRIS is involatile and can inhibit electrospray mass spectral 
analysis, and so was not used. However, the pH of the solution was adjusted to 7.3 
with aqueous NaOH in order to best recreate the titration conditions.  
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Figure 4.22   Observed ESI-HRMS (+) spectrum of a 1:2 solution of ZnCl2 and [TbL7] in H2O 
(pH 7.3). 
The spectrum shows the presence of protonated free complex (m/z = 861.3, 
{[TbL7]+H}+) as the major ion and two other main species. The ion at 462.1 exhibits the 
distinctive isotope pattern of Zn and is found to be the half mass of the doubly charged 
ion in a 1:1 stoichiometric complex {[TbL7]+Zn+H2O}2+. The ion corresponding to a mass 
of 941.2 is the related singly charged deprotonated complex {[TbL7]+Zn+OH}+ (Figure 
4.23). Typically, the inner sphere water molecules of lanthanide complexes are not 
seen by electrospray mass spectrometry. It is therefore reasonable to hypothesise that 
in solution two water molecules are bound to the complex, one residing on each metal 
centre and the water/hydroxide seen by mass spectrometry is bound to zinc. It is 
known that zinc aqua species possess relatively acidic coordinated water molecules, 
typically with a pKa value between 7 and 9. 
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Figure 4.23   (Top) Simulated ESI-HRMS (+) spectrum of {[TbL7]+Zn+OH}+. (Bottom) Observed 
ESI-HRMS (+) spectrum of {[TbL7]+Zn+OH}+. 
No species corresponding to any other binding stoichiometry was present in the mass 
spectrum. Mass spectrometry however, cannot conclusively preclude the existence of 
other binding modes in solution.  
4.4.3 Diamagnetic NMR studies of [YL7]: Zn2+ response 
An initial NMR titration was conducted on the diamagnetic complex [YL7], maintaining 
the pD at 7.3 with 1 M TRIS buffer (Figure 4.24).  
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Figure 4.24   Stacked 1H NMR spectra of [YL7] at different concentrations of Zn2+; (top) 3 
equivalents and (bottom) no equivalents (D2O, 1 M TRIS-d11, pD 7.3, 11.7 T, 295 K).  
Upon addition of ZnCl2 new resonances appear in the aromatic and macrocyclic 
regions. Within the aromatic region, a general trend of the observed resonances 
shifting to higher frequency was observed, which is consistent with the association of a 
Zn2+ ion to the DPA moiety. The tert-butyl resonance of the free complex decreases 
and at least two new resonances appear (Figure 4.25). The major new tert-butyl 
resonance is now found at 1.4 ppm, compared to 1.2 ppm of free complex. The slight 
increase in chemical shift suggests that there has been a significant change to the 
chemical environment of the tert-butyl appended pyridine, as this tert-butyl resonance 
was found in ligand syntheses to be relatively insensitive to proximate functional group 
interconversion. The new resonances observed were broader than that of the free 
complex, which is indicative of a chemical exchange process occurring that is of the 
order of the NMR timescale. 
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Figure 4.25   Stacked 1H NMR spectra of the tert-butyl resonances of [YL7] as a function of Zn2+ 
(D2O, 1 M TRIS-d11, pD 7.3, 11.7 T, 295 K). 
During the NMR titration a precipitate was observed to form slowly at a Zn2+ 
equivalence greater than 1. Initially, it was thought that the precipitate was Zn(OH)2.  
To assess this possibility, the NMR solution was centrifuged and a small amount of the 
relatively insoluble solid was re-dissolved in a 50:50 mixture of acetonitrile and H2O. 
Electrospray mass spectral analysis of the dissolved solute revealed the presence of 
the free Y complex, {[YL7]+H}+ (791.4 and 396.4), but also {L7+2Zn}+ (833.3 and 417.3) 
and {L7+Zn+2H}+ (767.4),  in which the Y3+ has been lost and replaced by Zn2+ (Figure 
4.26 and 4.27). The species containing only one Zn2+ ion is assumed to be the 7-
coordinate complex, in which Zn2+ has displaced Y3+ from the DO3A macrocycle. 
 
Figure 4.26   Observed ESI-LRMS (+) spectrum of the 1:2 solution of ZnCl2 and [YL7] in 1:1 
H2O:MeCN. 
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Figure 4.27   Proposed structures of {L7 + Zn} (left) and {L7 + 2Zn} (right). 
As Zn2+ is a diamagnetic ion, distinguishing between the Zn2+ and Y3+ complexes using 
NMR is impracticable. However, as the Zn2+ substituted complexes were observed as a 
precipitate and were found to be insoluble in most solvents, the NMR spectra acquired 
during the original titration can be assumed to be species based on the 1:1 Y3+ 
complex, [YL7]. 
The time-dependent trans-metallation of DO3A-based lanthanide(III) complexes in the 
presence of metal cations, including Zn2+, is a known process (Equation 4.1). It is 
generally thought that this is normally an acid-catalysed process only occurring at low 
pH.29,30 
[LnL]n    +    M2+    ⇌    Ln3+    +    [ML]n-1 (4.1) 
The stability of various gadolinium contrast agents to trans-metallation by Zn2+ has 
been studied previously when assessing their kinetic stability in solution.29,30 The 
longitudinal relaxation rate of water was measured in a phosphate-buffered solution in 
the presence of Zn2+. If trans-metallation occurs, the released Gd3+ will react to form 
insoluble GdPO4 and can no longer enhance the relaxation rate of water. The decrease 
in proton relaxation rate is thus proportional to the extent of trans-metallation that 
has occurred. The studies were conducted on 9-coordinate macrocyclic Gd3+ contrast 
agents based on octadentate ligands (e.g. with DOTA and HPDO3A) at pH 7 and 310 K. 
It was found that after 3 days of stirring, more than 98% of relaxivity was retained; 
suggesting that trans-metallation with Zn2+ is extremely slow in these complexes. 
It is known that trans-metallation of lanthanides occurs more quickly in 7-coordinate 
complexes. Similar experiments have been conducted on [GdDO3A] in the presence of 
between 10 to 40 equivalents of Cu2+.31 Although [CuDO3A] was shown to have a 
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significantly higher stability constant (25.8) than [GdDO3A] (21.6), the half-life of 
[GdDO3A] in the presence of copper was calculated to be ~24 years. The rate constant 
of trans-metallation, kd, was assumed to be made up of two contributions, k0 and k1 
(Equation 4.2): 
kd = k0 + k1[H+] (4.2) 
where k0 describes the spontaneous dissociation of Gd3+ from [GdDO3A], followed by 
the fast reaction of the free ligand with Cu2+, and k1 describes the proton-assisted 
dissociation of Gd3+ and replacement with Cu2+. Values of k0 were found to be 
extremely low (10-8 - 10-9 s-1) and indicated that spontaneous dissociation does not 
contribute to trans-metallation. 
Significant trans-metallation of Zn2+ has occurred in [YL7] at room temperature in the 
presence of 3 equivalents of Zn2+ at pH 7.3. It is unlikely that trans-metallation occurs 
with the free complex [YL7], as this has been shown by luminescence lifetime and NMR 
analysis to be at least 8-coordinate. The ease of dissociation of Y3+ suggests that the 
initial complexation of Zn2+ to the DPA moiety induces a conformational change that 
increases the susceptibility of the complex to trans-metallation.   
4.4.4 Solid state structure analysis 
Crystals of [DyL7] were grown by slow diffusion of diethyl ether into a methanol 
solution of the complex (Figure 4.28). The complex crystallised in the centrosymmetric 
space group P21/c, meaning that both enantiomers were present within the crystal 
lattice and are symmetry related. Hydrogen bonding was present, involving two of the 
carbonyl groups serving as H-bond acceptors to two donor solvent methanol 
molecules.  
The coordination number of Dy3+ in [DyL7] is 9, in an environment of N6O3. The Dy3+ ion 
is coordinated by the four ring nitrogen atoms (N4) and the tert-butyl pyridine nitrogen 
atom and three anionic oxygen atoms (O3N) in a SAP geometry (Δ-(λλλλ)). The 
coordination sphere is completed by the DPA amine nitrogen atom, which is 
coordinated axially to the lanthanide ion. 
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Figure 4.28   (Right) Molecular structure of Δ-(λλλλ)-[DyL7]. (Left) Molecular structure of 
Δ-(λλλλ)-[DyL7] showing the hydrogen bonding to solvent methanol. H atoms are omitted for 
clarity. 
Bond distances between Dy3+ ion and the donors varied (Table 4.5). The bonds to the 
neutral nitrogen donors are much longer than those to the anionic carboxylate 
oxygens. A long, axial bond of 2.83 Å between the lanthanide and the DPA amine 
nitrogen was found, as predicted from the NMR studies.   
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The average distance of the tert-butyl protons to the Dy3+ ion was 6.78 Å, similar to 
that found with [YbLH] (6.70 Å), and in accordance with the ionic radius variation of the 
lanthanide contraction.  
The additional axial interaction with the DPA amine nitrogen (N6) results in the metal 
ion being shifted towards the O3N1 antiprism base.  In the related carboxylate complex 
[YbLH], the Yb3+ ion is found 1.07 and 1.44 Å from the O3N and N4 bases respectively. In 
[DyL7], the distances of the Dy3+ ion to the O3N and N4 bases are now 0.78 and 1.61 Å.  
In order to explore the nature of the Zn2+ binding to both the DPA moiety and the 
DO3A-macrocycle, crystals of the complex [YL7] in the presence of ZnCl2 were grown. A 
methanol solution of [YL7] with 1 equivalent of ZnCl2 and 1 equivalent of NH4PF6 to act 
as a bulky counter anion was prepared. Diffusion of diethyl ether into this mixture 
resulted in the growth of crystals. It was hoped that a 1:1 ratio of [YL7]:ZnCl would 
yield crystals of  [YZnL7],  however, analysis of the crystals grown proved them to be 
the trans-metallation product, [Zn2L7]+ (Figure 4.29). The cationic di-zinc complex 
crystallised as the chloride salt and hydrogen bonding to solvent methanol was 
observed for two of the carbonyl atoms.  
 
Figure 4.29   (Right) Molecular structure of [Zn2L7]. (Left) Molecular structure of [Zn2L7] 
showing the chloride counter ion and hydrogen bonding to solvent methanol. H atoms are 
omitted for clarity. 
The two Zn2+ ions of [Zn2L7] were 6- and 7- coordinate, with two of the carboxylate 
donors acting as bridging donors. The 7-coordinate metal (Zn1) was encapsulated 
within the DO3A-based macrocycle giving a N4O3 coordination environment. Zinc 
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species with such a high coordination number are relatively rare. Complexes 
containing a 7-coordinate Zn2+ ion in which the 7 donor atoms are provided by a single 
polydentate ligand are even more uncommon, although there are a few literature 
examples.32–37 The cyclen-based Zn2+ complex [ZnLG1], for example, has been 
synthesised and studied as a monomer for heterometallic coordination polymers 
(Figure 4.30).37 The coordination geometry is similar to that of Zn1, however one of the 
O donors arises from a neutral amide. 
 
Figure 4.30 Molecular structure of [ZnLG1]. H atoms are omitted for clarity.37  CCDC identifier: 
1443839 / MABVET. 
The 6-coordinate Zn2+ ion (Zn2) was ligated by the four nitrogen donors of the tripicolyl 
moiety and the two bridging carboxylates in a distorted octahedral (N4O2) geometry. 
The geometry of Zn2 is similar to that of the Zn-TPA complex [Zn2(TPA)2(OH)2]2+ 
(Figure 4.31),38 in which both Zn2+ ions are ligated in a distorted octahedral geometry 
by the 4 neutral nitrogen donors of the TPA ligand and two bridging O donors. In this 
case the bridging O donors are hydroxide groups, however, carboxylate bridges 
(μ-Ocarboxylate) in di-zinc species are also known.39–41 The Zn-Zn distance of [Zn2L7] was 
found to be 3.36 Å which is comparable to those reported in similar zinc complexes 
with (μ-Ocarboxylate)2 bridges (3.11 – 3.50 Å).38 
 
Figure 4.31 Molecular structure of [Zn2(TPA)2(OH)2]2+. H atoms of the TPA ligand are omitted 
for clarity. CCDC identifier: 1230684 / PEMBIS. 
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As the ionic radius of Zn2+ is much smaller than that of Dy3+, the metal-donor bond 
distances to the transition metal are decreased from those seen in [DyL7] (Table 4.6). 







Zn1-N1 2.418(5)  Zn2-N5py 2.236(4) 
Zn1-N2 2.237(4)  Zn2-N6 2.183(4) 
Zn1-N3 2.342(5)  Zn2-N7py 2.120(4) 
Zn1-N4 2.212(5)  Zn2-N8py 2.179(5) 
Zn1-O1 2.080(3)  Zn2-O1 2.125(3) 
Zn1-O3 2.123(4)  Zn2-O5 2.060(3) 
Zn1-O5 2.244(3)    
4.4.5 Paramagnetic NMR studies of [LnL7]: Zn2+ response 
The paramagnetic spectra of the Dy, Tb and Tm complexes of [LnL7] were measured in 
the absence and presence of varying Zn2+ concentrations. In each case, the intensity of 
the resonance corresponding to the tert-butyl of the free complex decreased upon 
addition of ZnCl2. As the concentration of Zn2+ increased, multiple new resonances 
appeared making the identification of the tert-butyl peaks challenging. After addition 
of one equivalent of Zn2+, all resonances were integrated and tert-butyl peaks were 
found by identifying a 9:1 ratio with other proton resonances. Trans-metallation of the 
lanthanide ion was not observable by NMR at this concentration, as no ligand 
resonances were observed in the diamagnetic region. However, above this 
concentration of added ZnCl2, a precipitate was observed and the integrals of the 
complex resonances decreased slightly.  
Upon addition of ZnCl2 to [DyL7] three new tert-butyl resonances appeared, as 
identified by integration (Figure 4.32, Table 4.7).  
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Figure 4.32   Stacked 1H NMR spectra of the tert-butyl resonances of [DyL7] as a function of 
Zn2+ (D2O, 1 M TRIS-d11, pD 7.3, 11.7 T, 295 K). 
A binding curve was produced by plotting the ratio of the integral of the free complex 
tert-butyl resonance and the sum of the newly formed tert-butyl integrals against the 
number of equivalents of added Zn2+ (Figure 4.33). The curve is similar in form to that 
found from luminescence titrations of [EuL7], and similarly the binding was too strong 
to be effectively fitted. 
 
Figure 4.33   Ratio of the integrals of tert-butyl resonances at +23, +13 and -8 ppm (Iδ +23, +13, -8) 
and the integral of tert-butyl resonance at -36 ppm (Iδ -23) of [DyL7] as a function of the number 
of equivalents of Zn2+ (D2O, 1 M TRIS-d11, pD 7.3, 11.7 T, 295 K). 
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Titrations with [TbL7] and [TmL7] yielded similar results; the NMR spectra of the initial 
and end points of the titration and the plotted binding curves are shown in Figure 4.34. 
As with [DyL7], addition of Zn2+ led to the appearance of additional tert-butyl peaks, 
some of which are also shifted in the opposite direction to the shift of the tert-butyl 
resonance in the free complex. Similarly to the Dy3+ complex, the binding was too 
strong (Kd < 1 μM) to be effectively fitted. 
 
Figure 4.34   (Left) Stacked 1H NMR spectra of the tert-butyl resonances of [TbL7] (top) and 
[TmL7] (bottom) before and after addition of excess Zn2+. (Right) Ratio of the integrals of tert-
butyl resonances of [TbL7] (top) and [TmL7] (bottom) as a function of the number of 
equivalents of added Zn2+ (D2O, 1 M TRIS-d11, pD 7.3, 11.7 T, 295 K). 
The shift and relaxation rate data of the identified tert-butyl resonances for [LnL7] 
before and after addition of Zn2+ are listed in Table 4.7.  
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Table 4.7   Comparison of NMR properties of the tert-butyl resonances in [DyL7] (top), [TbL7] 
(centre) and [TmL7] (bottom), with and without addition of Zn2+ (D2O, 1 M TRIS-d11, pD 7.3, 
11.7 T, 295 K). 
 
 Shift (ppm) Linewidth (Hz) R1 (Hz) Integral 
No Zinc -36 584 182 1 
Zinc +23 244 53 0.16 
 +13 255 55 0.31 
 -8 320 21 0.52 
 
 
 Shift (ppm) Linewidth (Hz) R1 (Hz) Integral 
No Zinc -30 280 112 1 
Zinc +20 109 44 0.33 
 +15 108 34 0.12 
 -1 185 16 0.27 
 -7 313 26 0.27 
 
 
 Shift (ppm) Linewidth (Hz) R1 (Hz) Integral 
No Zinc +17 488 63 1 
Zinc -23 105 17 0.36 
 -27 110 26 0.64 
All the longitudinal and transverse relaxation rates of the Zn2+-bound complex were 
significantly decreased compared to those measured in the free complex. A decrease 
in relaxation rates most likely arises from an increase in the internuclear distance, r. 
Additionally, the presence of new tert-butyl resonances that are shifted in the opposite 
direction to free [LnL7] indicates a dramatic change in the structure of the complex 
upon binding to Zn2+. The paramagnetic NMR titrations results are consistent with a 
process in which the tert-butyl appended pyridine moiety dissociates from the 
lanthanide ion upon addition of Zn2+ ions.  
Addition of excess Mg2+ and Ca2+ induced negligible changes in chemical shift 
behaviour of [DyL7] (Figures 4.35 and 4.36), consistent with the expected high 
selectivity for Zn2+. 
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Figure 4.35   Stacked 1H NMR spectra of [DyL7] (bottom) and after addition of excess Ca2+ 
(centre) or Mg2+ (top). (D2O, 1 M TRIS-d11, pD 7.3, 11.7 T, 295 K). 
 
Figure 4.36   Chemical shift of the tert-butyl resonance of [DyL7] as a function of the number of 
equivalents of Ca2+ (black) and Mg2+ (red). (D2O, 1 M TRIS-d11, pD 7.3, 11.7 T, 295 K). 
4.5 Conclusions and Future Work 
A novel NMR Zn2+ sensor, [LnL7], based on a DO3A macrocycle bearing a pendant 
pyridine arm containing both a tert-butyl reporter group and a DPA moiety has been 
synthesised and characterised.  
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The tripicolyl amine Zn2+ sensing arm was synthesised in moderate yield using a 10 
step linear synthesis, including a 100% regioselective reduction step, with the aid of 
simple protecting chemistry. Alkylation of the pendant arm onto both a 
trimethylphosphinate and carboxylate appended macrocycle proceeded successfully. 
However, complexation could only be achieved with the less sterically bulky 
carboxylate-based macrocycle, DO3A. 
Solid state structure analysis showed that the complex was 9-coordinate, with the 
amine nitrogen atom of the DPA moiety completing the coordination with a long, axial 
bond to the lanthanide. At high temperature or low pH this bond was weakened or 
lost, as observed from lifetime measurements of the Eu3+ and Tb3+ complexes and the 
diamagnetic and paramagnetic NMR spectra of the Y3+ and Dy3+ complexes. The pKa 
value of the complex was measured to be 5.7 by luminescence. This value is low 
enough that changes in pH within a biological range of 6.5-7.5 will have minimal 
impact on the behaviour of the complex. 
The tert-butyl resonance of the Dy, Tb and Tm complexes shift beyond the diamagnetic 
region, in principle allowing them to be imaged against zero background. The 
PARASHIFT properties of these resonances have been investigated at different 
temperatures and magnetic fields. High longitudinal relaxation rates at low fields allow 
for fast acquisition, and linear temperature sensitivities will allow for non-invasive 
temperature measurement.  
The binding to Zn2+ has been probed using both luminescence and NMR studies 
revealing an extremely strong affinity. Large changes are observed in emission and 
NMR properties of the complexes, indicating a 1:1 binding mode and suggesting a 
decrease in the coordination number of the lanthanide ion. Mass spectrometry studies 
provided further proof of the 1:1 binding mode. Selectivity was demonstrated for Zn2+ 
over Ca2+ and Mg2+ and binding reversibility was shown through competitive titrations 
with EDTA and DTPA. The affinity of the complex to Zn2+ could be adapted by 
modification of the chelating group. Removal of one of the pyridines of the DPA moiety 
could reduce the Zn2+ binding strength but the replacement chelator must be chosen 
carefully to avoid the loss of selectivity. 
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At higher concentrations of Zn2+, trans-metallation was observed in which the 
lanthanide is replaced to form a novel di-zinc species. Trans-metallation of DO3A-
based lanthanide complexes is unprecedented at this pH. X-ray crystallography 
elucidated the solid state structure of the trans-metallated di-zinc species. One Zn2+ 
ion was found to be 7-coordinate, an unusually high, although not unique, 
coordination number. Two carboxylate groups of the DO3A macrocycle were found to 
be bridging both Zn2+ ions. 
The kinetic stability of the complex with respect to trans-metallation within biological 
media must be explored. Further in vitro work to investigate any potential interactions 
with proteins is also required to ensure that binding to Zn2+ would be unperturbed in 
vivo. Additional titrations would allow for the creation of calibration curves and 
phantom imaging studies using a preclinical MRI scanner could then be used to 
demonstrate the feasibility of an in vivo measurement of Zn2+. 
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5. Summary and outlook 
The aim of this project was to investigate novel paramagnetic lanthanide complexes 
for use as responsive 1H PARASHIFT probes for magnetic resonance spectroscopy by 
incorporating varying responsive functional groups into previously reported 
complexes.  
The incorporation of a pH responsive, phosphonate group in close proximity to the 
reporter tert-butyl group revealed the pH dependence of the pseudocontact chemical 
shift. The observed pKa was around 7.2 enabling pH and temperature measurements 
of selected organs within a mouse model. Structural modification of the ligand 
backbone was sought in order to change the biodistribution profile. The change from 
trimethylphosphinate to tribenzylphosphinate caused neither minimal changes to 
paramagnetic properties nor the rate of clearance in vivo. However, investigation of 
the dibenzylphosphinate analogue showed large and unexpected variations in the shift 
and relaxation properties of the trans-disubstituted complex.  
In order to further probe how this structural modification affects the paramagnetic 
NMR properties of such probes an in-depth NMR investigation was undertaken on the 
analogous benzylphosphinate complexes with no pH responsive behaviour. This study 
revealed that the change of symmetry of the complex drastically affects the magnetic 
susceptibility tensor, with both a change in the nature, sign and orientation of the 
principal component observed.  
Finally, a Zn2+ responsive probe was investigated through the incorporation of a 
specific Zn2+ chelating group (dipicolylamine). The complex was found to bind Zn2+ 
extremely strongly through a number of techniques. In particular, the paramagnetic 
NMR of the complexes was found to drastically vary, both in chemical shift and 
relaxation, upon addition of Zn2+. 
The work undertaken in this thesis demonstrates that responsive behaviour can be 
incorporated into existing probes through the addition of specific functional groups. 
Whilst only two responsive functionalities have been investigated (pH and Zn2+), the 
concept could be extended to other biologically relevant markers (e.g. Ca2+, Mg2+). 
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Further modification to these probes to include targeting vectors, would improve the 
potential application of PARASHIFT probes. 
However, ligand modification must be performed judiciously, as it has been 
demonstrated in this work that variations in the symmetry of complexes results in 
dramatic changes to the magnetic susceptibility tensor. The changes to the 
paramagnetic NMR properties of such complexes may not be immediately obvious 
from chemical shift or relaxation data alone. 
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6. Experimental Methods 
6.1 General procedures 
Commercially available reagents were used as received. Solvents were laboratory 
grade and were dried over appropriate drying agents when required. 
Diethylbenzylphosphite was prepared by Dr. P. Kanthi Senanayake. Reactions requiring 
anhydrous conditions were carried out under an atmosphere of argon using Schlenk-
line techniques. Where appropriate, solvents were degassed using three freeze-pump-
thaw cycles.  
Thin layer chromatography (TLC) was carried out on aluminium-backed silica gel plates 
with 0.2 mm thick silica gel 60 F254 (Merck) or 0.2 mm thick neutral alumina gel 60 F254 
(Merck). Compounds were visualised by UV irradiation at 254 nm, or by staining with 
either iodine or Dragendorff’s reagent (solution of bismuth nitrate and potassium 
iodide in AcOH and H2O). Preparative flash column chromatography was performed 
using flash silica gel 60 (230-400 mesh) from Merck or Fluorochem or neutral alumina 
(Merck Aluminium Oxide 90, activity II-III, 70-230 mesh), with the latter pre-soaked in 
ethyl acetate overnight before use.  
Electrospray mass spectra were obtained on a TQD mass spectrometer equipped with an 
Acquity UPLC system, an electrospray ion source and an Acquity photodiode array 
detector (Waters Ltd., UK). Accurate masses were recorded on an LCT Premier XE mass 
spectrometer or a QToF Premier Mass spectrometer, both equipped with an Acquity UPLC, 
a lock-mass electrospray ion source and an Acquity photodiode array detector (Waters 
Ltd., UK). Methanol or acetonitrile were used as the carrier solvents. 
pH measurements were carried out at 295 K using a Jenway 3320 pH meter with a 
Sigma Aldrich micro-pH combination electrode. Calibration was performed using 
commercially available buffer solutions at pH 4.00±0.02, pH 7.00±0.02, and pH 
10.00±0.02 (Sigma Aldrich). Diluted aqueous solutions of NaOD and DCl (in D2O) were 
used for pD adjustments; NaOH and HCl (in H2O) for pH adjustments. For 
measurements in D2O, the pD is calculated as pD = pH + 0.41, where pH is the meter 
reading.  
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6.2 NMR Spectroscopy 
1H, 13C and 31P NMR spectra were recorded in commercially available deuterated 
solvents on a Varian Mercury-200 (1H at 199.975, 13C at 50.289, 31P at 80.985 MHz), 
Varian Mercury-400 (1H at 399.960, 13C at 100.572, 31P at 161.943 MHz), Bruker 
Avance-400 (1H at 400.052, 13C at 100.603, 31P at 161.980 MHz), Varian Inova-500 (1H 
at 499.722, 13C at 125.671, 31P at 202.375 MHz), Appleby VNMRS-600 (1H at 599.832, 
13C at 150.828, 31P at 242.862 MHz), or Varian VNMRA-700 (1H at 699.731, 13C at 
175.948, 31P at 283.256 MHz) spectrometer. All chemical shifts are given in ppm and all 
coupling constants are reported in Hz, to the nearest 0.5. Where required, the 
operating temperature of the spectrometer was measured with the aid of an internal 
calibration solution of ethylene glycol. Measurements at 1.0 T (1H at 42.5 MHz) were 
made on a Magritek Spinsolve spectrometer. The recorded free induction decays were 
processed using backward linear prediction, optimal exponential weighting, zero-
filling, Fourier transform, phasing and baseline correction. The signals were integrated 
by Lorentzian line fitting. 
Concentrations of the lanthanide(III) complexes were calculated using the bulk 
magnetic susceptibility (BMS) method, using 10% tBuOH/ H2O solutions of the 
complexes, with a coaxial insert containing the same solution without the complex 
added. 
1H longitudinal relaxation times were measured in dilute D2O solutions at 295 K using 
the inversion-recovery technique, on spectrometers operating at fields of 1.0, 4.7, 9.4, 
11.7, 14.1 and 16.4 T. Each relaxation time measurement was repeated at least three 
times to reduce experimental error. The number of transients used in the 
measurements was determined by the signal-to-noise ratio of the sample. The signal 
was fully recovered during the inversion-recovery sequence to minimise the 
experimental error. Fitting errors were determined by calculating the standard 
deviation of a set of relaxation times. The line width data were obtained by Lorentzian 
line fitting.  
Relaxation rate data was fitted using a modified algorithm originally provided by Dr. 
Ilya Kuprov at the University of Southampton. The algorithm uses the SBM equations 
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to fit the measured relaxation rate data using the Matlab R2014a internal Levenberg-
Marquardt minimisation of the non-linear squares error function and the results were 
analysed iteratively. Some parameters were used globally in the series, and others 
used for each lanthanide individually. Magnetic moments for each lanthanide(III) were 
taken from the literature. 
Variable temperature NMR spectroscopy was carried out using the Varian Inova-500 
spectrometer with the assistance using the ethylene glycol method described above to 
confirm the operating temperature of the spectrometer at each temperature 
measured. 
Protonation constants were measured at 295 K and 500 MHz in D2O, unless otherwise 
stated. The resulting curves reporting the 1H NMR chemical shift vs. pD were fitted by 
non-linear least squares iterative analysis by Boltzmann using OriginPro 2016 software, 
producing estimates of the pKa values. 
6.3 Optical techniques 
All solution state optical analyses were carried out in quartz cuvettes with a path 
length of 1 cm. UV/Vis absorbance spectra were measured on an ATI Unicam UV/Vis 
spectrometer (Model UV2) using Vision software (version 3.33). Emission spectra were 
recorded using either an ISA Jobin-Yvon Spex Fluorolog-3 luminescence spectrometer 
using DataMax software (version 2.2.10) or a HORIBA Jobin-Yvon Fluorolog-3 
luminescence spectrometer equipped with an iHR320 module, which selects either a 
HORIBA FL-1073 (Hammatsu R928P) photomultiplier tube or a HORIBA Synapse BIDD 
CCD for detection of emitted light, using FluorEssence software (based on Origin® 
software).  
Lifetime measurements were carried out using a Perkin Elmer LS55 spectrometer using 
FL Winlab software. The obtained decay curves were fitted using OriginPro 2016 
software. 
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6.4 HPLC analysis 
Reverse phase HPLC was performed at 295 K using a Shimadzu system comprising a 
Degassing Unit (DGU-20A5R), a Prominence Preparative Liquid Chromatography pump 
(LC-20AP), a Prominence UV-Vis Detector (SPD-20A) and Communications Bus Module 
(CBM-20A). For preparative HPLC an XBridge C18 OBD column was used (19 x 100 mm, 
5 μm) with a flow rate of 17 mL/min. Fraction collection was performed manually. A 
solvent system of H2O / CH3CN was used with gradient elution as follows: 
Time (min) % H2O % CH3CN 
0 90 10 
3 90 10 
13 0 100 
16 0 100 
17 90 10 
6.5 X-Ray studies 
X-ray diffraction structures were carried out by Dr. Andrei S. Batsanov or Dr. Dmitry S. 
Yufit. Single crystal X-ray data was collected at 120 K on D8V_Mo diffractometer. The 
crystal was kept at 120 K during data collection. Using Olex2,1 the structure was solved 
with the ShelXT2 structure solution program using Intrinsic Phasing and refined with 
the ShelXL3 refinement package using Least Squares minimisation. X-ray crystal 
structure images were produced using Mercury CSD 3.10 software. 
6.6 DFT studies 
The model geometries of [YL4], as a neutral species, and [YL5]+, as a cation, were fully 
optimised without symmetry constraints using the hybrid-DFT B3LYP functional4,5 and 
3-21G* basis set3–7 for all atoms with the Gaussian 09 package.11 B3LYP/3-21G* is 
shown elsewhere12 to be an appropriate functional/basis set for Y3+ complexes and 
therefore suitable models for Yb3+ complexes. The paramagnetic Yb3+ complexes are 
very difficult to model computationally. The Gaussian09 default polarisation 
continuum solvent model (IEFPCM)13 was applied to all calculations using water as 
solvent. Many other optimised geometries of [YL4] and [YL5]+ were located with higher 
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total energies. These higher energy geometries differed in the orientations of the 
CH2Ph groups. Frequency calculations confirmed all the geometries to be true minima. 
The relative energies reported here were obtained as single point calculations at 
M062X/SDD:3-21G* from the most stable geometries at B3LYP/3-21G*. The M062X 
functional14 with a mixed pseudopotential15: basis set was shown previously to be 
appropriate for relative energy calculations of closely related Y and Yb isomer 
complexes.16 Figures of the lowest energy optimised geometries were generated using 
GaussView software.17 
6.7 Assignment and fitting 
Processing and deconvolution of 1H spectra were done using the MestReNova v11.0.3 
software in order to obtain positions, linewidths and integrals for all signals. The 
signals with small integrals were assigned to minor conformer and were excluded from 
the further analysis. Molecular frames of the optimized geometries were unified so 
that the origin is located at the lanthanide position, the z-axis is pointing in the middle 
of four nitrogen atoms of the cyclen group and the  x-axis is pointing at the first 
nitrogen atom of the cyclen group located under pyridine. It was assumed that 
hyperfine shift (difference between observed paramagnetic shift and the shift of 
diamagnetic reference) is dominated by the pseudocontact contribution (PCS) and can 
be described by Equation 5.3, using the molecular frame coordinate system: 




2 −  𝑧2) + 𝜒𝑥𝑦(2𝑥𝑦) + 𝜒𝑥𝑧(2𝑥𝑧)
+  𝜒 𝑦𝑦(𝑦
2 −  𝑧2) +  𝜒𝑦𝑧(2𝑦𝑧)] 
(5.3) 
where shift is in the units of ppm, coordinates are defined relative to the lanthanide 
in Å, components of the traceless part of the susceptibility tensor are in the units of Å3 
in SI system. Atomic coordinates were taken from DFT optimized geometries, and for 
the tert-butyl group the structural functions were averaged assuming their fast 
rotation. Since PCS depends linearly on five components of the susceptibility tensor 
the robust linear regression with 'bisquare' weight function as implemented in 
MATLAB R2017a was used to fit their values. The permutation with the largest 
adjusted Pearson coefficient was taken as the best fit. Using the best fit tensor the PCS 
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for all other protons have been predicted. The line widths were fitted using a simple 
isotropic model (Equation 5.4): 
∆𝑣 =  
𝐶1
𝑟6
+  𝐶2  
(5.4) 
where the constants C1 and C2 were fitted for the assigned signals and used to predict 
the linewidth for all other protons. The total shift vs width plots of predicted and 
experimentally observed signals were used for further assignment. Well isolated 
groups of experimental signals were assigned to closely located groups of predicted 
signals and all possible permutations within the groups were checked, the assignment 
that gave the largest adjusted Pearson coefficient was chosen as the best fit.  
The contact contribution to paramagnetic shift was neglected as it was assumed that 
for protons it is smaller than the standard deviation of PCS of the model, which is 
mostly due to errors in the structural function defined by DFT.  
The best fit susceptibility tensors are presented in the main text as axiality, rhombicity 
and three Euler angles. The following convention is used for defining axiality, 
rhombicity and Euler angles of a traceless susceptibility tensor. Diagonalization of a 
traceless susceptibility tensor gives eigenvalues and eigenvectors which are labelled to 
satisfy the relation |𝜒𝑥|<|𝜒𝑦|<|𝜒𝑧|  Then, the axiality is defined as 3/2 𝜒𝑧 and 
rhombicity as (𝜒𝑥 - 𝜒𝑦)/2. In such a definition, axiality and rhombicity have the same 
sign and the limiting value of the ratio of rhombicity to axiality is 1/3 (0 < 𝜒𝑟ℎ/
𝜒𝑎𝑥< 1/3). 
Euler angles specify the orientation of the labelled eigenvectors of the susceptibility 
tensor with respect to the chosen molecular frame. In the axial case only two angles 
are defined: the angle β between the z-axis of the frame and eigenvector of 𝜒𝑧 
(0 ≤ β ≤ π) and the angle α between the x-axis and the projection of 𝜒 𝑧 onto the xy 
plane (0 ≤ α ≤ 2π), in the direction from the x-axis to the y-axis). If rhombicity is non-
zero then the 𝜒 𝑥 vector defines the direction of a dip in the PCS. The angle between 
the projection of 𝜒 𝑧 and the projection of 𝜒 𝑥 onto the xy-plane is the angle γ 
(0 ≤ γ < 2π, counting in the same direction from x to y). 
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6.8 Imaging studies 
Imaging studies were carried out by Prof. Andrew Blamire, Ian Wilson and Dr. Dara 
O’Hogain at the Newcastle Magnetic Resonance Centre. In vitro and in vivo imaging 
experiments were performed by using a 7 T preclinical MRI system (20 cm bore, Varian 
Direct Drive scanner, Agilent, Palo Alta, CA) equipped with a 30mm i.d. quadrature 
birdcage RF coil (Rapid Biomedical GmbH, Germany) for excitation and detection of the 
water and PARASHIFT agent signals. 
Two types of scan acquisition were used 3-dimensional gradient echo (3DGE) imaging 
and 2-dimensional spectroscopic imaging (2DSI), which were applied either for imaging 
single resonances or for triple frequency imaging. In every case, the excitation RF pulse 
was a 500 ms duration Gaussian modulated pulse which has a FWHM bandwidth of 
2100 Hz, falling to a fractional excitation of <10-3 at 20 kHz. This pulse specification 
allows separate excitation of water only or the tert-butyl group of the PARASHIFT 
probes by varying the transmit frequency. 
6.9 Synthetic procedures 
1,4,7-Tri-benzyl-1,4,7,10-tetraazacyclododecane-1,4,7-tricarboxylate, 1 
 
1,4,7,10-Tetraazacyclododecane (2.50 g, 14.5 mmol) was dissolved in anhydrous CH2Cl2 
(80 mL) and to this triethylamine (6.3 mL, 45 mL) was added. The resulting solution 
was stirred under argon at 5oC and a solution of benzyl chloroformate (6.4 mL, 
45 mmol) in CH2Cl2 (20 mL) was added dropwise. The reaction was stirred at room 
temperature for a further 18 h before the solvent was removed under reduced 
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pressure. The resulting yellow oil was purified by silica gel column chromatography 
(100% CH2Cl2 to 2% MeOH/ CH2Cl2) to yield a colourless oil (4.78 g, 57%). Rf (10% 
MeOH/ CH2Cl2) = 0.54. 1H NMR (400 MHz,CDCl3) δ 7.48-7.11 (m, 15H, ArH), 5.19-5.00 
(m, 6H, CH2O) 3.89-2.21 (m, 16H, cyclen CH2); 13C NMR (101 MHz, CDCl3) δ 156.1 (CO), 
136.4 (Ar), 136.3 (Ar), 128.4 (Ar), 128.3 (Ar), 127.7 (Ar), 127.6 (Ar), 127.4 (Ar), 67.2 
(CH2O), 66.8 (CH2O), 53.5 (cyclen CH2), 50.6 (cyclen CH2), 50.3 (cyclen CH2), 50.2 (cyclen 
CH2), 50.1 (cyclen CH2), 45.6 (cyclen CH2); ESI-LCMS (+) m/z 575.1 [M+H]+. ESI-HRMS (+) 
calcd for [C32H39N4O6]+ 575.2870, found 575.2864. 
1,4,7-Tri-benzyl 10-tert-butyl 1,4,7,10-tetraazacyclododecane 1,4,7-tricarboxylate, 2 
 
1,4,7-Tri-benzyl-1,4,7,10-tetraazacyclododecane-1,4,7-tricarboxylate (4.68 g, 
8.3 mmol) was dissolved in anhydrous CH2Cl2 (60 mL) and to this triethylamine (1.6 mL, 
10.8 mmol) was added. The resulting solution was stirred under argon before the 
addition of di-tert-butyl dicarbonate (2.36 g, 10.8 mmol). After addition, the solution 
was stirred at room temperature for a further 18 h. The solvent was removed under 
reduced pressure and the resulting yellow oil was purified by silica gel column 
chromatography (100% CH2Cl2 to 2% MeOH/ CH2Cl2) to yield a white solid (5.2 g, 93%). 
Rf (10% MeOH/ CH2Cl2) = 0.69. 1H NMR (400 MHz,CDCl3) δ 7.58-6.90 (m, 15H, ArH), 
5.09-4.76 (m, 6H, CH2O) 3.87-2.70 (m, 16H, cyclen CH2) 1.31 (s, 9H, C(CH3)3); 13C NMR 
(101 MHz, CDCl3) δ 156.8 (CO), 136.4 (Ar), 128.6 (Ar), 128.4 (Ar), 128.3 (Ar), 128.2 (Ar), 
82.8 (C(CH3)3), 67.3 (CH2O), 50.7-49.9 (br, cyclen CH2), 28.4 (C(CH3)3), ESI-LCMS (+) m/z 
675.5 [M+H]+. ESI-HRMS (+) calcd for [C37H47N4O8]+ 675.3394, found 675.3406. 





(3.5 g, 5.2 mmol) was dissolved in MeOH (30 mL) and to this was added Pd(OH)2/C 
(~100 mg). The reaction vessel was loaded onto a Parr hydrogenator, where it was 
subjected to agitation for 18 h, under a 30 psi pressure of H2. The resulting solution 
was filtered through celite to ensure removal of catalyst and the solvent removed 
under reduced pressure to yield a pale yellow oil (1.23 g, 87%). 1H NMR 
(400 MHz,CDCl3) δ 5.31 (br s, NH), 3.75-2.83 (m, 16H, cyclen CH2) 1.48 (s, 9H, C(CH3)3); 
13C NMR (101 MHz, CDCl3) δ 157.5 (CO) , 82.3 (C(CH3)3),  48.2 (cyclen CH2), 46.9 (cyclen 
CH2), 45.6 (cyclen CH2), 44.5 (cyclen CH2), 28.7 (C(CH3)3), ESI-LCMS (+) m/z 273.8 




tert-Butyl-1,4,7,10-tetraazacyclododecane-1,4,7-tricarboxylate (0.60 g, 2.21 mmol) and 
paraformaldehyde (1.45 g, 46.3 mmol) were dissolved in anhydrous THF (30 mL) and 
the resulting suspension was stirred under argon at 80oC for 30 min. Diethyl 
methylphosphonite (1.94 g, 13.27 mmol) was added and the reaction was stirred at 
80oC for a further 18 h. The solution was filtered and the solvent was removed under 
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reduced pressure. The resulting orange oil was purified by alumina gel column 
chromatography (100% CH2Cl2 to 2% MeOH/ CH2Cl2) to yield a yellow oil (435 mg, 
38%). Rf (10% MeOH/ CH2Cl2) = 0.76. 1H NMR (400 MHz,CDCl3) δ 4.07-3.86 (m, 6H, 
POCH2CH3), 3.62-3.12 (br m, 6H, PCH2NH), 3.04-2.44 (br m, 16H, cyclen CH2), 1.53-1.37 
(m, 9H, PCH3), 1.35 (s, 9H, C(CH3)3), 1.21 (t, 3J = 7, 9H, POCH2CH3); 31P NMR (162 MHz, 
CDCl3) δ 53.1-52.0; 13C NMR (101 MHz, CDCl3) δ 155.5 (CO) , 79.5 (C(CH3)3), 60.1-59.9 
(m, POCH2)  55.1-52.7 (m, cyclen CH2), 45.9 (PCH2N), 45.6 (PCH2N), 45.5 (PCH2N), 28.4 
(C(CH3)3), 16.6 (POCH2CH3), 13.9-13.5 (m, PCH3); ESI-LCMS (+) m/z 633.1 [M+H]+. ESI-





tetraazacyclododecane-1-carboxylate (435 mg, 0.69 mmol) was dissolved in anhydrous 
CH2Cl2 (3 mL) and to this was added TFA (3 mL). The solution was stirred at room 
temperature for 18 h, before the solvent was removed under reduced pressure. The 
resulting yellow oil was dissolved in H2O (1 mL) and the pH of this solution was 
adjusted to 12 with solid NaOH pellets before the aqueous solution was extracted with 
CH2Cl2 (4 x 10 mL). The organic layers were combined, dried over MgSO4, and the 
solvent removed under reduced pressure to yield a yellow oil (266 mg, 75%). 1H NMR 
(400 MHz,CDCl3) δ 4.08-3.90 (m, 6H, POCH2), 3.32-2.60 (br m, 22H, cyclen CH2, PCH2N ), 
1.46 (s, 9H, PCH3), 1.25 (t, 3JPH= 7, 9H, POCH2CH3); 31P NMR (162 MHz, CDCl3) δ 
54.2-50.4; 13C NMR (101 MHz, CDCl3) δ  60.6-60.1 (m, POCH2),  56.6-56.2 (m, cyclen 
CH2), 55.5-55.1 (m, cyclen CH2), 53.2-52.5 (m, cyclen CH2), 47.3-46.8 (PCH2N), 16.7 
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(POCH2CH3); ESI-LCMS (+) m/z 533.3 [M+H]+. ESI-HRMS (+) calcd for [C20H48N4O6P3]+ 
533.2787, found 533.2811. 
5-tert-Butyl-2-methylpyridine, 6 
 
Copper(I) cyanide (20 mg) was added to a solution of anhydrous THF (15 mL) and 
anhydrous Et2O (100 mL) under argon. The resulting suspension was cooled to -78oC 
before tert-butylmagnesium chloride (58 mL, 2.0 M in Et2O, 116.2 mmol) was added. 
5-Bromo-2-methylpyridine (10.0 g, 58.1 mmol) was added and the resulting yellow 
solution was allowed to warm to room temperature and stirred for a further 18 h. The 
reaction was quenched by the dropwise addition of NH4OH (sat. aq. solution, 50 mL) 
and the aqueous layer was extracted with Et2O (3 x 200 mL). The organic layers were 
combined and dried with MgSO4. The solvent was removed under reduced pressure to 
yield a pale yellow liquid that was used without further purification. 1H NMR 
(400 MHz,CDCl3) δ 8.43 (s, 1H, H6), 7.44 (dd, 3J = 8, 4J = 2, 1H, H4), 6.95 (d, 3J = 8, 1H, 
H3), 2.38 (s, 3H, CH3), 1.20 (s, 9H, C(CH3)3); 13C NMR (101 MHz, CDCl3) δ 154.8 (C2), 
146.1 (C6), 142.3 (C5), 132.8 (C4), 122.1 (C3), 32.8 (C(CH3)3), 30.6 (C(CH3)), 20.4 (CH3); 




5-tert-Butyl-2-methylpyridine (8.53 g, 57.25 mmol) was dissolved in CHCl3 (200 mL) 
and to this was added mCPBA (17.0 g, 98.5 mmol). The resulting solution was stirred 
for 18 h at room temperature under argon, before the reaction was quenched by 
Na2SO4 (sat. aq. solution, 50 mL). The organic layer was extracted and washed with 
aqueous NaOH solution (0.5 M, 5 x 100 mL). The aqueous layer was extracted with 
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CH2Cl2 (3 x 200 mL). The organic layers were combined and dried over MgSO4 and the 
solvent removed under reduced pressure to yield a yellow oil (5.25 g, 54% over two 
steps). Rf (10% MeOH/ CH2Cl2) = 0.46. 1H NMR (400 MHz,CDCl3) δ 8.22 (s, 1H, H6), 
7.19-7.14 (m, 2H, H3, H4), 2.41 (s, 3H, CH3), 1.22 (s, 9H, C(CH3)3); 13C NMR (101 MHz, 
CDCl3) δ 146.5 (C2), 144.8 (C6), 136.4 (C5), 124.8 (C4), 123.0 (C3), 32.6 (C(CH3)3), 32.6 
(C(CH3)), 16.4 (CH3); ESI-LCMS (+) m/z 166.1 [M+H]+. ESI-HRMS (+) calcd for [C10H16NO]+ 
166.1232, found 166.1232. 
5-tert-Butyl-4-nitro-2-methylpyridin-1-oxide, 8 
 
5-tert-Butyl-2-methylpyridin-1-oxide (5.25 g, 31.8 mmol) was dissolved in conc. H2SO4 
(98%, 18 mL, 342.8 mmol) at 5oC. Conc. HNO3 (70%, 11.5 mL, 264.5 mmol) was added 
dropwise and the resulting solution was stirred at 100oC for a further 18 h. The 
solution was then poured over ice and stirred for 1 h. This aqueous solution was 
extracted with CH2Cl2 (3 x 200 mL). The organic layers were combined, dried over 
MgSO4 and the solvent was then removed under reduced pressure. The resulting pale 
green oil was purified by silica gel column chromatography (100% CH2Cl2 to 2% MeOH/ 
CH2Cl2) to yield a yellow oil (4.00 g, 60%). Rf (10% MeOH/ CH2Cl2) = 0.47. 1H NMR 
(400 MHz,CDCl3) δ 8.50 (s, 1H, H6), 7.48 (s, 1H, H3), 2.53 (s, 3H, CH3), 1.38 (s, 9H, 
C(CH3)3); 13C NMR (101 MHz, CDCl3) δ 152.5 (C2), 151.1 (C5), 142.3 (C6), 139.3 (C4), 
122.6 (C3), 35.7 (C(CH3)3), 29.9 (C(CH3)), 17.5 (CH3); ESI-LCMS (+) m/z 211.1 [M+H]+. 
ESI-HRMS (+) calcd for [C10H15N2O3]+ 211.1083, found 211.1088. 




5-tert-Butyl-4-nitro-2-methylpyridin-1-oxide (2.00 g, 9.5 mmol) was dissolved in MeOH 
(30 mL) and to this was added Pd/C (~300 mg). The reaction vessel was loaded onto a 
Parr hydrogenator, where it was subjected to agitation for 18 h, under a 30 psi 
pressure of H2. The resulting solution was filtered through celite to ensure removal of 
catalyst and the solvent was removed under reduced pressure to yield a yellow oil 
(1.54 g, 90%). Rf (10% MeOH/ CH2Cl2) = 0.28. 1H NMR (400 MHz,CD3OD) δ 7.84 (s, 1H, 
H6), 6.61 (s, 1H, H3), 2.34 (s, 3H, CH3), 1.33 (s, 9H, C(CH3)3); 13C NMR (101 MHz, CD3OD) 
δ 157.2 (C2), 148.0 (C5), 138.1 (C3), 129.4 (C6), 112.2 (C4), 34.1 (C(CH3)3), 28.6 (C(CH3)), 
16.9 (CH3); ESI-LCMS (+) m/z 181.1 [M+H]+. ESI-HRMS (+) calcd for [C10H17N2O]+ 
180.1263, found 180.1260. 
5-tert-Butyl-4-iodo-2-methylpyridine-1-oxide, 10 
 
5-tert-Butyl-4-amino-2-methylpyridin-1-oxide (1.5 g, 8.33 mmol) was dissolved in cold 
H2O (40 mL) and to this was added HBF4 (2.2 mL, 16.7 mmol). A solution of NaNO2 
(1.15g, 16.7 mmol) in H2O (5 mL) was added dropwise. Potassium iodide (1.94 g, 
11.7 mmol) was added in portions over 30 min and the resulting brown solution was 
stirred for 5 min. The mixture was then heated to 60oC and stirred for a further 30 min 
and then allowed to cool to room temperature. The pH of the solution was adjusted to 
10 with 2.5 M aqueous KOH solution, and the solution washed with CH2Cl2 (3 x 
150 mL). The organic layers were combined and dried over MgSO4 and the solvent 
removed under reduced pressure. The resulting brown oil was purified using silica gel 
column chromatography (100% CH2Cl2 to 2% MeOH/ CH2Cl2) to yield an orange oil 
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(1.25 g, 52%). Rf (10% MeOH/ CH2Cl2) = 0.37. 1H NMR (400 MHz,CDCl3) δ 8.20 (s, 1H, 
H6), 7.77 (s, 1H, H3), 2.37 (s, 3H, CH3), 1.45 (s, 9H, C(CH3)3); 13C NMR (101 MHz, CDCl3) δ 
146.5 (C5), 146.4 (C2), 139.7 (C3), 138.3 (C6), 89.8 (C4), 35.8 (C(CH3)3), 29.1 (C(CH3)), 16.6 
(CH3); ESI-LCMS (+) m/z 292.0 [M+H]+. ESI-HRMS (+) calcd for [C10H15127INO]+ 292.0198, 
found 292.0200.   
(5-tert-Butyl-4-iodopyridin-2-yl)methyl acetate, 11 
 
5-tert-Butyl-4-iodo-2-methylpyridin-1-oxide (1.25 g, 4.3 mmol) was dissolved in acetic 
anhydride (16 mL) and this was stirred for 3 h at 75oC. The solvent was removed under 
reduced pressure and the resulting orange oil was purified using silica gel column 
chromatography (100% CH2Cl2 to 2% MeOH/ CH2Cl2) to yield an orange oil (1.09 g, 
52%). Rf (10% MeOH/ CH2Cl2) = 0.62. 1H NMR (400 MHz,CDCl3) δ 8.50 (s, 1H, H6), 7.91 
(s, 1H, H3), 5.09 (s, 2H, CH2), 2.14 (s, 3H, CH3), 1.52 (s, 9H, C(CH3)3); 13C NMR (101 MHz, 
CDCl3) δ 170.8 (CO), 153.6 (C2), 147.7 (C5), 145.0 (C3), 136.3 (C6), 107.0 (C4), 65.6 (CH2), 
36.0 (C(CH3)3), 29.6 (C(CH3)), 21.1 (CH3); ESI-LCMS (+) m/z 334.0 [M+H]+. ESI-HRMS (+) 
calcd for [C12H17127INO2]+ 334.0304, found 334.0310. 
[5-tert-Butyl-4-(diethoxyphosphoryl)pyridin-2-yl]methyl acetate, 12 
 
(5-tert-Butyl-4-iodopyridin-2-yl)methyl acetate (750 mg, 2.25 mmol) was dissolved in 
triethylphosphite (10 mL, 58.4 mmol). Pd2(dba)3 (211 mg, 0.23 mmol) was added and 
the solution was degassed (freeze-pump-thaw cycle x 3). The resulting solution was 
stirred under argon at 120oC for 18 h. The solvent was removed by vacuum distillation 
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and the resulting brown oil was purified using silica gel column chromatography (100% 
CH2Cl2 to 2% MeOH/ CH2Cl2) to yield a yellow oil (580 mg , 75%). Rf (10% MeOH/ 
CH2Cl2) = 0.56. 1H NMR (400 MHz,CDCl3) δ 8.61 (d, 4JHP = 8, 1H, H6), 7.59 (d, 3JHP = 16, 
1H, H3), 4.99 (s, 2H, CH2), 3.99-3.90 (m, 4H, POCH2), 1.92 (s, 3H, COCH3), 1.35 (s, 9H, 
C(CH3)3), 1.17-1.05 (m, 6H, POCH2CH3) ; 31P NMR (162 MHz, CDCl3) δ 16.1; 13C NMR 
(101 MHz, CDCl3) δ 170.0 (CO), 152.8 (d, 3JCP = 12, C6), 148.7 (d, 3JCP = 13, C2), 145.0 (d, 
2JCP = 11, C5), 136.5 (d, 1JCP = 178, C4), 107.0 (C3), 65.9 (CH2O), 62.2 (d, 2JCP = 6, POCH2) 
35.4 (C(CH3)3), 31.1 (C(CH3)), 20.4 (CH3), 15.8 (d, 3JCP = 6, POCH2CH3) ; ESI-LCMS (+) m/z 
344.1 [M+H]+. ESI-HRMS (+) calcd for [C16H27NO4P]+ 344.1627, found 344.1628. 
5-tert-Butyl-4-(diethoxyphosphoryl)-2-hydroxymethyl-pyridine, 13 
 
[5-tert-Butyl-4-(diethoxyphosphoryl)pyridin-2-yl]methyl acetate (300 mg, 0.87 mmol) 
was dissolved in anhydrous EtOH (7 mL) and the solution was purged with argon for 
10 min before the addition of sodium metal (~15 mg). The reaction was stirred at room 
temperature and monitored by TLC. After 1 h, ionic cation exchange resin was added 
and the solution was stirred for a further 10 min. The reaction was filtered and the 
solvent was removed under reduced pressure and the resulting brown oil was 
dissolved in CH2Cl2 (7 mL) and washed with H2O (10 mL). The aqueous layer was 
extracted with CH2Cl2 (3 x 7 mL), and the organic layers were combined, dried over 
MgSO4 and the solvent removed under reduced pressure. The resulting brown oil was 
purified using silica gel column chromatography (100% CH2Cl2 to 2% MeOH/ CH2Cl2) to 
yield a yellow oil (213 mg, 82%). Rf (10% MeOH/ CH2Cl2) = 0.48. 1H NMR 
(400 MHz,CDCl3) δ 8.69 (d, 4JHP = 8, 1H, H6), 7.78 (d, 3JHP = 16, 1H, H3), 4.72 (s, 2H, CH2), 
4.16-3.97 (m, 4H, POCH2), 1.50 (s, 9H, C(CH3)3), 1.31-1.23 (m, 6H, POCH2CH3) ; 31P NMR 
(162 MHz, CDCl3) δ 15.6; 13C NMR (101 MHz, CDCl3) δ 157.3 (d, 3JCP = 11, C6), 148.1 (d, 
3JCP = 13, C2), 146.7 (d, 2JCP = 11, C5), 136.5 (d, 1JCP = 178, C4), 123.5 (C3), 64.2 (CH2O), 
62.7 (d, 2JCP = 6, POCH2) 35.8 (C(CH3)3), 31.6 (C(CH3)), 16.3 (d, 3JCP = 6, POCH2CH3) ; ESI-
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LCMS (+) m/z 302.1 [M+H]+. ESI-HRMS (+) calcd for [C16H27NO4P]+ 302.1521, found 
302.1525. 
[5-tert-Butyl-4-(diethoxyphosphoryl)pyridine-4-yl]methyl methane sulfonate, 14 
 
5-tert-Butyl-4-(diethoxyphosphoryl)-2-hydroxymethyl-pyridine (213 mg, 0.71 mmol) 
was dissolved in anhydrous THF (5 mL) and stirred at 5oC for 10 min, before the 
addition of NEt3 (199 µL, 1.42 mmol). Mesyl chloride (83 µL, 1.07 mmol) was added 
dropwise and the resulting solution was allowed to stir at room temperature for 
30 min. The solvent was removed under reduced pressure and the residue was 
dissolved in H2O (5 mL) and extracted with CH2Cl2 (3 x 10 mL). The organic layers were 
combined, dried over MgSO4 and the solvent removed under reduced pressure. The 
resulting orange oil was used without further purification (248 mg, 92%). 1H NMR 
(400 MHz, CDCl3) δ 8.78 (d, 4JHP = 8, 1H, H6), 7.84 (d, 3JHP = 15, 1H, H3), 5.26 (s, 2H, CH2), 
4.06-4.16 (m, 4H, POCH2), 3.05 (s, 3H, CH3), 1.52 (s, 9H, C(CH3)3), 1.29 (m, 6H, 
POCH2CH3); 31P NMR (162 MHz, CDCl3) δ 15.6; ESI-LCMS (+) m/z 380.0 [M+H]+. 






yl)methyl](methyl)phosphinate (216 mg, 0.49 mmol) was dissolved in anhydrous MeCN 
(3 mL) and K2CO3 (69 mg, 0.49 mmol) was added. [5-tert-Butyl-4-
(diethoxyphosphoryl)pyridin-2-yl]methyl methane sulfonate (190 mg, 0.5 mmol) was 
then added dropwise as a solution in anhydrous MeCN (5 mL). The resulting solution 
was heated to 70oC and stirred for 18 h after which the reaction was filtered to remove 
inorganic salts. The solvent was removed under reduced pressure and the resulting red 
oil was purified by alumina gel column chromatography (100% CH2Cl2 to 2% MeOH/ 
CH2Cl2) to yield a yellow oil (90 mg, 22%). Rf (10% MeOH/ CH2Cl2) = 0.65; 1H NMR 
(400 MHz, CDCl3) δ 8.73 (d, 4JHP = 8, 1H, H6), 7.88 (d, 3JHP = 16, 1H, H3), 4.09-4.16 (m, 
4H, POCH2), 3.93-4.05 (m, 6H, POCH2), 3.50-3.74 (m, 8H, NCH2), 2.53-3.49 (br m, 16H, 
cyclen CH2), 1.39-1.54 (m, 18H, C(CH3)3, PCH3), 1.20-1.32 (m, 15H, POCH2CH3); 31P NMR 
(162 MHz, CDCl3) δ 53.5-51.5 (NCH2P), 16.6-14.4 (pyP); 13C NMR (101 MHz, CDCl3) δ 
149.0 (C2), 136.2 (C5), 129.5 (C6), 127.3 (C4), 111.7 (C3), 62.5-62.8 (m, POCH2), 59.7-60.3 
(m, POCH2), 53.0-55.0 (m, PCH2N, pyCH2, cyclen CH2), 36.3 (C(CH3)3), 31.3 (C(CH3)3), 
16.6 (d, 3JCP = 6, POCH2CH3), 16.2 (d, 3JCP = 6, POCH2CH3), 13.0-14.9 (m, PCH3); ESI-LCMS 
(+) m/z 816.7 [M+H]+. ESI-HRMS (+) calcd for [C34H70N5O9P4]+ 816.4129, found 
816.4129. 
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Terbium(III) complex of {5-tert-butyl-2-[(4,7,10-
tri{[hydroxy(methyl)phosphoryl]methyl}-1,4,7,10-tetraazacyclododecan-1-
yl)methyl]pyridine-4-yl}phosphonic acid, [TbL1]  
 
Diethyl {5-tert-butyl-2-[(4,7,10-tri{[ethoxy(methyl)phosphoryl]methyl}-1,4,7,10-
tetraazacyclododecan-1-yl)methyl]pyridine-4-yl}phosphonate (22 mg, 0.027 mmol) 
was dissolved in aqueous HCl (1 mL, 6 M) and stirred at 70oC for 18 h. Complete ester 
cleavage was confirmed by ESI-MS (+) (LR: m/z 676.6 [M+H]+). The solvent was 
removed under reduced pressure to yield a yellow oil which was dissolved in H2O 
(2 mL), the pH of the resulting solution was adjusted to 5.5 using aqueous NaOH 
solution (2.5 M), before TbCl3·6H2O (14 mg, 0.037 mmol) was added. The solution was 
stirred at 70oC for 18 h before the solvent was removed under reduced pressure. The 
resulting yellow solid was purified by reverse-phase HPLC (10-100% MeOH in H2O over 
10 min; tR = 2.3 min) to yield a white solid (4 mg, 19%).  ESI-LCMS (-) m/z 829.7 [M-H]-. 
ESI-HRMS (+) calcd for [C24H47N5O9P4159Tb]+ 832.1578, found 832.1578.   
[HoL1]  
An analogous procedure to that described for the synthesis of [TbL1] was followed 
using diethyl {5-tert-butyl-2-[(4,7,10-tri{[ethoxy(methyl)phosphoryl]methyl}-1,4,7,10-
tetraazacyclododecan-1-yl)methyl]pyridine-4-yl}phosphonate (15 mg, 0.02 mmol) and 
DyCl3·6H2O (15 mg, 0.04 mmol), to yield a white solid (4 mg, 24%). ESI-LCMS (-) m/z 
837.2 [M-H]-; ESI-HRMS (-) calcd for [C24H45N5O9P4165Ho]- 836.1471, found 836.1473. 
[DyL1]  
An analogous procedure to that described for the synthesis of [Tb.L1] was followed 
using diethyl {5-tert-butyl-2-[(4,7,10-tri{[ethoxy(methyl)phosphoryl]methyl}-1,4,7,10-
tetraazacyclododecan-1-yl)methyl]pyridine-4-yl}phosphonate (38 mg, 0.046 mmol) and 
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DyCl3·6H2O (23 mg, 0.06 mmol), to yield a white solid (18 mg, 47%). ESI-LCMS (-) m/z 
835.8 [M-H]-. ESI-HRMS (+) calcd for [C24H47N5O9P4160Dy]+ 833.1576, found 833.1573. 
[TmL1]  
An analogous procedure to that described for the synthesis of [TbL1] was followed 
using diethyl {5-tert-butyl-2-[(4,7,10-tri{[ethoxy(methyl)phosphoryl]methyl}-1,4,7,10-
tetraazacyclododecan-1-yl)methyl]pyridine-4-yl}phosphonate (15 mg, 0.02 mmol) and 
TmCl3·6H2O (11 mg, 0.03 mmol), to yield a white solid (8 mg, 48%). ESI-LCMS (+) m/z 




10-tert-Butyl-1,4,7,10-tetraazacyclododecane-10-carboxylate (320 mg, 1.2 mmol) and 
paraformaldehyde (800 mg, 24.7 mmol) were dissolved in anhydrous THF (30 mL) and 
the resulting suspension was stirred under argon at 80oC for 30 min. Diethyl 
benzylphosphonite (1.5 mL, 7.1 mmol) was added and the reaction was stirred at 80oC 
for a further 18 h. The solution was filtered and the solvent was removed under 
reduced pressure. The resulting orange oil was purified by alumina gel column 
chromatography (100% CH2Cl2 to 1% MeOH/ CH2Cl2) to yield a yellow oil (380 mg, 
44%). Rf (5% MeOH/ CH2Cl2) = 0.48. 1H NMR (600 MHz,CDCl3) δ 7.32-7.07 (m, Ar), 4.09-
3.64 (m, 6H, POCH2), 3.59-2.40 (m, 28H, PCH2N, PCH2Ar, cyclen CH2), 1.30 (s, 9H, 
C(CH3)3), 1.21-1.03 (m, 9H, POCH2CH3); 31P NMR (243 MHz, CDCl3) δ 51.5-47.5; 13C NMR 
(151 MHz, CDCl3) δ 155.7 (CO), 131.3-127.7 (Ar), 79.9 (C(CH3)3), 64.4 (PCH2N), 60.7 
(POCH2)  55.1-51.5 (m, cyclen CH2), 37.3-35.0 (m, CH2Ar), 28.5 (C(CH3)3), 16.5 
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(POCH2CH3); ESI-LCMS (+) m/z 861.4 [M+H]+. ESI-HRMS (+) calcd for [C43H68N4O8P3]+ 




tetraazacyclododecane-10-carboxylate (350 mg, 0.41 mmol) was dissolved in 
anhydrous CH2Cl2 (2 mL) and to this was added TFA (2 mL). The solution was stirred at 
room temperature for 18 h, before the solvent was removed under reduced pressure. 
The resulting yellow oil was dissolved in H2O (1 mL) and the pH of this solution was 
adjusted to 12 using aqueous NaOH solution (2.5 M) before the aqueous solution was 
extracted with CH2Cl2 (4 x 10 mL). The organic layers were combined, dried over 
MgSO4, and the solvent removed under reduced pressure to yield a yellow oil (285 mg, 
75%). 1H NMR (400 MHz,CDCl3) δ 7.35-7.14 (m, 15H, Ar), 4.20-3.58 (m, 6H, POCH2), 
3.37-2.44 (m, 28H, PCH2N, PCH2Ar, cyclen CH2), 1.23-1.10 (m, 9H, POCH2CH3); 31P NMR 
(162 MHz, CDCl3) δ 50.5-47.0; ESI-LCMS (+) m/z 761.2 [M+H]+. ESI-HRMS (+) calcd for 
[C38H60N4O6P3]+ 761.3726, found 761.3734. 
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1,4,7-Tri{[ethoxy(benzyl)phosphoryl]methyl}-10-(5-tert-butyl-4-
(diethoxyphosphoryl)pyridine-2-yl)methyl- 1,4,7,10-tetraazacyclododecane, L2 
 
1,4,7-Tri{[ethoxy(benzyl)phosphoryl]methyl}-1,4,7,10-tetraazacyclododecane (190 mg, 
0.25 mmol) was dissolved in anhydrous MeCN (2 mL) and to this was added Cs2CO3 
(130 mg, 0.4 mmol). [5-tert-Butyl-4-(diethoxyphosphoryl)pyridine-4-yl]methyl 
methane sulfonate (150 mg, 0.4 mmol) was then added dropwise as a solution in 
anhydrous MeCN (4 mL). The resulting solution was heated to 70oC and stirred for 18 h 
after which the reaction was filtered to remove inorganic salts. The solvent was 
removed under reduced pressure and the resulting red oil was purified by alumina gel 
column chromatography (100% CH2Cl2 to 2% MeOH/ CH2Cl2) to yield a yellow oil 
(135 mg, 52%). Rf (5% MeOH/ CH2Cl2) = 0.58; 1H NMR (700 MHz, CDCl3) δ 8.69 (s, 1H, 
H6), 7.93 (s, 1H, H3), 7.31 - 7.05 (m, 15H, Ar), 4.23 – 4.05 (m, 4H, POCH2), 3.99 – 3.70 
(m, 8H, POCH2, NCH2py), 3.30 – 2.52 (m, 30H, , PCH2N, PCH2Ar, cyclen CH2), 1.49 (s, 9H, 
C(CH3)3), 1.3 (t, 3J = 7, 6H, POCH2CH3), 1.14-1.06 (m, 9H, POCH2CH3); 31P NMR (162 
MHz, CDCl3) δ 49.2 (NCH2P), 47.8 (NCH2P), 15.5 (pyP) 13C NMR (175 MHz, CDCl3) δ 
131.5-131 (CA), 130.0-129.6 (CB), 128.7-128.4 (CC), 127.0-126.6 (CD), 62.8 (POCH2), 61.0-
60.7 (POCH2, NCH2py), 54.6-50.2 (cyclen CH2, NCH2P), 37.1-35.9 (m, CH2Ar), 35.9 
(C(CH3)3), 31.4 (C(CH3)3), 16.8-16.1 (POCH2CH3); ESI-LCMS (+) m/z 1044.5 [M+H]+; ESI-
HRMS (+) calcd for [C52H82N5O9P4]+ 1044.5063, found 1044.5082. 
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(diethoxyphosphoryl)pyridine-2-yl)methyl- 1,4,7,10-tetraazacyclododecane (16 mg, 
0.015 mmol) was dissolved in aqueous HCl (1 mL, 6 M) and stirred at 70oC for 18 h. 
Complete ester cleavage was confirmed by ESI-MS (-) (LR: m/z 902.4 [M-H]-). The 
solvent was removed under reduced pressure to yield a yellow oil which was dissolved 
in H2O (2 mL). The pH of the resulting solution was adjusted to 5.5 using aqueous 
NaOH solution (2.5 M) and TmCl3·6H2O (9 mg, 0.023 mmol) was added. The solution 
was stirred at 70oC for 18 h before the solvent was removed under reduced pressure. 
The resulting yellow solid was purified by reverse-phase HPLC (10-100% MeCN in H2O 
over 10 min; tR = 8.3 min) to yield a glassy white solid (5 mg, 31%). ESI-LCMS (+) m/z 
1070.2 [M+H]+; ESI-HRMS (+) calcd for [C42H58N5O9P4169Tm]+ 1070.2605, found 
1070.2650. 
[GdL2] 
An analogous procedure to that described for the synthesis of [TmL2] was followed 
using 1,4,7-tri{[ethoxy(benzyl)phosphoryl]methyl}-10-(5-tert-butyl-4-
(diethoxyphosphoryl)pyridine-2-yl)methyl- 1,4,7,10-tetraazacyclododecane (22 mg, 
0.020 mmol) and GdCl3·6H2O (15 mg, 0.04 mmol), to yield a white solid (7 mg, 33 %) . 
ESI-LCMS (+) m/z 1058.9 [M+H]+; ESI-HRMS (+) calcd for [C42H58N5O9P4158Gd]+ 
1059.2515, found 1059.2563. 
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 (5-tert-Butylpyridin-2-yl)methanol, 17  
 
5-tert-Butyl-2-methylpyridin-1-oxide (5.0 g, 30.3 mmol) was dissolved in anhydrous 
CH2Cl2 (40 mL) and TFA (22 mL, 156.8 mmol) was added. The resulting solution was 
stirred for 18 h at 60°C under argon. The reaction was monitored by 1H NMR 
spectroscopy, and upon completion the solvent was removed under reduced pressure. 
The resulting yellow oil was stirred in a mixture of H2O (25 mL) and EtOH (25 mL) at 
room temperature for 2h. The solution was concentrated (ca. 15 mL) and extracted 
with CH2Cl2 (3 x 100 mL). The organic layers were combined, dried over MgSO4 and the 
solvent removed under reduced pressure. The resulting orange oil was purified by 
silica gel column chromatography (100% CH2Cl2 to 5% MeOH/ CH2Cl2) to yield a yellow 
oil (4.3 g, 86%). Rf (10% MeOH/ CH2Cl2) = 0.46. 1H NMR (400 MHz, CDCl3) δ 8.57 (s, 1H, 
H6), 8.26 (d, J = 8 Hz, 1H, H4), 7.75 (d, J = 8 Hz, 1H, H3), 4.88 (s, 2H, CH2OH), 1.26 (s, 9H, 
C(CH3)3). 13C NMR (101 MHz, CDCl3) δ 154.4 (C2), 149.1 (C6), 142.9 (C5), 137.9 (C3), 
124.3 (C4), 60.0 (CH2OH), 34.1 (C(CH3)3), 30.2 (C(CH3)3). ESI-LCMS (+) m/z 166.3 [M+H]+. 
ESI-HRMS (+) calcd for [C10H16NO]+ 166.1232, found 166.1231. 
(5-tert-Butylpyridin-2-yl)methyl methanesulfonate, 18  
 
(5-tert-Butylpyridin-2-yl)methanol (200 mg, 1.2 mmol) was dissolved in anhydrous THF 
(5 mL) and stirred at 5oC for 10 min, before the addition of NEt3 (340 µL, 2.4 mmol). 
Mesyl chloride (140 µL, 1.8 mmol) was added dropwise and the resulting solution was 
allowed to stir at room temperature for 30 min. The solvent was removed under 
reduced pressure and the residue was dissolved in H2O (5 mL) and extracted with 
CH2Cl2 (3 x 10 mL). The organic layers were combined, dried over MgSO4 and the 
solvent removed under reduced pressure. The resulting orange oil was used without 
further purification (247 mg, 84 %). Rf (10% MeOH/ CH2Cl2) = 0.76; 1H NMR (400 MHz, 
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CDCl3) δ 8.57 (s, 1H, H6), 8.15 (d, J = 8 Hz, 1H, H4), 7.75 (d, J = 8 Hz, 1H, H3), 5.44 (s, 2H, 




1,4,7-Tri{[ethoxy(benzyl)phosphoryl]methyl}-1,4,7,10-tetraazacyclododecane (285 mg, 
0.38 mmol) was dissolved in anhydrous MeCN (2 mL) and to this was added Cs2CO3 
(210 mg, 0.64 mmol). (5-tert-Butylpyridin-2-yl)methyl methanesulfonate (130 mg, 
0.525 mmol) was then added dropwise as a solution in anhydrous MeCN (4 mL). The 
resulting solution was heated to 70oC and stirred for 18 h before being cooled to room 
temperature and filtered to remove inorganic salts. The solvent was removed under 
reduced pressure and the resulting red oil was purified by alumina gel column 
chromatography (100% CH2Cl2 to 2% MeOH/ CH2Cl2) to yield an orange oil (90 mg, 
22%). Rf (5% MeOH/ CH2Cl2) = 0.45; 1H NMR (400 MHz, CDCl3) δ 8.62 (s, 1H, H6), 
7.78 - 7.68 (m, 2H, H3, H4), 7.30-7.14 (m, 15H, Ar), 4.68 (s, 2H, NCH2Py), 4.24-2.44 (m, 
34H, POCH2, PCH2N, PCH2Ar, cyclen CH2), 1.52-1.37 (m, 9H, POCH2CH3), 1.29 (s, 9H, 
C(CH3)3); 31P NMR (162 MHz, CDCl3) δ 52.5 – 48.3 (mixture of isomers); ESI-LCMS (+) 
m/z 908.3 [M+H]+; ESI-HRMS (+) calcd for [C48H73N5O6P3]+ 908.4774, found 908.4774.  
Chapter 6: Experimental Methods 
216 




1,4,7,10-tetraazacyclododecane (11 mg, 0.011 mmol) was dissolved in aqueous HCl 
(1 mL, 6 M) and stirred at 100oC for 18 h. Complete ester cleavage was confirmed by 
ESI-MS (+) (LR: m/z 824.4  [M+H]+). The solvent was removed under reduced pressure 
to yield a yellow oil which was dissolved in H2O (2 mL). The pH of the solution was 
adjusted to 5.5 using aqueous NaOH solution (2.5 M) and DyCl3·6H2O (20 mg, 
0.053 mmol) was added. The solution was stirred at 70oC for 18 h before the solvent 
was removed under reduced pressure. The resulting yellow solid was purified by 
reverse-phase HPLC (10-100% MeCN in H2O over 10 min; tR = 10.0 min) to yield a glassy 
white solid (6 mg, 52%). ESI-LCMS (+) m/z 985.3 [M+H]+. ESI-HRMS (+) calcd for 
[C42H58N5O6P3160Dy]+ 981.2852, found 981.2886. 
[TbL4] 
An analogous procedure to that described for the synthesis of [DyL4] was followed 
using 1,4,7-tri{[ethoxy(benzyl)phosphoryl]methyl}-10-(5-tert-butylpyridin-2-yl)methyl-
1,4,7,10-tetraazacyclododecane (35 mg, 0.039 mmol) and TbCl3·6H2O (17 mg, 
0.045 mmol), to yield a white solid (27 mg, 71%).  ESI-LCMS (+) m/z 980.1 [M+H]+. ESI-
HRMS (+) calcd for [C42H58N5O6P3159Tb]+ 980.2840, found 980.2884 
[HoL4] 
An analogous procedure to that described for the synthesis of [DyL4] was followed 
using 1,4,7-tri{[ethoxy(benzyl)phosphoryl]methyl}-10-(5-tert-butylpyridin-2-yl)methyl-
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1,4,7,10-tetraazacyclododecane (76 mg, 0.083 mmol) and HoCl3·6H2O (38 mg, 
0.016 mmol), to yield a white solid (4 mg, 47%). ESI-LCMS (+) m/z 987.8 [M+H]+. ESI-
HRMS (+) calcd for [C42H58N5O6P3165Ho]+ 986.2903, found 986.2906. 
 [ErL4] 
An analogous procedure to that described for the synthesis of [DyL4] was followed 
using 1,4,7-tri{[ethoxy(benzyl)phosphoryl]methyl}-10-(5-tert-butylpyridin-2-yl)methyl-
1,4,7,10-tetraazacyclododecane (17 mg, 0.019 mmol) and ErCl3·6H2O (10 mg, 
0.03 mmol), to yield a white solid (12 mg, 64%). ESI-LCMS (+) m/z 987.4 [M+H]+. ESI-
HRMS (+) calcd for [C42H58N5O6P3164Er]+ 985.2892, found 985.2911. 
[TmL4] 
An analogous procedure to that described for the synthesis of [DyL4] was followed 
using 1,4,7-Tri{[ethoxy(benzyl)phosphoryl]methyl}-10-(5-tert-butylpyridin-2-yl)methyl-
1,4,7,10-tetraazacyclododecane (35 mg, 0.039 mmol) and TmCl3·6H2O (17 mg, 
0.045 mmol), to yield a white solid (25 mg, 65%).  ESI-LCMS (+) m/z 990.8 [M+H]+. ESI-
HRMS (+) calcd for [C42H58N5O6P3169Tm]+ 990.2942, found 990.2952. 
[YbL4] 
An analogous procedure to that described for the synthesis of [DyL4] was followed 
using 1,4,7-tri{[ethoxy(benzyl)phosphoryl]methyl}-10-(5-tert-butylpyridin-2-yl)methyl-
1,4,7,10-tetraazacyclododecane (44 mg, 0.049 mmol) and YbCl3·6H2O (21 mg, 
0.055 mmol), to yield a white solid (33 mg, 68%).  ESI-LCMS (+) m/z 995.4 [M+H]+. ESI-
HRMS (+) calcd for [C42H58N5O6P3170Yb]+ 991.2948, found 991.2958.  
Crystals of the ytterbium complex were grown by slow diffusion of diethyl ether into a 
solution of methanol and examined by X-ray crystallography: C42H57N5O6P3Yb x 
3
2
 CH3OH x H2O, Mr = 1106.02 g/mol, monoclinic, space group P21/c (no. 14), a = 
30.3971(15) Å, b = 17.3173(8) Å, c = 19.4270(10) Å, β = 100.7201(16) , V = 10047.8(9) 
Å3, Z = 2, T = 120 K, μ(MoKα) = 2.015 mm-1, Dcalc = 1.462 g/cm3, 192170 reflections 
measured (3.92°≤ 2Θ ≤ 60°), 29289 unique (Rint = 0.0425, Rsigma = 0.0318) which were 
used in all calculations. The final R1 was 0.0381 (I > 2σ(I)) and wR2 was 0.0942 (all data). 
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[EuL4] 
An analogous procedure to that described for the synthesis of [DyL4] was followed 
using 1,4,7-tri{[ethoxy(benzyl)phosphoryl]methyl}-10-(5-tert-butylpyridin-2-yl)methyl-
1,4,7,10-tetraazacyclododecane (38 mg, 0.042 mmol) and EuCl3·6H2O (18 mg, 
0.05 mmol), to yield a white solid (25 mg, 61%). ESI-LCMS (+) m/z 972.2 [M+H]+. ESI-
HRMS (+) calcd for [C42H58N5O6P3151Eu]+ 972.2799, found 972.2820. 
[YL4] 
An analogous procedure to that described for the synthesis of [DyL4] was followed 
using 1,4,7-tri{[ethoxy(benzyl)phosphoryl]methyl}-10-(5-tert-butylpyridin-2-yl)methyl-
1,4,7,10-tetraazacyclododecane (35 mg, 0.038 mmol) and YCl3·6H2O (18 mg, 
0.05 mmol), to yield a white solid (22 mg, 64%). 31P NMR (162 MHz, CD3OD) δ 37.2 (d, 
2JYP = 6 Hz, P1), 36.4 (d, 2JYP = 6 Hz, P2), 34.2 (d, 2JYP = 6 Hz, P3); 1H NMR (600 MHz, 
CD3OD) and 13C NMR (151 MHz, CD3OD): 
Carbon Label Shift, ppm (CP coupling) Proton Label Shift, ppm  
py2 156.1   
py3 124.9 py3 7.45 
py4  py4 8.05 
py5 147.7   
py6 146.0 py6 9.04  
tbu 34.9   
tbu 31.3 tbu 1.39 
c1 51.6 ax 3.69 
eq 2.50 
c2 54.9 ax 3.81 
eq 2.59 
c3 53.5 (15) ax 3.56 
eq 2.43 
c4 55.7 ax 3.85 
eq 2.50 
c5 53.0 (13) ax 3.60 
eq 2.33 
c6 55.2 ax 4.27 
eq 2.45 
c7 53.5 (15) ax 3.56 
eq 2.36 
c8 54.3 ax 3.21 
eq 2.51 
ap 61.2 ax 4.72 
eq 3.72 
a1 58.0 (94.9) ax 3.67 
eq 2.52 
a2 57.14 (95.2) ax 4.04 
eq 2.54 
a3 57.06 (97.9) ax 2.95 
eq 2.44 
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r1 38.6 (90.8) ax 3.24 
eq 2.92 
r2 39.0 (91.7) ax 3.65 
eq 3.35 
r3 40.4 (91.6) ax 3.21 
eq 2.97 
ph1i 134.4   
ph1o 131.5 ph1o 7.12 
ph1m 128.8 ph1m 7.12 
ph1p 126.7 ph1p 7.06 
ph2i 127.1   
ph2o 131.5 ph2o 7.61 
ph2m 129.2 ph2m 7.27 
ph2p 127.1 ph2p 7.15 
ph3i 134.3   
ph3o 130.8 ph3o 7.29 
ph3m 129.6 ph3m 7.21 
ph3p 127.6 ph3p 7.17 
1,7-Dibenzyl 1,4,7,10-tetraazacyclododecane 1,7-dicarboxylate, 19 
 
1,4,7,10-Tetraazacyclododecane (3.5 g, 20.3 mmol) was dissolved in a solution of 
distilled H2O:1,4-dioxane (50:20 mL) and to this was added Na2HPO4 (9.8 g, 
69.0 mmol). The pH of the solution was adjusted to 2.5 by addition of conc. HCl (aq). A 
solution of benzyl chloroformate (7.3 mL, 50.8 mmol) in 1,4-dioxane (10 mL) was 
added dropwise over a period of 30 min and the resulting solution was stirred at room 
temperature for 18 h. The solvent was removed under reduced pressure and the 
residue dissolved in H2O (200 mL) and the pH adjusted to 7 by the addition of conc. 
KOH (aq). The resulting aqueous solution was then washed with Et2O (3 x 100 mL) to 
remove side products, the aqueous phase was then extracted with CH2Cl2 (3 x 100 mL). 
The organic phases were combined, dried over MgSO4 and the solvent removed under 
reduced pressure to yield a colourless oil. The oil was redissolved in CH2Cl2 (5 mL) 
followed by precipitation of the desired product via the addition of cold Et2O (200 mL) 
to yield a white solid that was collected by filtration (6.12 g, 69%).  1H NMR 
(700 MHz,CDCl3) δ 7.14-6.81 (m, 10H, ArH), 4.81 (s, 4H, CH2O), 3.49-3.14 (m, 8H, cyclen 
CH2), 2.83-2.45 (m, 8H, cyclen CH2); 13C NMR (176 MHz, CDCl3) δ 154.9 (COCH2Ar), 
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135.1 (Ar), 127.7-126.9 (Ar), 66.5 (COCH2Ar), 49.4-48.1 (cyclen CH2); ESI-LCMS (+) m/z 




1,7-Di-benzyl-1,4,7,10-tetraazacyclododecane-1,7-dicarboxylate (1.1 g, 2.5 mmol) was 
dissolved in anhydrous CH2Cl2 (20 mL) and to this was added triethylamine (0.9 mL, 
6.5 mmol) was added. The resulting solution was stirred under argon for 10 minutes 
before the addition of di-tert-butyl dicarbonate (1.4 g, 6.5 mmol). After addition, the 
solution was stirred at room temperature for a further 18 h. The solvent was removed 
under reduced pressure and the resulting yellow oil was purified by silica gel column 
chromatography (100% CH2Cl2 to 2% MeOH/ CH2Cl2) to yield a white solid (1.49 g, 
95%). Rf (10% MeOH/ CH2Cl2) = 0.66. 1H NMR (400 MHz,CDCl3) δ 7.34-7.14 (m, 10H, 
Ar), 5.04 (s, 4H, OCH2Ar) 3.29 (br, 16H, cyclen CH2) 1.31 (s, 18H, C(CH3)3); 13C NMR 
(101 MHz, CDCl3) δ 156.9 (CO), 136.4 (Ar), 128.6 (Ar), 128.4 (Ar), 128.3 (Ar), 80.1 
(C(CH3)3), 67.3 (CH2O), 50.2 (br, cyclen CH2), 28.4 (C(CH3)3), ESI-LCMS (+) m/z 641.0 
[M+H]+. 





tetracarboxylate (1.4 g, 2.2 mmol) was dissolved in MeOH (20 mL) and to this was 
added Pd(OH)2/C (~300 mg). The reaction mixture was loaded onto a Parr 
hydrogenator, where it was subjected to agitation for 18 h, under an atmosphere of H2 
(30 psi). The resulting solution was filtered through celite to ensure removal of 
catalyst, the solvent was then removed under reduced pressure to yield a pale yellow 
oil (0.66 g, 80%). 1H NMR (400 MHz,CDCl3) δ 5.31 (br s, NH), 3.75-2.83 (m, 16H, cyclen 
CH2) 1.48 (s, 9H, C(CH3)3); 13C NMR (101 MHz, CDCl3) δ 157.5 (CO) , 82.3 (C(CH3)3), 48.2 
(cyclen CH2), 46.9 (cyclen CH2), 45.6 (cyclen CH2), 44.5 (cyclen CH2), 28.7 (C(CH3)3), ESI-




tert-Butyl-1,4,7,10-tetraazacyclododecane-1,7-dicarboxylate (1.08 g, 2.9 mmol) and 
paraformaldehyde (1.3 g, 40 mmol) were dissolved in anhydrous THF (60 mL) and the 
resulting suspension was stirred under argon at 80oC for 10 minutes. Diethyl 
benzylphosphonite (2.5 mL, 11.6 mmol) was added and the reaction was stirred at 
80oC for a further 18 h. The solution was filtered and the solvent was removed under 
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reduced pressure. The resulting yellow oil was purified by alumina gel column 
chromatography (100% CH2Cl2 to 1% MeOH/ CH2Cl2) to yield a colourless oil (1.82 mg, 
82%). Rf (10% MeOH/ CH2Cl2) = 0.76. 1H NMR (700 MHz,CDCl3) δ 7.32-7.16 (m, 10H, 
Ar), 3.99-3.75 (m, 4H, POCH2CH3), 3.46-2.72 (m, 24H, PCH2N, PCH2Ar, cyclen CH2), 1.39 
(s, 9H, C(CH3)3), 1.14 (t, 3J = 8, 6H, POCH2CH3); 31P NMR (283 MHz, CDCl3) δ 48.9; 13C 
NMR (176 MHz, CDCl3) δ 155.9 (CO), 131.6 (d, 2JCP = 8, CA), 129.9 (d, 3JCP = 5.5, CB), 
128.6 (d, 4JCP = 2.5, CC), 126.8 (CD), 79.6 (C(CH3)3), 60.7 (POCH2), 55.7 (br, cyclen CH2), 
52.3 (d, 1JCP = 104.5, NCH2P), 46.4 (cyclen CH2), 35.9 (d, 1JCP = 104.5, PCH2Ar), 28.2 
(C(CH3)3), 16.6 (POCH2CH3); ESI-LCMS (+) m/z 764.9 [M+H]+. ESI-HRMS (+) calcd for 




tetraazacyclododecane-1,7-carboxylate (250 mg, 0.33 mmol) was dissolved in 
anhydrous CH2Cl2 (2 mL) and to this was added TFA (2 mL). The solution was stirred at 
room temperature for 18 h after which the solvent was removed under reduced 
pressure. The resulting yellow oil was dissolved in H2O (1 mL) and the pH of this 
solution was adjusted to 12 with aqueous NaOH solution (2.5 M) before being 
extracted with CH2Cl2 (4 x 10 mL). The organic layers were combined, dried over 
MgSO4, and the solvent removed under reduced pressure to yield a yellow oil (148 mg, 
79%). 1H NMR (700 MHz,CDCl3) δ 7.31-7.13 (m, 10H, Ar), 4.04-3.78 (m, 4H, POCH2CH3), 
3.26-2.75 (m, 24H, PCH2N, PCH2Ar, cyclen CH2), 1.18 (t, 3J = 6, 6H, POCH2CH3); 31P NMR 
(283 MHz, CDCl3) δ 49.6; 13C NMR (176 MHz, CDCl3) δ 130.8 (d, 2JCP = 7.5, CA), 129.8 (d, 
3JCP = 5.5, CB), 128.9 (d, 4JCP = 2.5, CC), 127.3 (CD), 61.5 (POCH2), 52.0 (br, NCH2P), 44.5 
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(cyclen CH2), 36.1 (d, 1JCP = 78.5, PCH2Ar), 16.4 (POCH2CH3); ESI-LCMS (+) m/z 564.9 




1,7-Tri{[ethyoxy(benzyl)phosphoryl]methyl}-1,4,7,10-tetraazacyclododecane (150 mg, 
0.27 mmol) was dissolved in anhydrous MeCN (3 mL) and to this was added Cs2CO3 
(350 mg, 1.07 mmol). (5-tert-Butylpyridin-2-yl)methyl methanesulfonate (183 mg, 
0.74 mmol) was then added dropwise as a solution in anhydrous MeCN (6 mL). The 
resulting solution was heated to 70oC and stirred for 18 h after which the reaction was 
filtered to remove inorganic salts. The solvent was removed under reduced pressure 
and the resulting red oil was purified by alumina gel column chromatography (100% 
CH2Cl2 to 2% MeOH/ CH2Cl2) to yield a yellow oil (220 mg, 27%). Rf (5% MeOH/ CH2Cl2) 
= 0.46. 1H NMR (700 MHz,CDCl3) δ  8.52 (d, 4J = 2.5, 2H, H6), 7.54 (dd, 3J = 8, 4J = 2.5, 2H, 
H4), 7.44(d, 3J = 8, 2H, H3), 7.31-7.09 (m, 10H, Ar), 4.07-3.66 (m, 12H, POCH2, PCH2N, 
NCH2py), 3.23-3.04 (m, 4H, PCH2Ar), 3.00-2.90 (br m, 4H, cyclen CH2), 2.86-2.76 (br m, 
4H, cyclen CH2), 2.74-2.62 (br m, 8H, cyclen CH2), 1.24 (s, 18H, C(CH3)3), 1.06 (t, 3J = 7, 
6H, POCH2CH3); 31P NMR (243 MHz, CDCl3) δ 49.4, 48.9; ESI-LCMS (+) m/z 859.5 
[M+H]+; ESI-HRMS (+) calcd for [C48H73N6O4P2]+ 859.5169, found 859.5174. 
Chapter 6: Experimental Methods 
224 
Dysprosium (III) complex of 1,7-(5-tert-butylpyridin-2-yl)methyl-4,10-di{[ 
benzylphosphoryl]methyl}-1,4,7,10-tetraazacyclododecane chloride [DyL5]Cl 
 
1,7-(5-tert-Butylpyridin-2-yl)methyl-1,4,7,10-tetraazacyclododecane (220 mg, 
0.26 mmol) was dissolved in aqueous HCl (5 mL, 6 M) and stirred at 70oC for 18 h. 
Complete ester cleavage was confirmed by ESI-MS (-) (LR: m/z 801.4 [M-H]-). The 
solvent was removed under reduced pressure to yield a yellow oil which was dissolved 
in H2O (2 mL). The pH of the solution was adjusted to 5.5 using aqueous NaOH solution 
(2.5 M) and DyCl3·6H2O (20 mg, 0.053 mmol) was added. The solution was stirred at 
70oC for 18 h before the solvent was removed under reduced pressure. The resulting 
yellow solid was purified by reverse-phase HPLC (10-100% MeCN in H2O over 10 min; 
tR = 9.3 min) to yield a glassy white solid (15 mg, 39%). ESI-LCMS (+) m/z 964.1 [M]+. 
ESI-HRMS (+) calcd for [C44H62N6O4P2160Dy]+ 960.3560, found 960.3569. 
[TbL5]Cl 
An analogous procedure to that described for the synthesis of [DyL5]Cl was followed 
using 1,7-(5-tert-butylpyridin-2-yl)methyl-4,10-di{[benzylphosphoryl]methyl}-1,4,7,10-
tetraazacyclododecane (8 mg, 0.01 mmol) and TbCl3·6H2O (6 mg, 0.016 mmol), to yield 
a white solid (5 mg, 52%). ESI-LCMS (+) m/z 959.4 [M]+. ESI-HRMS (+) calcd for 
[C44H62N6O4P2159Tb]+ 959.3561, found 959.3588. 
The complex [TbL5]Cl (1 eq.) was dissolved in methanol and to this solution was added 
ammonium hexafluorophosphate (5 eq.). The solvent was removed under reduced 
pressure and the resulting white solid was suspended in water (1.5 mL). The 
suspension was centrifuged and the white solid was isolated and dried under vacuum. 
Crystals of the terbium complex were grown by slow diffusion of diethyl ether into a 
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solution of methanol and examined by X-ray crystallography: C44H62N6O4P2Tb x PF6 x 
3 CH3OH, Mr = 1297.07 g/mol, triclinic, space group P-1 (no. 2), a = 13.0815(7) Å, b = 
13.3828(7) Å, c = 33.0590(17) Å, α = 84.676(2), β = 85.9292(19), γ = 82.7638(19), V = 
5706.4(5) Å3, Z = 4, T = 120 K, μ(MoKα) =  1.403 mm-1, Dcalc = 1.510 g/cm3, 111088 
reflections measured (3.886° ≤ 2Θ ≤ 60.068°), 33377 unique (Rint = 0.0393, Rsigma = 
0.0521) which were used in all calculations. The final R1 was 0.0366 (I > 2σ(I)) 
and wR2 was 0.0809 (all data). 
[HoL5]Cl 
An analogous procedure to that described for the synthesis of [DyL5]Cl was followed 
using 1,7-(5-tert-butylpyridin-2-yl)methyl-4,10-di{[benzylphosphoryl]methyl}-1,4,7,10-
tetraazacyclododecane (4 mg, 0.005 mmol) and TbCl3·6H2O (3 mg, 0.008 mmol), to 
yield a white solid (2.2 mg, 44 %). ESI-LCMS (+) m/z 965.6 [M]+. ESI-HRMS (+) calcd for 
[C44H62N6O4P2165Ho]+ 965.3611, found 965.3643. 
[ErL5]Cl 
An analogous procedure to that described for the synthesis of [DyL5]Cl was followed 
using 1,7-(5-tert-butylpyridin-2-yl)methyl-4,10-di{[benzylphosphoryl]methyl}-1,4,7,10-
tetraazacyclododecane (8 mg, 0.01 mmol) and ErCl3·6H2O (6 mg, 0.016 mmol), to yield 
a white solid (6.3 mg, 65%). ESI-LCMS (+) m/z 966.3 [M]+. ESI-HRMS (+) calcd for 
[C44H62N6O4P2164Er]+ 964.3600, found 964.3606. 
[TmL5]Cl 
An analogous procedure to that described for the synthesis of [DyL5]Cl was followed 
using 1,7-(5-tert-butylpyridin-2-yl)methyl-4,10-di{[benzylphosphoryl]methyl}-1,4,7,10-
tetraazacyclododecane (8 mg, 0.01 mmol) and TmCl3·6H2O (6 mg, 0.016 mmol), to 
yield a white solid (5.5 mg, 57%). ESI-LCMS (+) m/z 969.4 [M]+. ESI-HRMS (+) calcd for 
[C44H62N6O4P2169Tm]+ 969.3650, found 969.3679. 
[YbL5]Cl 
An analogous procedure to that described for the synthesis of [DyL5]Cl was followed 
using 1,7-(5-tert-butylpyridin-2-yl)methyl-4,10-di{[benzylphosphoryl]methyl}-1,4,7,10-
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tetraazacyclododecane (12 mg, 0.015 mmol) and YbCl3·6H2O (8 mg, 0.02 mmol), to 
yield a white solid. ESI-LCMS (+) m/z 974.2 [M]+. ESI-HRMS (+) calcd for 
[C44H62N6O4P2170Yb]+ 970.3656, found 970.3677. 
The complex [YbL5]Cl (1 eq.) was dissolved in methanol and to this solution was added 
ammonium hexafluorophosphate (5 eq.). The solvent was removed under reduced 
pressure and the resulting white solid was suspended in water (1.5 mL). The 
suspension was centrifuged and the white solid was isolated and dried under vacuum. 
Crystals of the ytterbium complex [YbL5]PF6 were grown by slow diffusion of diethyl 
ether into a solution of methanol and examined by X-ray crystallography: 
C44H62N6O4P2Yb x PF6 x 3 CH3OH, Mr = 1215.07 g/mol, triclinic, space group P-1 (no. 2), 
a = 13.0386(7) Å, b = 13.3379(7) Å, c = 17.3611(9) Å, α = 92.8811(19), β = 
108.9003(18), γ = 96.7856(19), V = 2823.8(3) Å3, Z = 1, T = 120 K, μ(MoKα) = 1.811 mm-
1, Dcalc = 1.429 g/cm3, 62291 reflections measured (4.146° ≤ 2Θ ≤ 60.324°), 16643 
unique (Rint = 0.0471, Rsigma = 0.0556) which were used in all calculations. The final R1 
was 0.0586 (I > 2σ(I)) and wR2 was 0.1430 (all data). 
 [YL5]Cl 
An analogous procedure to that described for the synthesis of [DyL5]Cl was followed 
1,7-(5-tert-butylpyridin-2-yl)methyl-4,10-di{[benzylphosphoryl]methyl}-1,4,7,10-
tetraazacyclododecane (12 mg, 0.015 mmol) and YCl3·6H2O (8 mg, 0.02 mmol), to yield 
a white solid. ESI-LCMS (+) m/z 889.3 [M]+. ESI-HRMS (+) calcd for [C44H62N6O4P2Y]+ 
889.3366, found 889.3381. 31P NMR (243 MHz, CD3OD) δ 34.9;,1H NMR (600 MHz, 
CD3OD) and 13C NMR (151 MHz, CD3OD): 
Carbon Label Shift, ppm (CP coupling) Proton Label Shift, ppm  
py2 155.6   
py3 125.2 py3 7.60 
py4 139.4 py4 8.22 
py5 148.3   
py6 146.1 py6 8.94  
tbu 34.9   
tbu 31.3 tbu 1.39 
c1 51.6 ax 3.84 
eq 2.58 
c2 54.9 ax 4.25 
eq 2.64 
c3 54.1 (14.4) ax 3.64 
eq 2.53 
c4 54.6 ax 3.34 
eq 2.59 
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ap 60.0 ax 5.15 
eq 3.87 
a1 57.4 (97.9) ax 3.06 
eq 2.56 
r1 39.0 (91.7) ax 3.01 
eq 2.87 
ph1i 133.8 (6.9)   
ph1o 130.6 (5.9) ph1o 7.13 
ph1m 129.6 (2) ph1m 7.20 
ph1p 127.7 ph1p 7.17 
[EuL5]Cl 
An analogous procedure to that described for the synthesis of [DyL5]Cl was followed 
using 1,7-(5-tert-butylpyridin-2-yl)methyl-4,10-di{[benzylphosphoryl]methyl}-1,4,7,10-
tetraazacyclododecane (4 mg, 0.005 mmol) and EuCl3·6H2O (3 mg, 0.008 mmol), to 
yield a white solid (2.2 mg, 44%). ESI-LCMS (+) m/z 953.4 [M]+. ESI-HRMS (+) calcd for 
[C44H62N6O4P2151Eu]+ 951.3506, found 951.3516.  
3-tert-Butyl-2,6-dimethylpyridine, 24 
 
Copper(I) cyanide (20 mg) was suspended in THF (150 mL) under argon. The resulting 
suspension was cooled to -78oC before tert-butylmagnesium chloride (27 mL, 2.0 M in 
Et2O, 54 mmol) was added. 3-Bromo-2,6-dimethylpyridine (5.0 g, 26.9 mmol) was 
added and the resulting yellow solution was allowed to warm to room temperature 
and then heated to 50oC stirred for a further 18 h. NH4OH (sat. aq. solution, 20 mL) 
was added dropwise to the resulting red solution. The resulting suspension was 
filtered and the solid was washed with Et2O (3 x 200 mL). The organic layers were 
combined and dried over MgSO4. The solvent was removed under reduced pressure to 
yield an orange liquid that was purified by silica gel column chromatography (100% 
hexane to 5% EtOAc/ hexane) to yield a yellow liquid (2.68 g, 61%). Rf (20% EtOAc/ 
hexane) = 0.43. 1H NMR (700 MHz,CDCl3) δ 7.42 (d, 3J = 8, 1H, H4), 6.80 (d, 3J = 8, 1H, 
H5), 2.63 (s, 3H, C2H3), 2.38 (s, 3H, C6H3), 1.30 (s, 9H, C(CH3)3); 13C NMR (176 MHz, 
CDCl3) δ 155.8 (C2), 154.1 (C6), 139.9 (C3), 134.0 (C4), 120.2 (C5), 34.1 (C(CH3)3), 30.5 
(C(CH3)), 26.1 (C2H3), 23.6 (C6H3); ESI-LCMS (+) m/z 164.8 [M+H]+; ESI-HRMS (+) calcd 
for [C11H18N]+ 164.1439, found 164.1448. 




3-tert-Butyl-2,6-dimethylpyridine (1.08 g, 6.6 mmol) was dissolved in CHCl3 (30 mL) 
and to this was added mCPBA (1.4 g, 8.1 mmol). The resulting solution was stirred for 
18 h at room temperature under argon, before being quenched by Na2SO4 (sat. aq. 
solution, 20 mL). The organic layer was extracted and washed with aqueous NaOH 
solution (2 x 20 mL, 0.5 M), dried over MgSO4 and the solvent removed under reduced 
pressure to yield a pale yellow liquid (1.1 g, 96%). Rf (10% MeOH/ CH2Cl2) = 0.49. 1H 
NMR (600 MHz,CDCl3) δ 7.02 (d, 3J = 8.5, 1H, H4), 6.91 (d, 3J = 8.5, 1H, H5), 2.56 (s, 3H, 
C2H3), 2.34 (s, 3H, C6H3), 1.24 (s, 9H, C(CH3)3); 13C NMR (101 MHz, CDCl3) δ 149.0 (C2), 
145.7 (C6), 143.9 (C3), 122.4 (C4), 121.9 (C5), 34.6 (C(CH3)3), 30.4 (C(CH3)), 18.1 (C6H3), 
17.5 (C2H3); ESI-LCMS (+) m/z 179.9 [M+H]+; ESI-HRMS (+) calcd for [C11H18NO]+ 
180.1388, found 180.1378. 
(6-Methyl-3-tert-butyl-pyridin-2-yl)methanol, 26 
 
3-tert-Butyl-2,6-dimethylpyridin-1-oxide (1.67 g, 9.34 mmol) was dissolved in 
anhydrous DCM (10 mL) and trifluoroacetic anhydride (7 mL, 49.9 mmol) was added. 
The resulting solution was stirred for 18 h at 60°C under an atmosphere of argon. The 
reaction was monitored by 1H NMR spectroscopy, and upon completion the solvent 
was removed under reduced pressure. The resulting yellow oil was stirred in a mixture 
of H2O (10 mL) and EtOH (10 mL) at room temperature for 2 h. The solution was 
concentrated under reduced pressure (ca. 5 mL) and extracted with DCM (3 x 50 mL). 
The organic layers were combined, dried over MgSO4, and the solvent removed under 
reduced pressure. The resulting orange oil was purified by silica gel column 
chromatography (100% CH2Cl2 to 1% MeOH/ CH2Cl2) to yield a yellow oil (1.1 g, 64%). 
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Rf (10% MeOH/ CH2Cl2) = 0.74. 1H NMR (700 MHz, CDCl3) δ 7.54 (d, 3J = 8, 1H, H4), 6.97 
(d, 3J = 8, 1H, H5), 4.80 (s, 2H, CH2OH), 2.46(s, 3H, CH3) 1.30 (s, 9H, C(CH3)3). 13C NMR 
(176 MHz, CDCl3) δ 155.1 (C2), 153.0 (C6), 139.0 (C3), 133.9 (C4), 121.5 (C5), 62.7 
(CH2OH), 34.3 (C(CH3)3), 30.6 (C(CH3)3), 23.3 (CH3). ESI-LCMS (+) m/z 180.3 [M+H]+; ESI-
HRMS (+) calcd for [C11H18NO]+ 180.1388, found 180.1391. 
(6-Methyl-3-tert-butyl-pyridin-2-yl)methyl methanesulfonate, 27 
 
(6-Methyl-3-tert-butyl-pyridin-2-yl)methanol (98 mg, 0.55 mmol) was dissolved in 
anhydrous THF (2 mL) and stirred at 5oC for 10 min, before the addition of NEt3 
(125 µL, 0.9 mmol). Mesyl chloride (47 µL, 0.6 mmol) was added dropwise and the 
resulting solution was allowed to stir at room temperature for 30 min. The solvent was 
removed under reduced pressure and the residue was dissolved in H2O (5 mL) and 
extracted with DCM (3 x 10 mL). The organic layers were combined and dried over 
MgSO4 and the solvent removed under reduced pressure. The resulting orange oil was 
used immediately (133 mg, 94 %). Rf (10% MeOH/ CH2Cl2) = 0.81; 1H NMR (400 MHz, 
CDCl3) δ 7.59 (d, 3J = 8, 1H, H4), 7.00 (d, 3J = 8, 1H, H5), 4.83 (s, 2H, CH2OMs), 3.07 (s, 
3H, SCH3), 2.46 (s, 3H, pyCH3) 1.25 (s, 9H, C(CH3)3). ESI-LCMS (+) m/z 258.9 [M+H]+. ESI-
HRMS (+) calcd for [C12H20NO3S]+ 258.1164, found 258.1139. 




K2CO3 (345 mg, 2.5 mmol) was suspended in anhydrous MeCN (2 mL) and to this 
suspension was added dipicolylamine (430 μL, 2.4 mmol). (6-methyl-3-tert-butyl-
pyridin-2-yl)methyl methanesulfonate (396 mg, 1.54 mmol) was then added dropwise 
as a solution in anhydrous MeCN (3 mL). The resulting solution was heated to 70oC and 
stirred for 18 h before being cooled to room temperature and filtered to remove 
inorganic salts. The resulting orange oil was purified by reverse-phase HPLC (10-100% 
MeCN in H2O over 10 min; tR = 11.1 min) to yield a yellow oil (233 mg, 42%). 1H NMR 
(700 MHz, CDCl3) δ 8.45 (m, 2H, HA), 7.65 (d, 3J = 7.5, 2H, HD), 7.56 (m, 2H, HB), 7.47 (d, 
3J = 8, 1H, H4), 7.04 (m, 2H, HC), 6.86 (d, 3J = 8, 2H, H5), 4.14 (s, 2H, CXH2), 3.98 (s, 4H, 
CYH2), 2.46 (s, 3H, CH3), 1.26 (s, 9H, C(CH3)3). 13C NMR (176 MHz, CDCl3) δ 160.3 (CE), 
156.2 (C2), 154.3 (C6), 148.7 (CA), 141.1 (C3), 136.2 (CB), 134.5 (C4), 123.5 (CD), 121.7 
(CC), 121.0 (C5), 60.3 (CYH2), 58.8 (CXH2), 34.4 (C(CH3)3), 31.4 (C(CH3)3), 23.8 (CH3). ESI-




(6-Methyl-3-tert-butyl-pyridin-2-yl)methanol (540 mg, 3 mmol) was dissolved in CHCl3 
(30 mL) and to this was added mCPBA (650 mg, 3.6 mmol). The resulting solution was 
stirred for 18 h at room temperature under argon, before being quenched by Na2SO4 
(sat. aq. solution, 15 mL). The organic layer was extracted and washed with aqueous 
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NaOH solution (2 x 20 mL, 0.5 M), dried over MgSO4 and the solvent removed under 
reduced pressure to yield a pale yellow liquid (550 mg, 93%). Rf (10% MeOH/ CH2Cl2) = 
0.66. 1H NMR (600 MHz,CDCl3) δ 7.22 (d, 3J = 8.5, 1H, H4), 7.10 (d, 3J = 8.5, 1H, H5), 4.98 
(s, 2H, CH2OH), 2.42 (s, 3H, CH3), 1.34 (s, 9H, C(CH3)3); 13C NMR (101 MHz, CDCl3) δ 
149.8 (C2), 146.5 (C6), 144.4 (C3), 124.4 (C4), 124.0 (C5), 59.5 (CH2OH), 34.7 (C(CH3)3), 
31.4 (C(CH3)), 17.6 (CH3); ESI-LCMS (+) m/z 196.2 [M+H]+; ESI-HRMS (+) calcd for 
[C11H18NO2]+ 196.1338, found 196.1337. 
2-([Methanesulfonyloxy]methyl)- 6-methyl-3-tert-butyl-pyridin-1-oxide, 30 
 
2-(Hydroxymethyl)-6-methyl-3-tert-butyl-pyridin-1-oxide (200 mg, 1 mmol) was 
dissolved in anhydrous THF (2 mL) and stirred at 5oC for 10 min, before the addition of 
N,N-diisopropylethylamine (350 µL, 1.5 mmol). Methanesulfonic anhydride (260 mg, 
2 mmol) was added and the resulting solution was allowed to stir at room temperature 
for 30 min. The solvent was removed under reduced pressure and the residue was 
dissolved in H2O (5 mL) and extracted with DCM (3 x 10 mL). The organic layers were 
combined and dried over MgSO4 and the solvent removed under reduced pressure. 
The resulting orange oil was used immediately (133 mg, 94 %). Rf (10% MeOH/ CH2Cl2) 
= 0.81; 1H NMR (400 MHz, CDCl3) δ 7.26 (s, 1H, H4), 7.21 (s, 1H, H5), 5.67 (s, 2H, 
CH2OMs), 3.31 (s, 3H, SCH3), 2.46 (s, 3H, pyCH3) 1.42 (s, 9H, C(CH3)3). ESI-LCMS (+) m/z 
274.4 [M+H]+; ESI-HRMS (+) calcd for [C12H20NO4S]+ 274.1113, found 274.1117. 




K2CO3 (305 mg, 2.2 mmol) was suspended in anhydrous MeCN (1 mL) and to this 
suspension was added dipicolylamine (360 μL, 2 mmol). 2-
([Methanesulfonyloxy]methyl)- 2-([methanesulfonyloxy]methyl)- 6-methyl-3-tert-
butyl-pyridin-1-oxide(438 mg, 1.6 mmol) was then added dropwise as a solution in 
anhydrous MeCN (2 mL). The resulting solution was heated to 70oC and stirred for 18 h 
before being cooled to room temperature and filtered to remove inorganic salts. The 
solvent was removed under reduced pressure and the resulting orange oil was purified 
by reverse-phase HPLC (10-100% MeCN in H2O over 10 min; tR = 10.0 min) to yield a 
yellow oil (245 mg, 41%). 1H NMR (700 MHz, CDCl3) δ 8.38 (d, 3J = 5, 2H, HA), 7.56 – 
7.47 (m, 4H, HD, HB), 7.04 (d, 3J = 8.5, 1H, H4), 6.98 (ddd, 3J = 7, 3J = 5, 4J = 1.5, 2H, HC), 
6.95 (d, 3J = 8.5, 2H, H5), 4.40 (s, 2H, CXH2), 3.88 (s, 4H, CYH2), 2.36 (s, 3H, CH3), 1.29 (s, 
9H, C(CH3)3). 13C NMR (176 MHz, CDCl3) δ 160.1 (CE), 148.7 (CA), 148.6 (C2), 146.7 (C3), 
146.3 (C6), 136.1 (CB), 123.8 (C5), 123.1 (CD), 122.6 (C4), 121.6 (CC), 60.1 (CYH2), 50.7 
(CXH2), 35.5 (C(CH3)3), 31.7 (C(CH3)3), 18.5 (CH3). ESI-LCMS (+) m/z 377.3 [M+H]+; ESI-
HRMS (+) calcd for [C23H29N4O]+ 377.2341, found 377.2333. 
6-(Methoxycarbonyl)-3-tert-butylpyridine-2-carboxylic acid, 32 
 
3-tert-Butyl-2,6-dimethylpyridine (3 g, 18.4 mmol) was added to H2O (150 mL) and the 
two immiscible layers were stirred at 95°C for 10 min. KMnO4 (14.5 g, 92 mmol) was 
added and the reaction was stirred at 95°C for 18 h. The resulting suspension was 
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allowed to cool to room temperature and filtered over celite. The solvent was 
removed under reduced pressure to yield an off white solid that was used without 
further purification (LCMS (+) m/z 223.9 [M+H]-; ESI-HRMS (+) calcd for [C11H14NO4]+ 
224.0923, found 224.0928). The salt was suspended in anhydrous MeOH (40 mL) and 
the suspension was cooled to 0°C. Thionyl chloride (13 mL, 180 mmol) was added 
dropwise and the reaction was heated at 65°C for 18 h, after which the solvent was 
removed under reduced pressure. The resulting yellow oil was purified by silica gel 
column chromatography (100% CH2Cl2 to 5% MeOH/ CH2Cl2) to yield a yellow viscous 
oil  (1.53 g, 35%). Rf (5% MeOH/ CH2Cl2) = 0.16; 1H NMR (700 MHz, CDCl3) δ 8.04 (d, 
3J = 8.5, 1H, H5), 7.97 (d, 3J = 8.5, 1H, H4), 3.93 (s, 3 H, CO2CH3), 1.41 (s, 9H, C(CH3)3); 13C 
NMR (176 MHz, CDCl3) δ 169.1 (CO2H), 164.9 (CO2CH3), 150.1 (C2), 148.2 (C3), 143.4 
(C6), 137.2 (C4), 125.8 (C5), 53.0 (OCH3), 35.2 (C(CH3)3), 30.6 (C(CH3)); ESI-LCMS (+) m/z 
238.4 [M+H]+; ESI-HRMS (+) calcd for [C12H16NO4]+ 238.1079, found 238.1070. 
Dimethyl 3-tert-butyl-2,6-pyridinecarboxylate was also isolated from the column as a 
yellow oil (1.07 g, 23%). Rf (5% MeOH/ CH2Cl2) = 0.89; ESI-LCMS (+) m/z 252.0 [M+H]+. 
Dimethyl 3-tert-butyl-2,6-pyridinecarboxylate, 33 
 
6-(Methoxycarbonyl)-3-tert-butylpyridine-2-carboxylic acid (2.7 g, 11.4 mmol) was 
dissolved in a solution of anhydrous DCM (20 mL) and anhydrous MeOH (1 mL) and 
stirred at 0oC under argon. DCC (3.76 g, 19.38 mmol) and DMAP (280 mg, 2.28 mmol) 
were added and the reaction mixture was allowed to warm to room temperature. The 
solution was stirred for 18h. The solvent was removed under reduced pressure and the 
resulting yellow oil was dissolved in CH2Cl2 (20 mL) and washed with H2O (3 x 10 mL). 
The aqueous layer was extracted with CH2Cl2 (2 x 20 mL). The organic layers were 
combined, dried over MgSO4 and the solvent removed under reduced pressure. The 
resulting yellow oil was purified by silica gel column chromatography (100% CH2Cl2 to 
1% MeOH/ CH2Cl2) to yield a pale yellow oil (1.78 g, 62%). Rf (5% MeOH/ CH2Cl2) = 
0.87; 1H NMR (700 MHz, CDCl3) δ 8.10 (d, 3J = 8.5, 1H, H5), 7.96 (d, 3J = 8.5, 1H, H4), 3.97 
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(s, 6H, OCH3), 1.41 (s, 9H, C(CH3)3); 13C NMR (176 MHz, CDCl3) δ 168.8 (C2O2CH3), 165.3 
(C6O2CH3), 150.7 (C2), 146.9 (C3), 144.8 (C6), 136.6 (C4), 125.8 (C5), 53.1 (OCH3), 53.0 
(OCH3), 35.1 (C(CH3)3), 30.9 (C(CH3)); ESI-LCMS (+) m/z 252.0 [M+H]+; ESI-HRMS (+) 
calcd for [C13H18NO4]+ 252.1236, found 252.1227. 
Methyl 6-hydroxymethyl-3-tert-butyl-2-pyridinecarboxylate, 34 
 
Dimethyl 3-tert-butyl-2,6-pyridinecarboxylate (500 mg, 1.98 mmol) was dissolved in a 
solution of anhydrous DCM (2 mL) and  anhydrous MeOH (2 mL) and stirred at 0oC. 
NaBH4 (166 mg, 4.4 mmol) was added and the reaction was stirred at 0oC for 30 min 
after which it was allowed to warm to room temperature and stirred for a further 1 h. 
The solution was cooled to 0oC before the addition of DCM (2 mL) and dilute HCl (2 mL, 
1 M) to quench the reaction. The mixture was washed with water (5 mL) and the 
organic layer was dried with MgSO4 before the solvent was removed under reduced 
pressure. The resulting yellow oil was purified by silica gel column chromatography 
(100% CH2Cl2 to 2% MeOH/ CH2Cl2) to yield a pale yellow oil (424 mg, 96%). Rf (5% 
MeOH/ CH2Cl2) = 0.47; 1H NMR (700 MHz, CDCl3) δ 7.78 (d, 3J = 8.5, 1H, H4), 7.29 (d, 
3J = 8.5, 1H, H5), 4.69 (s, 2H, CH2OH), 3.91 (s, 3 H, CO2CH3), 1.34 (s, 9H, C(CH3)3); 13C 
NMR (176 MHz, CDCl3) δ 169.7 (CO2CH3), 156.3 (C6), 149.0 (C2), 141.2 (C3), 136.3 (C4), 
121.3 (C5), 64.0 (CH2OH), 52.7 (OCH3), 34.3 (C(CH3)3), 31.0 (C(CH3)); ESI-LCMS (+) m/z 
223.8 [M+H]+; ESI-HRMS (+) calcd for [C12H18NO3]+ 224.1287, found 224.1266. 
Methyl 3-tert-butyl-6-(tetrahydropyran-2-yloxymethyl)-2-pyridinecarboxylate, 35 
 
Methyl 6-hydroxymethyl-3-tert-butyl-2-pyridinecarboxylate (840 mg, 3.8 mmol) was 
dissolved in anhydrous DCM (6 mL) and stirred at 0oC. 3,4-dihydro-2H-pyran (700 μL, 
Chapter 6: Experimental Methods 
235 
7.6 mmol) and a catalytic amount of p-TsOH (10 mg, 0.04 mmol) was then added. The 
reaction was allowed to warm to room temperature and stirred for 72 h and then 
washed with NaHCO3 (sat. aq. solution, 2 x 10 mL). The organic layer was dried over 
MgSO4. The solvent removed was under reduced pressure and the resulting yellow oil 
was purified by silica gel column chromatography (100% CH2Cl2 to 1% MeOH/ CH2Cl2) 
to yield a yellow oil (1.09 g, 93 %). Rf (5% MeOH/ CH2Cl2) = 0.61; 1H NMR (700 MHz, 
CDCl3) δ 7.76 (d, 3J = 8.5, 1H, H4), 7.45 (d, 3J = 8.5, 1H, H5), 4.79 (m, 1H, CH2OTHP), 4.67 
(m, 1H, HE), 4.55 (m, 1H, CH2OTHP), 3.88 (s, 3H, CO2CH3), 3.80 (m, 1H, HA), 3.46 (m, 1H, 
HA), 1.88 – 1.40 (m, 6H, HB, HC, HD), 1.31 (s, 9H, C(CH3)3); 13C NMR (176 MHz, CDCl3) δ 
169.6 (CO2CH3), 155.5 (C6), 149.3 (C2), 140.9 (C3), 135.9 (C4), 121.9 (C5), 98.3 (CE), 69.1 
(CH2OTHP), 62.1 (CA), 52.6 (OCH3), 34.2 (C(CH3)3), 30.9 (C(CH3)), 30.5 (CD), 25.4 (Cb), 
19.3 (CC); ESI-LCMS (+) m/z 307.9 [M+H]+; ESI-HRMS (+) calcd for [C17H26NO4]+ 
308.1862, found 308.1865. 
(3-tert-Butyl-6-(tetrahydropyran-2-yloxymethyl)-pyridin-2-yl) methanol, 36 
 
Methyl 3-tert-butyl-6-(tetrahydropyran-2-yloxymethyl)-2-pyridinecarboxylate (890 mg, 
2.9 mmol) was dissolved in anhydrous THF (5 mL). The solution was cooled to 0oC and 
LiAlH4 (2M in THF) (3 mL, 6 mmol) added dropwise. The reaction was stirred at 0oC for 
3 h and then diluted with EtOAc (10 mL) and quenched by the addition of water 
(0.5 mL) and aqueous NaOH solution (0.5 mL, 2.5 M). The mixture was then filtered 
and extracted with EtOAc (2 x 50 mL), the organic layers were combined and dried 
over MgSO4. The solvent removed was removed under reduced pressure and the 
resulting yellow oil was purified by silica gel column chromatography (100% CH2Cl2 to 
2% MeOH/ CH2Cl2) to yield a yellow liquid (780 mg, 96 %). Rf (5% MeOH/ CH2Cl2) = 
0.44; 1H NMR (600 MHz, CDCl3) δ 7.64 (d, 3J = 8, 1H, H4), 7.26 (d, 3J = 8, 1H, H5), 4.79 (d, 
2J = 13.5, 1H, CH2OTHP), 4.79 (s, 2H, CH2OH), 4.70 (t, 3J = 3.5, 1H, HE), 4.55 (d, 2J = 13.5, 
1H, CH2OTHP), 3.84 (m, 1H, HA), 3.48 (m, 1H, HA), 1.83 – 1.78 (m, 1H, HC), 1.71 – 1.60 
(m, 2H, HD), 1.54 – 1.43 (m, 3H, HB, HC), 1.29 (s, 9H, C(CH3)3); 13C NMR (151 MHz, CDCl3) 
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δ 155.3 (C2), 153.3 (C6), 140.7 (C3), 135.1 (C4), 119.8 (C5), 98.3 (CE), 69.1 (CH2OTHP), 
62.7 (CH2OH), 62.1 (CA), 34.4 (C(CH3)3), 30.5 (CD), 30.4 (C(CH3)), 25.4 (Cb), 19.3 (CC); ESI-






(3-tert-Butyl-6-(tetrahydropyran-2-yloxymethyl)-pyridin-2yl) methanol (150 mg, 
0.53 mmol) was dissolved in anhydrous THF (2 mL) and stirred at 5oC for 10 min, 
before the addition of NEt3 (125 µL, 0.9 mmol). Mesyl chloride (47 µL, 0.6 mmol) was 
added dropwise and the resulting solution was allowed to stir at room temperature for 
30 min. The solvent was removed under reduced pressure and the residue was 
dissolved in H2O (5 mL) and extracted with DCM (3 x 10 mL). The organic layers were 
combined and dried over MgSO4 and the solvent removed under reduced pressure. 
The resulting yellow oil was used immediately (180 mg, 95 %). 1H NMR (400 MHz, 
CDCl3) δ 7.73 (d, 3J = 8.5, 1H, H4), 7.35 (d, 3J = 8.5, 1H, H5), 5.50 (s, 2H, CH2OMs), 4.79 
(d, 2J = 13.5, 1H, CH2OTHP), 4.70 (t, 3J = 3.5, 1H, HE), 4.54 (d, 2J = 13.5, 1H, CH2OTHP), 
3.84 (m, 1H, HA), 3.50 (m, 1H, HA), 3.14 (s, 3H, CH3) 1.88 –1.46 (m, 3H, HB, HC, HD), 
1.38 (s, 9H, C(CH3)3); ESI-LCMS (+) m/z 358.3 [M+H]+; ESI-HRMS (+) calcd for 
[C17H28NO5S]+ 358.1702, found 358.1699. 





K2CO3 (207 mg, 1.5 mmol) was suspended in anhydrous MeCN (1 mL) and to this 
suspension was added dipicolylamine (270 μL, 1.5 mmol). 2-
([Methanesulfonyloxy]methyl)- 2-([methanesulfonyloxy]methyl)- 6-methyl-3-tert-
butyl-pyridin-1-oxide(445 mg, 1.25 mmol) was then added dropwise as a solution in 
anhydrous MeCN (2 mL). The resulting solution was heated to 70oC and stirred for 18 h 
before being cooled to room temperature and filtered to remove inorganic salts. The 
solvent was removed under reduced pressure and the resulting orange oil was purified 
by alumina gel column chromatography (100% CH2Cl2 to 1% MeOH/ CH2Cl2) to yield a 
pale orange oil (437 mg, 76%). Rf (2% MeOH/ CH2Cl2) = 0.48; 1H NMR (700 MHz, CDCl3) 
δ 8.43 (d, 3J = 6.5, 2H, HA1), 7.67 (d, 3J = 8, 2H, HD1), 7.59 (d, 3J = 8, 1H, H4), 7.55 (m, 2H, 
HB1), 7.19 (d, 3J = 8, 1H, H5), 7.07 (m, 2H, HC1), 4.85 (d, 2J = 13.5, 1H, CH2OTHP), 4.74 (t, 
3J = 3.5, 1H, HE), 4.60 (d, 2J = 13.5, 1H, CH2OTHP), 4.13 (s, 2H, CXH2), 3.98 (s, 4H, CYH2), 
3.88 (m, 1H, HA), 3.50 (m, 1H, HA), 1.83 (m, 1H, HC), 1.71 (m, 1H, HD), 1.64 (m, 1H, HD), 
1.55 (m, 1H, HB), 1.52 – 1.49 (m, 2H, HB, HC), 1.25 (s, 9H, C(CH3)3). 13C NMR (176 MHz, 
CDCl3) δ 160.4 (CE1), 156.5 (C2), 154.7 (C6), 148.7 (CA1), 142.6 (C3), 136.2 (CB1), 134.6 
(C4), 123.4 (CD1), 121.7 (CC1), 119.0 (C5), 98.4 (CE), 69.9 (CH2OTHP), 62.1 (CA), 60.3 
(CYH2), 58.5 (CXH2), 34.5 (C(CH3)3), 31.2 (C(CH3)3), 30.6 (CD), 25.5 (CB), 19.4 (CC); ESI-
LCMS (+) m/z 461.4 [M+H]+; ESI-HRMS (+) calcd for [C28H37N4O2]+ 461.2917, found 
461.2928. 
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(2-(Dipicolylaminomethyl)-3-tert-butyl-pyridin-6-yl) methanol, 39  
 
2-(Dipicolylaminomethyl)-3-tert-butyl-6-(tetrahydropyran-2-yloxymethyl)pyridine 
(106 mg, 0.23 mmol) was dissolved in MeOH (3 mL) and to this was added 
p-toluenesulfonic acid monohydrate (66 mg, 0.35 mmol). The resulting solution was 
stirred at 50°C for 18 h. The reaction was quenched with saturated aqueous NaHCO3 
(5 mL) and the solution concentrated under reduced pressure (ca. 4 mL). The resulting 
mixture was extracted with EtOAc (2 x 10 mL). The organic layers were combined, 
dried over MgSO4 and the solvent removed under reduced pressure to yield a yellow 
oil (79 mg, 91%). 1H NMR (600 MHz, CDCl3) δ 8.45 (d, 3J = 5, 2H, HA), 7.62 – 7.56 (m, 5H, 
HD, H4, HB), 7.07 (ddd, 3J = 7, 3J = 5, 4J = 2, 2H, HC), 6.97 (d, 3J = 8, 2H, H5), 4.65 (s, 2H, 
CH2OH), 4.15 (s, 2H, CXH2), 3.95 (s, 4H, CYH2), 1.30 (s, 9H, C(CH3)3). 13C NMR (151 MHz, 
CDCl3) δ 159.9 (CE), 155.8 (C2), 155.1 (C6), 148.9 (CA), 142.8 (C3), 136.5 (CB), 135.0 (C4), 
123.2 (CD), 123.0 (CC), 118.2 (C5), 63.6 (CH2OH), 60.5 (CYH2), 58.6 (CXH2), 34.6 (C(CH3)3), 
31.3 (C(CH3)3); ESI-LCMS (+) m/z 376.9 [M+H]+; ESI-HRMS (+) calcd for [C23H29N4O]+ 
377.2341, found 377.2353. 
(2-(Dipicolylaminomethyl)-3-tert-butyl-pyridin-6-yl) methyl methanesulfonate, 40 
 
(2-(Dipicolylaminomethyl)-3-tert-butyl-pyridin-6-yl) methanol (79 mg, 0.21 mmol) was 
dissolved in anhydrous THF (3 mL) and stirred at 5oC for 10 min, before the addition of 
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NEt3 (56 µL, 0.4 mmol). Mesyl chloride (19 µL, 0.24 mmol) was added dropwise and the 
resulting solution was allowed to stir at room temperature for 30 min. The solvent was 
removed under reduced pressure and the residue was dissolved in H2O (5 mL) and 
extracted with DCM (3 x 10 mL). The organic layers were combined and dried over 
MgSO4 and the solvent removed under reduced pressure. The resulting yellow oil was 
used immediately (88 mg, 92 %). 1H NMR (400 MHz, CDCl3) δ 8.46 (d, 3J = 5, 2H, HA), 
7.69 – 7.64 (m, 3H, H4, HD), 7.61 (td, 3J = 7.5, 4J = 2, 2H, HB), 7.21 (d, 3J = 8, 2H, H5), 
7.07 (m, 2H, HC), 5.35 (s, 2H, CH2OMs), 4.18 (s, 2H, CXH2), 3.99 (s, 4H, CYH2), 3.01 (s, 3H, 
CH3), 1.29 (s, 9H, C(CH3)3); ESI-LCMS (+) m/z 455.3 [M+H]+; ESI-HRMS (+) calcd for 
[C24H31N4O3S]+ 455.2117, found 455.2116. 
1,4,7-Tri{[ethoxy(methyl)phosphoryl]methyl}-10-(2-(dipicolylaminomethyl)-3-tert-
butyl-pyridin-6-yl) methyl-1,4,7,10-tetraazacyclododecane, L6 
 
1,4,7-Tri{[ethoxy(methyl)phosphoryl]methyl}-1,4,7,10-tetraazacyclododecane (113 mg, 
0.21 mmol) was dissolved in anhydrous MeCN (1 mL) and to this was added Cs2CO3 
(82 mg, 0.25 mmol). (2-(Dipicolylaminomethyl)-3-tert-butyl-pyridin-6-yl) methyl 
methanesulfonate (88 mg, 0.19 mmol) was then added dropwise as a solution in 
anhydrous MeCN (2 mL). The resulting solution was heated to 70oC and stirred for 18 h 
before being cooled to room temperature and filtered to remove inorganic salts. The 
solvent was removed under reduced pressure and the resulting oil was purified by 
alumina gel column chromatography, (100% CH2Cl2 to 2% MeOH/ CH2Cl2) to yield an 
orange oil (64 mg, 38%). Rf (5% MeOH/ CH2Cl2) = 0.40 1H NMR (400 MHz, CDCl3) δ 8.50 
(d, 3J = 5, 2H, HA), 7.70 (d, 3J = 8, 1H, H4), 7.66 – 7.62 (d, 3J = 7.5, 2H, HB), 7.47 (d, 3J = 8, 
2H, HD),  7.19 – 7.13 (m, 2H, HC), 7.07 (d, 3J = 8, 1H, H5), 4.68 – 4.17 (m, 8H, NCH2py), 
4.13 – 3.94 (m, 6H, OCH2CH3), 3.68 – 2.62 (m, 22H, cyclen CH2, NCH2P), 1.57 – 1.41 (m, 
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9H, PCH3), 1.30 (s, 9H, C(CH3)3), 1.28 – 1.18 (m, 9H, OCH2CH3); 31P NMR δ (162 MHz) δ 
52.6 – 50.0 (br m);  ESI-LCMS (+) m/z 891.6 [M+H]+; ESI-HRMS (+) calcd for 
[C43H74N8O6P3]+ 891.4944, found 891.4968. 
1,4,7-Tris(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane, 41 
 
Tert-butyl bromoacetate (2.3 mL, 15.7 mL) was added to a stirred solution of 
1,4,7,10-tetraazacyclododecane (1.00 g, 5.8 mmol) and NaHCO3 (1.30 g, 14.5 mmol) in 
anhydrous MeCN (40 mL). The resulting mixture was stirred at room temperature for 
18 h under argon before the inorganic salts were removed by filtration and the solvent 
was removed under reduced pressure. The resulting white residue was dissolved in the 
minimal amount of DCM and upon addition of Et2O a white solid precipitated out of 
solution (1.46 g, 49%). 1H NMR (600 MHz, CDCl3) δ 3.36 (s, 4H, CH2), 3.28 (s, 2H, CH2), 
3.08 (s, 4H, cyclen CH2), 3.68 – 2.62 (m, 12H, cyclen CH2), 1.44 (s, 18H, C(CH3)3), 1.44 (s, 
9H, C(CH3)3); ESI-LCMS (+) m/z 515.9 [M+H]+; ). 13C NMR (151 MHz, CDCl3) δ 170.6 (CO), 
169.7 (CO), 82.0 (C(CH3)3), 81.8 (C(CH3)3), 51.5 (cyclen CH2), 49.4 (cyclen CH2), 47.6 
(cyclen CH2), 28.4 (C(CH3)3), 28.3 (C(CH3)3); ESI-HRMS (+) calcd for [C26H51N5O6]+ 
515.3809, found 515.3809. 
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1,4,7-Tris(tert-butoxycarbonylmethyl)-10-(2-(dipicolylaminomethyl)-3-tert-butyl-
pyridin-6-yl) methyl-1,4,7,10-tetraazacyclododecane, L7 
 
1,4,7-Tris(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane (463 mg, 
0.9 mmol) was dissolved in anhydrous MeCN (1 mL) and to this was added Cs2CO3 
(359 mg, 1.1 mmol). (2-(Dipicolylaminomethyl)-3-tert-butyl-pyridin-6-yl) methyl 
methanesulfonate (346 mg, 0.83 mmol) was then added dropwise as a solution in 
anhydrous MeCN (2 mL). The resulting solution was heated to 70oC and stirred for 18 h 
before being cooled to room temperature and filtered to remove inorganic salts. The 
solvent was removed under reduced pressure and the resulting oil was purified by 
alumina gel column chromatography (100% CH2Cl2 to 2% MeOH/ CH2Cl2) to yield an 
orange oil (450 mg, 62%). Rf (10% MeOH/ CH2Cl2) = 0.56; 1H NMR (700 MHz, CDCl3) δ 
8.54 (d, 3J = 5, 2H, HA), 7.95 (d, 3J = 8.5, 1H, H4), 7.89 (m, 3J = 8, 4J = 2, 2H, HB), 7.70 (d, 
3J = 8.5, 1H, H5), 7.53 (d, 3J = 8, 2H, HD),  7.46 – 7.42 (m, 2H, HC), 4.86 (s, 2H, NCH2py), 
4.65 (s, 4H, NCH2py), 3.98 (s, 2H, NCH2py), 3.56 – 2.79 (m, 22H, cyclen CH2, NCH2CO2H), 
1.32 (s, 9H, C(CH3)3); ESI-LCMS (+) m/z 873.0 [M+H]+; ESI-HRMS (+) calcd for 
[C54H77N6O4]+ 873.6006, found 873.5986.  
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Dysprosium (III) complex of 1,4,7-tris(acetic acid)-10-(2-(dipicolylaminomethyl)-3-
tert-butyl-pyridin-6-yl) methyl-1,4,7,10-tetraazacyclododecane, [DyL7] 
 
1,4,7-Tris(tert-butoxycarbonylmethyl)-10-(2-(dipicolylaminomethyl)-3-tert-butyl-
pyridin-6-yl) methyl-1,4,7,10-tetraazacyclododecane (54 mg, 0.06 mmol) was dissolved 
in DCM (1 mL) and to this was added TFA (1 mL). The resulting solution was stirred at 
room temperature for 18 h. Complete ester cleavage was confirmed by ESI-MS (+) 
(LR: m/z 705.5 [M+H]+). The solvent was removed under reduced pressure and the 
resulting residue was dissolved in H2O (2 mL) and DyCl3·6H2O (34 mg, 0.09 mmol) was 
added. The pH of the resulting solution was adjusted to 5.5 using aqueous NaOH 
solution (2.5 M) and the reaction was stirred at 70oC for 18 h before the solvent was 
removed under reduced pressure. The resulting yellow solid was purified by reverse-
phase HPLC (10-100% MeCN in H2O over 10 min; tR = 8.0 min) to yield a glassy white 
solid (29 mg, 56%). ESI-LCMS (+) m/z 865.5 [M+H]+; ESI-HRMS (+) calcd for 
[C37H50N8O6160Dy]+ 862.3105, found 862.3134. 
Crystals of the dysprosium complex were grown by slow diffusion of diethyl ether into 
a solution of methanol and examined by X-ray crystallography: C37H49DyN8O6 x 2 
CH3OH, Mr = 928.42 g/mol, monoclinic, space group P21/n (no. 2), a = 8.8025(5) Å, b = 
14.0452(8) Å, c = 32.4607(18) Å, α = 90, β = 96.282(2), γ = 90, V = 3989.1(4) Å3, Z = 4, T 
= 120 K, μ(MoKα) = 1.935 mm-1, Dcalc = 1.546 g/cm3, 56391 reflections measured 
(4.688° ≤ 2Θ ≤ 58.998°), 11107 unique (Rint = 0.0607, Rsigma = 0.0577) which were used 
in all calculations. The final R1 was 0.0674 (I > 2σ(I)) and wR2 was 0.0855 (all data). 
[TmL7] 
An analogous procedure to that described for the synthesis of [DyL7] was followed 
using 1,4,7-tris(acetic acid)-10-(2-(dipicolylaminomethyl)-3-tert-butyl-pyridin-6-yl) 
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methyl-1,4,7,10-tetraazacyclododecane  (6 mg, 0.009 mmol) and TmCl3·6H2O (6 mg, 
0.016 mmol), to yield a white solid (5 mg, 68%). ESI-LCMS (+) m/z 871.3 [M+H]+; ESI-
HRMS (+) calcd for [C37H50N8O6169Tm]+ 871.3196, found 871.3220. 
[TbL7] 
An analogous procedure to that described for the synthesis of [DyL7] was followed 
using 1,4,7-tris(acetic acid)-10-(2-(dipicolylaminomethyl)-3-tert-butyl-pyridin-6-yl) 
methyl-1,4,7,10-tetraazacyclododecane  (54 mg, 0.06 mmol) and TbCl3·6H2O (34 mg, 
0.09 mmol), to yield a white solid (28 mg, 54%). ESI-LCMS (+) m/z 861.3 [M+H]+; ESI-
HRMS (+) calcd for [C37H50N8O6159Tb]+ 861.3107, found 861.3130. 
[EuL7] 
An analogous procedure to that described for the synthesis of [DyL7] was followed 
using 1,4,7-Tris(acetic acid)-10-(2-(dipicolylaminomethyl)-3-tert-butyl-pyridin-6-yl) 
methyl-1,4,7,10-tetraazacyclododecane  (18 mg, 0.02 mmol) and EuCl3·6H2O (18 mg, 
0.05 mmol), to yield a white solid (10 mg, 59%). ESI-LCMS (+) m/z 855.4 [M+H]+; ESI-
HRMS (+) calcd for [C37H50N8O6151Eu]+ 853.3052, found 853.3092.  
[YbL7] 
An analogous procedure to that described for the synthesis of [DyL7] was followed 
using 1,4,7-tris(acetic acid)-10-(2-(dipicolylaminomethyl)-3-tert-butyl-pyridin-6-yl) 
methyl-1,4,7,10-tetraazacyclododecane  (54 mg, 0.06 mmol) and YbCl3·6H2O (27 mg, 
0.09 mmol), to yield a white solid (27 mg, 57%). ESI-LCMS (+) m/z 791.2 [M+H]+; ESI-
HRMS (+) calcd for [C37H50N8O6170Yb]+ 872.3201, found 872.3242. 
[YL7] 
An analogous procedure to that described for the synthesis of [DyL7] was followed 
using 1,4,7-tris(acetic acid)-10-(2-(dipicolylaminomethyl)-3-tert-butyl-pyridin-6-yl) 
methyl-1,4,7,10-tetraazacyclododecane  (54 mg, 0.06 mmol) and YCl3·6H2O (27 mg, 
0.09 mmol), to yield a white solid (27 mg, 57%). ESI-LCMS (+) m/z 791.2 [M+H]+; ESI-
HRMS (+) calcd for [C37H50N8O689Y]+ 791.2912, found 791.2921. 1H NMR (700 MHz, 
D2O) δ 8.60-6.81 (br, m, 6H, HA, HC, HD), 7.94 (d, 3J = 8, 1H, H4), 7.68 (m, 2H, HB), 7.30 
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(d, 3J = 8, 1H, H5), 7.53 (d, 3J = 8, 2H, HD), 4.85 – 3.72 (br, m, 11H, NCH2py, NCH2CO2H) 
3.62 – 2.07 (br, m, 19H, cyclen CH2, NCH2CO2H), 1.25 (s, 9H, C(CH3)3); ESI-LCMS (+) m/z 
873.0 [M+H]+; ESI-HRMS (+) calcd for [C54H77N6O4]+ 873.6006, found 873.5986. 
[Zn2L7]Cl 
 
ZnCl2 (3 eq.) was added to a solution of the yttrium(III) complex of 1,4,7-tris(acetic 
acid)-10-(2-(dipicolylaminomethyl)-3-tert-butyl-pyridin-6-yl)-methyl-1,4,7,10-
tetraazacyclododecane (1 eq.) in D2O (0.5 mL). The resulting solution was centrifuged 
and the white precipitate was isolated and washed with water (2 mL), methanol (2 mL) 
and dichloromethane (5 mL). ESI-LCMS (+) m/z 833.3 [M]+. 
 
Crystals of the di-Zinc complex were grown by slow diffusion of diethyl ether into a 
solution of methanol containing 1 eq. of hexafluorophosphate and examined by X-ray 
crystallography: C37H49N8O6Zn2 x Cl x 6 CH3OH x H2O, Mr = 1078.30 g/mol, monoclinic, 
space group P21/C (no. 14), a = 20.8675(15) Å, b = 15.3507(11) Å, c = 16.1152(12) Å, β 
= 94.545(2), V = 5146.0(6) Å3, Z = 4, T = 120 K, μ(MoKα) = 1.051 mm-1, Dcalc = 1.392 
g/cm3, 77628 reflections measured (4.064° ≤ 2Θ ≤ 50.052°), 9090 unique (Rint = 0.0593, 
Rsigma = 0.0383) which were used in all calculations. The final R1 was 0.0677 (I > 2σ(I)) 
and wR2 was 0.1722 (all data). 
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Comparison of tri- and dibenzylphosphinate complexes 
 








Figure S3   1H NMR spectra of the phosphinate resonances of [LnL5]Cl (CD3OD, 1 T, 300 K). 
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Table S1   Assigned proton chemical shifts of [LnL4] excluding benzyl resonances (CD3OD, 1 T, 
300 K). 
Proton Label [YL4] [YbL4] [TbL4] [DyL4] [ErL4] [TmL4] 
py3 7.45 9.6   -25.9  
py4 8.05      
py6 9.04 144.7 -631.5 -619.0 331.4 570.8 
tbu 1.39 20.2 -82.6 -85.0 44.2 76.0 
c1ax 3.69 -40.8 189.4  -108.3 -146.4 
c1eq 2.5   -46.9  61.6 
c2ax 3.81 52.9 -555.8 -459.1 220.9 405.7 
c2eq 2.59  -106.3 -46.9  93.2 
c3ax 3.56 -18.3 184.0 290.5 -54.8 -223.3 
c3eq 2.43  -158.1 -41.6  93.2 
c4ax 3.85 122.4 -563.6 -619.0 276.8 553.2 
c4eq 2.5 49.8 -240.5 -206.4 87.6 143.1 
c5ax 3.6 38.7  -230.6  -55.0 
c5eq 2.33 56.6 -170.6 -294.4 79.2 146.7 
c6ax 4.27 102.8 -444.1 -541.7 257.9 499.5 
c6eq 2.45 36.3  -141.8  119.5 
c7ax 3.56 -73.0 465.5 489.3 -196.7 -273.7 
c7eq 2.36 -5.7  91.86  35.1 
c8ax 3.21 47.6 -419.2 -318.9 172.6 431.1 
c8eq 2.51   50.8  61.6 
apax 4.72 -57.7 564.3 412.5 -208.0 -402.8 
apeq 3.72   131.2 -93.5 -99.6 
a1ax 3.67 -71.4 222.6 290.5 -133.1 -320.2 
a1eq 2.52   197.1 -61.9 -147.8 
a2ax 4.04 -39.3 498.6 259.5 -144.1 -348.5 
a2eq 2.54 16.3  -52.5  -90.0 
a3ax 2.95 -50.8 298.7 228.4 -124.0 -303.2 
a3eq 2.44   197.1 -82.5 -148.5 
Table S2   Assigned proton chemical shifts of [LnL5]Cl excluding benzyl resonances (CD3OD, 1 T, 
300 K). 
Proton Label [YL5]Cl [YbL5]Cl [TbL5]Cl [DyL5]Cl [ErL5]Cl [TmL5]Cl 
py3 7.60 13.2  -76.6  -54.6 
py4 8.22 14.8  -81.2 14.5 1.6 
py6 8.94 63.5 -565.5 -470.5 225.6 438.1 
tbu 1.39 9.3 -72.1 -66.8 30.0 57.4 
c1ax 3.84 44.1 -414.5 -320.9 179.7 369.6 
c1eq 2.58  -142.4 -54.2 49.2 74.2 
c2ax 4.25 32.5 -406.8 -401.7  -67.9 
c2eq 2.64 25.8 -234.0 -288.2 49.2 74.2 
c3ax 3.64 57.1 -447.3 -401.7 204.2 443.4 
c3eq 2.53 15.5 -117.7 -114.4 41.2 72.3 
c4ax 3.34 -50.7 553.8 553.5 -154.2 -214.0 
c4eq 2.59 -6.4 78.0 99.7 7.5 39.5 
apax 5.15 -27.2 255.0 312.5 -194.9 -353.3 
apeq 3.87 13.74 413.9 -140.2 -34.9 -103.0 
a1ax 3.06 -34.1  333.6 -73.7 -222.4 




Figure S4 Comparison of the observed and ‘best- fit’ PCS values for [LnL4]. Tm: R2 = 0.996; Er: R2 
= 0.994; Dy: R2 = 0.992; Tb: R2 = 0.999. Assignments of selected resonances have been 
highlighted. 
 
Figure S5 Comparison of the observed and ‘best- fit’ PCS values for [LnL5]Cl. Tm: R2 = 0.997; Er: 
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